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A mouse model for the induction of periodontal disease by the
oral inoculation of live Actinomyces viscosus at concentrations of
1.6 x 10^ cfu, 1.6 x 107 cfu and 1.6 x 10^ cfu was first
described in 1981 by Jordan et al. While many of the previous
findings are confirmed, this thesis has extended the model both by
examining the effects produced in eight different mouse genotypes
and by increasing the number of host responses examined.
In all genotypes, bone loss determined from defleshed
hemimandibles was maximal in those animals which had received
inoculations of 1.6 x 107 cfu live Actinomyces viscosus. There
was no apparent relationship between inoculum dose and the number
of organisms recovered. This was interpreted as suggesting that
periodontal destruction occurred as a result of the host response
to the initial inoculum.
A consistent pattern of specific serum anti-Actinomyces
viscosus immunoglobulin A emerged, with peak levels in animals
which had maximum bone loss and which had beem inoculated with
1.6 x 107 cfu Actinomyces viscosus. It was postulated that the
high levels of this immunoglobulin actively sequestered foreign
antigen within the gingival crevice and promoted bone loss, perhaps
in association with osteoclast activating factor. It was further
suggested that the other two inoculum dosages induced low and high
zone tolerance respectively, which could account for the low level
of periodontal destruction and the low immunoglobulin response
in these inoculum groups.
(ii)
Cellular immunity studies including macrophage suppression
tests were undertaken but the results were not detailed enough to
)
either confirm or refute the hypotheses generated by the bone loss
and immunoglobulin findings.
Polymorph studies showed a negative correlation between
myeloperoxidase activity and the ratio of 1.6 x 10^ cfu-induced
bone loss to the control, and a positive correlation between
chemiluminescence and this ratio over all genotypes. These results
suggest that myeloperoxidase activity is essentially protective,
whereas overall polymorph function is essentially destructive.
Histological findings were inconclusive but further
investigation is already underway.
Preliminary attempts at immunisation revealed that intravenous
inoculation of live Actinomyces viscosus conferred protection
against bone loss normally induced by oral inoculation of 1.6 x
10^ cfu.
The study has highlighted the value of immunological mutants
in disclosing components of the immune system of importance in
induced periodontal disease in the mouse, and has posed a number of
questions that could form the basis of future work.
(iii)
DECLARATION
I declare that this thesis has been composed by myself and




This thesis would not have been possible without the help and
support given by the following people whom I now gratefully
acknowledge. Professor J C Southam who, as head of department,
provided laboratory facilities; Dr David Wray who willingly
spent many hours of his own time both teaching laboratory
techniques and discussing results; the staff of the Faculty
Animal Area who were, without exception, patient and informative;
Mr Ronnie Sutherland for his advice and humour while the polymorph
studies were undertaken; Mr Bob Brown who gave a number of hours
of enjoyable practical bacteriological instruction; Mrs Dawn
McKinnon and Mrs Lin Christie for their considerable efforts with
the histological work; Mr John Mitchell and Mrs Jan Ramsay, whose
humorous encouragement was often truly invaluable; Messrs Ian
Goddard and Robert Renton for their photographic skills; and, of
course, Mrs Carolyn Forsyth, who has proved more than helpful in
her professional approach to all the problems of typing.
I reserve final and particular thanks for my supervisor, Dr
Jeffrey Sofaer, who spent many painstaking hours of meticulous
work on this thesis. His unstinting advice and expertise are
deeply appreciated.
(v)
"Where there is much desire to learn, there of necessity will
be much arguing, much writing, many opinions: for opinion in good




CHAPTER 1 - INTRODUCTION Page
1.1 HUMAN PERIODONTAL DISEASE 2
1.1.1 CONTRIBUTION TO DENTAL ILL HEALTH 2
1.1.2 DIAGNOSTIC METHODS 3
1.1.2.1 Gingival inflammation 3
1.1.2.2 Pocket depth 4
1.1.2.3 Bone loss 6
1.1.2.4 Crevicular fluid flow and
composition 8
1.1.2.5 Conclusions 10
1.1.3 TYPES OF PERIODONTITIS 10
1.1.3.1 Prepubertal periodontitis 10
1.1.3.2 Juvenile periodontitis 12
1.1.3.3 Adult periodontitis 15
1.1.3.4 Acute periodontitis 16
1.1.3.5 Other types of periodontitis 16
1.1.4 PERIODONTAL PATHOGENS 17
1.1.4.1 Organisation of subgingival plaque 17
1.1.4.2 Pathogenic mechanisms 18
1.1.4.3 Microbial floras associated with
periodontal health and disease 19
1.1.4.4 Effects of sampling 24
1.1.4.5 Conclusions 24
1.1.5 HOST DEFENCE SYSTEM ' 25
1.1.6 CONCLUDING REMARKS 26
1.2 PERIODONTAL DISEASE IN
EXPERIMENTAL ANIMALS 28
1.2.1 SIZE AND TIME 28
1.2.2 MICE AS EXPERIMENTAL ANIMALS 29
1.2.3 PHYSIOLOGICAL CHANGES IN MICE 32
(vii)
CHAPTER 1 - INTRODUCTION (Ccratd) Page
1.2.4 PERIODONTAL DISEASE IN MICE 33
1.2.4.1 Spontaneous periodontal disease
in the wild 33
1.2.4.2 Importance of age 33
1.2.4.3 Variation in susceptibility between
strains 34
1.2.4.4 Sublethal X-irradiation 36
1.2.4.5 Histological features 36
1.2.5 BACTERIAL INVOLVEMENT IN MURINE PERIODONTAL
DISEASE 37
1.2.5.1 Bone loss in germ-free mice 37
1.2.5.2 Implantation of bacteria into the
mouths of germ-free mice 38
1.2.5.3 Effect of chlorhexidine 38
1.2.5.4 Induction of bone loss by Actinomyces
viscosus 39
1.2.6 CONCLUDING REMARKS 41
1.3 OBJECTIVES OF THE STUDY 42
CHAPTER 2 - MATERIALS, GENERAL METHODS AND
PRELIMINARY EXPERIMENTS
2.1 M I C E 46




2.1.2.3 X-linked immune deficiency 54
2.1.3 MAINTENANCE AND CROSSES 56
2.1.4 SUSCEPTIBILITY TO BACTERIAL PATHOGENS 57
(viii)









2.2.3.1 Source and stock 64
2.2.3.2 Culture 64
2.2.3.3 Identification 66
2.2.3.4 Comparison of A. viscosus recovery
from blood agar and semi-selective agar 69
2.2.3.5 Preparation of an EDTA antigen extract
from A. viscosus 71
2.2.3.6 SDS PAGE of EDTA A. viscosus extract 71
2.3 PRELIMINARY EXPERIMENT 74
2.3.1 INTRODUCTION 74
2.3.2 MATERIALS AND METHODS 74
2.3.3 RESULTS 77
2.3.4 DISCUSSION 77
2.4 MAIN EXPERIMENTAL SCHEDULE 81
2.5 STATISTICAL ANALYSIS 84
(ix)
CHAPTER 3 - BONE LOSS Page
3.1 PREVIOUS METHODS OF
ASSESSMENT 86
3.2 METHOD OF ASSESSMENT USED
INPRESENTSTUDY 89
3.3 NATURALLY OCCURRING BONE
LOSS 91
3.4 INDUCED BONE LOSS 94
3.4.1 SIX WEEKS AFTER INOCULATION 94
3.4.2 TWELVE WEEKS AFTER INOCULATION 95
3.4.2.1 Special diet alone 97
3.4.2.2 Inbred strains 98
3.4.2.3 Beige 101
3.4.2.4 Obese 106
3.4.2.5 X-linked immune deficiency 109
3.4.3 DISCUSSION 112
CHAPTER 4 - HISTOLOGY
4.1 I N T R 0 D U C T I 0 N 121
4.2 MATERIALS AND METHODS 124
4.3 R E S U L T S 125
4.4 DISCUSSION 136
(x)
CHAPTER 5 - RECOVERY OF A. VISCOSUS Page
5.1 I N T R 0 D U C T I 0 N 138
5.2 MATERIALS AND METHODS 138
5.3 R E S U L T S 138
5.4 D I S C U S S I 0 N 142
CHAPTER 6 - POLYMORPHS
6.1 INTRODUCTION 145
6.1.1 ORAL POLYMORPHS 146
6.1.2 PROTECTIVE ROLE 149
a
6.1.3 DESTRUCTIVE ROLE 152
6.1.4 POLYMORPH FUNCTION 154
6.1.5 SCOPE OF PRESENT STUDY 157
6.2 MATERIALS AND METHODS 158
6.2.1 POLYMORPHS 158
6.2.2 MYELOPEROXIDASE ASSAY 159
6.2.3 CHEMILUMINESCENCE ASSAY 160
(xi)
CHAPTER 6 - POLYMORPHS (Contd) Page
6.3 R E S U L T S 162
6.3.1 POLYMORPH FUNCTION TESTS 162
6.3.2 POLYMORPH FUNCTION AND BONE LOSS 168
6.4 D I S C U S S I 0 N 174
6.4.1 DIFFERENCES BETWEEN GENOTYPES 174
6.4.2 DIFFERENCES BETWEEN STIMULANTS AND ENHANCERS 176
6.4.3 ASSOCIATION BETWEEN POLYMORPH FUNCTION AND
BONE LOSS 177
6.4.4 CONCLUSION 179
CHAPTER 7 - LYMPHOCYTES
7.1 I N T R 0 D U C T I 0 N 182
7.1.1 THE BLASTOGENIC RESPONSE 182
7.1.2 THE ROLE OF T-CELLS 183
7.1.3 INTERACTIONS BETWEEN T AND B CELLS 184
7.1.4 IS GINGIVAL LYMPHOCYTE ACTIVATION ANTIGENIC
OR MITOGENIC? 186
7.1.5 THE PERIPHERAL MONOCYTE BLASTOGENIC RESPONSE
AND PERIODONTAL DISEASE 189
7.1.6 THE PRESENT STUDY 193
(xii)
CHAPTER 7 - LYMPHOCYTES (Contd) Page
7.2 MATERIALS AND METHODS 194
7.2.1 LYMPHOCYTE TRANSFORMATION 194
7.2.2 MACROPHAGE MEDIATED SUPPRESSION 196
7.3 R E S U L T S 197
7.3.1 DIFFERENCES BETWEEN RUNS ON DIFFERENT DAYS 197
7.3.2 DIFFERENCES BETWEEN GENOTYPES 197
7.3.3 DIFFERENCES BETWEEN INOCULUM GROUPS 198
7.3.4 DIFFERENCES BETWEEN MLN AND SPLEEN CELLS 198
7.3.5 DIFFERENCES BETWEEN STIMULANTS 198
7.3.6 MACROPHAGE SUPPRESSION 199
7.3.7 CO-CULTURES 199
7.4 D I S C U S S I 0 N 207
7.4.1 DIFFERENCES BETWEEN GENOTYPES 207
7.4.2 DIFFERENCES BETWEEN INOCULUM GROUPS 208
7.4.3 DIFFERENCES BETWEEN MLN AND SPLEEN CELLS 208
7.4.4 DIFFERENCES BETWEEN STIMULANTS 209
7.4.5 MACROPHAGE SUPPRESSION 210
7.4.6 CO-CULTURES 211
7.4.7 GENERAL DISCUSSION 211
7.5 DESCRIPTIVE STATISTICS 217
(xiii)
CHAPTER 8 - IMMUNOGLOBULINS Page
8.1 I N T R 0 D U C T I 0 N 235
8.1.1 SOURCE 235
8.1.2 SPECIFICITY 235
8.1.3 IMMUNOGLOBULIN LEVELS IN RESPONSE TO TREATMENT 237
8.1.4 THE PRESENT STUDY 239
8.2 MATERIALS AND METHODS 240
8.2.1 THE ELISA TECHNIQUE 240
8.2.2 NON-SPECIFIC IMMUNOGLOBULIN 241
8.2.3 SPECIFIC ANTI-A. VISCOSUS IMMUNOGLOBULIN 242
8.3 R E S U L T S 243
8.3.1 SOURCES OF VARIATION 243
8.3.2 NON-SPECIFIC IMMUNOGLOBULIN AND INOCULUM SIZE 243
8.3.3 SPECIFIC IMMUNOGLOBULIN AND INOCULUM SIZE 244
8.3.4 THE RATIO OF SPECIFIC/NON-SPECIFIC
IMMUNOGLOBULINS 245
8.4 DISCUSSION 254
8.4.1 DIFFERENCES BETWEEN GENOTYPES 264
8.4.2 DIFFERENCES BETWEEN SPECIFIC AND NON-SPECIFIC
IMMUNOGLOBULIN 265
8.4.3 DIFFERENCES BETWEEN IMMUNOGLOBULIN CLASSES 265
8.4.4 THE IgA PEAK AT 107 CFU 266
8.5 CONCLUSION 269
(xiv)
CHAPTER 9 - IMMUNISATION Page
9.1 I N T R 0 D U C T I 0 N 271
9.2 MATERIALS AND METHODS 271
9.3 R E S U L T S 273
9.4 D I S C U S S I 0 N 281
CHAPTER 10 - OVERVIEW
10.1 THEPRESENTSTUDY 285







1.1 HUMAN PERIODONTAL DISEASE
1.1.1 CONTRIBUTION TO DENTAL ILL HEALTH
Inflammatory periodontal disease is one of the most
widespread ailments to affect man. In 1978, the Adult Dental
Health Survey reported that 82% of the adult dentate population in
England, Scotland and Wales had gingivitis and that 27% had
periodontitis (Todd et al, 1982). The treatment of periodontal
disease has recently become a growth area within the General
Dental Service (GDS) (Elderton & Eddie, 1983). In 1975 less than
1% of courses of treatment involved periodontal therapy other than
routine scaling but by 1982 this had increased to 3.1% in Scotland
and 7.5% in England and Wales (Dental Estimates Board Annual
Report, 1976, 1983; Summary Report of the Scottish Dental
Estimates Board, 1976, 1983). Only 12.1% of the total cost of the
GDS went on scaling and other periodontal treatment in 1982 in
England, Scotland and Wales, which compares with 51.7% on restor¬
ative treatment. Thus, in spite of the high prevalence of
periodontal disease, with its possible implications for eventual
tooth loss, a relatively small proportion of the resource is
devoted to its prevention and treatment.
The reasons for this are many, but a 5 year longitudinal
survey of 720 Scottish adults by Eddie and Davies (1984), showed
that even in patients designated as having severe periodontal
disease, only 25.4% were aware of having had bleeding gums in the
four weeks before the start of the survey and only 7.7% were aware
of having swollen, inflamed gums. Thus, because periodontal
3.
disease patients are often symptom free, patient awareness of the
disease is low. Consequently, the demand for treatment is low.
In absolute financial terms, it has been estimated that the
total annual cost of treatment for the proportion of the United
States' population that receives periodontal care is currently 1.5
billion dollars. In order to provide care for the more than 25
million Americans with periodontal disease who receive no
treatment, the minimal cost would be over 7 billion dollars per
year (United States Public Health Service Survey: quoted in Poison
& Goodson, 1985). Thus, inflammatory periodontal disease has a
substantial impact on public health and expenditure and is
therefore a problem demanding a high priority in dental research.
1.1.2 DIAGNOSTIC METHODS
The diagnostic indicators currently used to assess
periodontal status are directed towards measuring gingival
inflammation, destruction of connective tissue (through
periodontal pocket depth and alveolar bone loss) and crevicular
fluid flow and composition.
1.1.2.1 Gingival inflammation
Recognition of the signs of inflammatory gingival disease may
be important for early diagnosis (Muhlemann & Son, 1971).
Indicators used have included the colour of the gingival surfaces
and whether or not gingival bleeding occurred after gentle probing
(Massler & Schour, 1949). As estimation of colour change is
essentially subjective, it has been suggested that gingival
bleeding on probing is the more sensitive and objective clinical
indicator (Nowicki et al 1981; Poison & Goodson, 1985). However,
4.
the insertion of a periodontal probe into the gingival sulcus and
its subsequent movement along the tissues has a strong subjective
component, as there is no strict control of the forces applied.
Indeed it has been shown that a great variation in periodontal
probing pressure occurs even among experienced clinicians (Hassell
et al, 1973). Periodontal probes which allow control of insertion
pressure have thus been developed to reduce intra- and
interexaminer variability (van der Velden & de Vries, 1978; Vitek
et al, 1979). The relationship between bleeding on probing and
the histological characteristics of the inflamed gingival tissue
has been clarified by using a standardised probe insertion force
as the stimulus for gingival bleeding followed by gingival
biopsy. Reactive gingivae were found to have a significantly
greater percentage of cell-rich, collagen-poor connective tissue
in the region of the specimen adjacent to the tooth surface
(Greenstein et al, 1981).
1.1.2.2 Pocket depth:
Connective tissue destruction - soft tissue
The periodontal probe is used for measurement of both
periodontal pocket depth and loss of connective tissue attachment
to a root surface. While measurements are simple to perform,
reproducibility is a major problem because of variations in
probing force, size of probe, angle of probe insertion and the
precision with which probe calibrations can be read (Proceedings
of the Workshop on Quantitative Evaluation of Periodontal Diseases
by Physical Measurement Techniques, 1979). Furthermore, the probe
routinely has been found to penetrate the coronal level of the
5.
junctional epithelium (Armitage et al, 1977; Robinson & Vitek,
1979; Poison et al, 1980), thus clinical pocket depths do not
coincide with histological pocket depths. This disparity may be
due to variables affecting gingival integrity, notably degree of
inflammation (Armitage et al, 1977; Robinson & Vitek, 1979), as
well as those relating to probing technique and probe diameter
(Hassel et al, 1973; van der Velden & de Vries, 1978; Listgarten,
1980). A number of studies over the past decade have tried to
determine the precise location of probe tip penetration into the
gingival tissues (Listgarten et al, 1976; Sivertson & Burgett,
1976; Spray et al, 1978; Garnick et al, 1980). When manual
probing forces were used in periodontitis the probe tip
either coincided with the coronal level of connective tissue
attachment (Sivertson & Burgett, 1976) or was forced apical to
this within the connective tissue (Listgarten et al, 1976;
Armitage et al, 1977). In order to minimise the variation due to
probing forces, studies were conducted using controlled probe
insertion pressures (Robinson & Vitek, 1979; Poison et al, 1980)
of 25 g. In all these studies the probe tip was found to be
within the junctional epithelium. In the presence of visual signs
of inflammation, probe penetration was greater but the tip
remained in the junctional epithelium until a force of 30 g was
reached at which point penetration of the connective tissue
occurred. Consequently, it appears that studies are needed to
clarify the relationships between probe penetration and both
clinical and histological signs of inflammation.
6.
1.1.2.3 Bone loss
The traditional method of assessing bone loss has been from
dental radiographs. Here too, the accuracy is only fair, due to
variables such as angulation of X-rays and differences in
processing. Although improvements have been made, there is still
not enough sensitivity to detect the initial bone loss associated
with periodontitis, to visualise morphology of osseous defects
between the cortical plates and to obtain images of buccal and
lingual bone levels (Chilton & Miller, 1977). In spite of these
limitations, standardised radiographs have been shown to be valid
in evaluating changes in longitudinal studies (Rosling et al,
1976; Poison & Heijl, 1978) and clinical trials (Kelly et al,
1975).
Orthopantomographs have been compared with both long-cone
paralleling and short-cone bisecting techniques and, while there
was agreement between techniques for approximately 50% of the
teeth, orthopantomography had a tendency to underestimate minor
marginal bone destruction and overestimate major marginal bone
destruction (Grondahl et al, 1971). Xerography is a
diagnostic X-ray imaging process which uses a xerographic copying
system to read X-ray images, and has been applied tc> dental
structures (Gratt et al, 1977; 1978; Gratt, 1979). It has been
claimed that fine structures, such as bone trabeculae, and subtle
density differences such as those found in gingival soft tissues,
are made more visible due to a phenomenon termed edge enhancement.
A comparison between conventional radiographs and dental
xerographs indicated that the latter provided superior images of
7.
the crestal alveolar bone (Gratt et al, 1980). Development of
this system may thus offer an accurate, low radiation and rapid
alternative to conventional intraoral radiography.
A break in the continuity of the crestal lamina dura has been
described as the earliest radiographic change in periodontitis,
and interpreted as a sign of active disease. It is thought that
the changes are due to extension of inflammation from the
interdental gingiva to the alveolar bone, resulting in a loss of
bone density. The importance of density changes in the crestal
lamina dura has been emphasised in early diagnosis of periodontal
breakdown (Proceedings of the Workshop on Quantitative Evaluation
of Periodontal Diseases by Physical Measurement Techniques, 1979).
A study by Greenstein et al (1981) demonstrated that the integrity
of the crestal lamina dura, evaluated on either periapical or
bitewing radiographs, was not related to the presence or absence
of clinically observed inflammation, bleeding on probing,
periodontal pocketing, or loss of connective tissue attachment in
the corresponding interdental area. These findings suggest that
caution should be exercised when using integrity of crestal lamina
dura as an indicator of disease activity or the need for
periodontal treatment. Digitisation of radiographic images and
subsequent computer subtraction has resulted in a significant
improvement in diagnostic interpretation of small periodontal bone
lesions (Grondahl & Grondahl, 1981).
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An I absorption technique developed by Henrikson
(Henrikson, 1967; Henrikson & Julin, 1971) involves passing a 1 mm
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diameter highly collimated photo beam just beneath the alveolar
crest, midway between the approximal surfaces of two adjacent
teeth, and comparing bone mass measurements at different time
points. Initial findings indicate that the method can detect
alterations in mineral density of the crestal region. However,
interpreting these changes as being the result of active
periodontal disease is difficult as there are several sources of
error associated with reproducibility of beam location and
angulation and the technique only evaluates an extremely small
bone field. In addition, it is possible that such changes in bone
density could be caused, at least in part, by normal bone turnover
(Poison & Goodson, 1985).
1.1.2.4 Crevicular fluid flow and composition
Several studies in the last decade have confirmed earlier
findings that crevicular fluid flow shows a high correlation with
clinical assessment of gingivitis and/or microscopically observed
inflammation (Oliver et al, 1969; Rudin et al, 1970; Wilson &
McHugh, 1971; Cimasoni, 1974; Shapiro et al, 1979). Fluid
measurements have therefore been considered an indirect method for
measuring gingival inflammation in experimental situations.
However, the interpretation of fluid flow rates from periodontal
pockets is uncertain (Cimasoni, 1974).
Measurement of crevicular fluid flow has been performed by
both intra- and extracrevicular techniques with the former being
criticised for providing a stimulus which may itself initiate flow
(Poison & Goodson, 1985). Fluid collection has involved using
either calibrated microcapi1lary tubes or filter paper strips
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placed into, or at the entrance of, the crevice for a fixed time
period. In the microcapi1lary tube method, measurement of the
fluid volume is time consuming and requires a large sample size to
be considered accurate (Golub & Kleinberg, 1976). In the filter
paper method, there can be variation in depth and position of
strip placement, type of paper used and the techniques for
visualising the fluid area on the paper (Washer, 1973). An
electronic meter (Harco Periotron) has been developed which
provides a direct measure of the fluid volume collected on filter
paper strips. However, difficulties with instrument calibration
have been reported (Taggart et al, 1980; Eid et al, 1981).
High crevicular fluid flow rates have been observed in
clinically healthy sites (Muhlemann & Son, 1971) and it has been
suggested that the fluid results initially from an osmotic
gradient set up between plaque and tissues and later, after
penetration of the basement membrane by biologically active
molecules, from the development of an inflammatory exudate
(Pashley, 1976; Alfano et al, 1976). These ideas may in part
explain the high flow rates at healthy sites.
Attempts have been made to measure the concentration of
common electrolytes in crevicular fluid but the results are
inconsistent and need further clarification (Matsue, 1967; Kaslick
et al, 1970; Bang et al, 1973).
Collagenase content of crevicular fluid has been examined
(Golub & Kleinberg, 1976; Golub et al, 1976) and it has been
suggested that tissues with chronic periodontitis produce more
collagenase than do normal tissues (Robertson & Simpson, 1976).
10.
However, the work is complex and the assays are regarded with
reservation (Poison & Goodson, 1985).
1.1.2.5 Conclusions
There exists a critical need for objective diagnostic methods
to enable clinicians to identify periodontal sites having active
disease. At present disease activity is evaluated by periodically
repeating clinical evaluations and measurements, many of which,
such as probing and radiography, detect disease only when it has
already occurred. Elucidation of rate of disease progression
would help to identify those patients whose dentitions are at a
high risk of destruction. Emphasis should be placed on early
recognition of gingival disease and objective diagnosis of early
periodontal lesions.
1.1.3 TYPES OF PERIODONTITIS
The forms of periodontitis observed in children and young
adults have been shown to differ in many respects from those
commonly seen in adults. In addition, confusion has arisen
because of ongoing controversy as to both the nature of, and
terminology used to describe, periodontal diseases found in
children and young adults. Page and Schroeder (1982) proposed the
following classification.
1.1.3.1 Prepubertal periodontitis
This form of the disease has onset during or immediately
following eruption of the primary teeth, and may be either
generalised or localised to particular teeth. There is gingival
hyperaemia and inflammation with spontaneous haemorrhage and
cauliflower-like gingival proliferation. Gingival clefts may
subsequently be formed and, with time, the periodontal tissues
recede to the tooth apex. Alveolar bone and root resorption are
rapid (Altman et al, 1980) and, in some cases, the primary teeth
are lost by age 2-3 years (Rosenthal, 1951; Hawes, 1960). The
gingival cellular infiltrate is dominated by plasma cells and
lymphocytes (Rosenthal, 1951; Altman et al, 1980). Two cases of
localised prepubertal periodontitis have been reported (Altman et
al, 1980) in which only the free margin of gingival tissue showed
acute inflammation and proliferation and in which disease
progression was much slower than in its generalised counterpart.
It has been suggested by Baer (1971) that periodontitis per se
does not occur in children, except as a manifestation of some
other disease state. However, cases of generalised as well as
localised prepubertal periodontitis have been described in
otherwise apparently normal children (Fourel, 1974; Pleasants &
Nelson, 1975; Altman et al, 1980).
Prepubertal periodontitis may be followed either by
completely normal periodontal status in the permanent dentition
(Pleasants & Nelson, 1975) or by periodontitis associated with the
permanent teeth (Rosenthal, 1951; Giansanti et al, 1973; Jorgenson
et al, 1975). Disease associated with the permanent teeth may be
severe enough to cause loss of many if not all permanent teeth by
the mid-teens (Rosenthal, 1951; Giansanti et al, 1973). Six cases
of prepubertal periodontitis have been shown to have defective
neutrophils or monocytes as determined by in vitro chemotaxis or
phagocytosis tests (Roberts & Walker, 1976; Shurin et al, 1979;
Altman et al, 1980). In addition, observations indicate that
prepubertal periodontitis is more prevalent in females than in
males and that it tends to run in families (Fourel, 1972; Altman
et al, 1980).
1.1.3.2 Juvenile periodontitis
There is a great deal of discussion regarding the type of
periodontitis occurring in teenagers and young adults. It is an
uncommon condition, characterised by severe loss of attachment and
destruction of alveolar bone around one or more permanent teeth in
an otherwise healthy adolescent (Davies et al, 1985). Baer et al
(1963b) and Baer (1971) found that the amounts of microbial
deposits present were not consistent with the degree of
periodontal destruction. The disease was first accurately
described by Wannenmacher (1938) who noted that lesions were
confined to incisor and first molar regions only. Deep
periodontal pockets could be present while the gingival tissue
appeared healthy. However, the disease may also be more
generalised (Davies et al, 1985). Baer (1971) considered that
localised and generalised forms were different manifestations of
the same disease process. Age of onset is circumpubertal. In
localised juvenile periodontitis prevalence in females is higher
than in males, with a female to male ratio varying from 2 to 3.5:1
(Benjamin & Baer, 1967; Manson & Lehner, 1974; Melnick et al,
1975). A familial pattern has been identified in a number of
studies (Butler, 1969; Jorgenson et al, 1975; Melnick et al, 1975)
and X-linked inheritance has been suggested (Melnick et al, 1975;
Fretwell et al, 1982), but both sexes are affected and an autosomal
recessive pattern of inheritance seems more likely (Saxen, 1980).
Studies of HLA antigens in juvenile periodontitis have been
equivocal but have provided some evidence of a negative
association with HLA-A2 and of positive associations with HLA-A9
and HLA-B15 (Saxen & Koskimies, 1984; Tiwari & Terasaki, 1985)
suggesting the possibility of an immunogenetic basis for the
disease.
The lesions progress with extreme rapidity immediately after
onset, and destruction appears to slow with time (Baer &
Socransky, 1979). Recent data indicate that, while there is
evidence that localised disease may become generalised with time
(Hormand & Frandsen, 1979), the two forms may be distinct, as
summarised below.
Localised form
In localised juvenile periodontitis, Actinobaci1lus
actinomycetemcomitans, a Gram-negative facultative anaerobic rod,
has been found in large numbers and is thought to play a dominant
role in the disease process (Slots, 1976; Slots & Rosling, 1983;
Haffajee et al, 1984). Resolution of disease follows its
elimination from subgingival plaque and re-establishment of the
organism is associated with disease recurrence. Patients have
elevated serum immunoglobulin specific to the organism and high
levels of specific antibody in crevicular fluid and gingival
tissue (Chen et al, 1983; Haffajee et al, 1984). Following
successful treatment, the levels of antibody to this species
decrease significantly in both serum and crevicular fluid. The
organism has been found within gingival connective tissue of
affected individuals (Saglie et al, 1982).
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Between 75% and 80% of patients with localised juvenile
periodontitis have depressed neutrophil chemotaxis (Clark et al,
1977; Genco et al, 1980b; Van Dyke et al, 1980). This defect has
been shown to be intrinsic in that the neutrophils have a reduced
number of cell surface receptors for chemotactic factors (Van
Dyke et al, 1981; 1983). There is evidence that the chemotactic
defect is familial and that it persists into adulthood, even after
treatment of the disease (Van Dyke et al, 1980).
Generalised form (rapidly progressive periodontitis)
In this form of juvenile periodontitis, the first molars and
incisors are frequently among the teeth involved, but periodontal
destruction appears often to extend to other parts of the
dentition. Many patients may not present until the third or
fourth decade of life, making information concerning the onset and
progression of disease difficult to obtain. Evidence for
progression from the localised to the generalised form comes from
studies by Hormand and Frandsen (1979), Baer and Socransky (1979)
and Vandesteen et al (1981). However, Burmeister et al (1984)
showed that 39% of their patients with juvenile periodontitis
still had only first molar/incisor involvement when aged 21-30
years, implying that progression to the generalised form may not
be inevitable. Prevalence in females is higher than in males but,
in contrast to the localised form, no evidence of familial
occurrence has yet been found.
Preliminary studies of thirty patients with generalised
juvenile periodontitis by Davies et al (1985) have failed to
detect a consistent defect of neutrophil function. Page et al
(1983a; 1984) however reported a range of neutrophil chemotactic
activity in such patients, as well as abnormalities of monocyte
chemotaxis.
Data concerning the microflora associated with generalised
juvenile periodontitis are sparse, but certain Gram-negative,
anaerobic bacteria, notably Actinobacillus species and Bacteroides
gingivalis, have been implicated (Ranney et al, 1981; Slots, 1982;
Page et al, 1983a). These organisms have considerable pathogenic
potential and could provoke the severe tissue destruction found
in this condition (Slots & Genco, 1984). Page and co-workers
(1983a) believed generalised juvenile periodontitis to be a
distinct and entirely separate entity from the localised form and
were the first to use the term rapidly progressive periodontitis.
1.1.3.3 Adult periodontitis
The most common type of periodontitis is a chronic disease
termed 'Adult Periodontitis' by Page and Schroeder (1982). They
described it as being "characterised by an age range of 35 years
and older in which the presence of microbial deposits is
commensurate with the amount of periodontal destruction seen.
Bone loss can be either generalised or localised, horizontal or
vertical but not of the distinct pattern seen in juvenile
periodontitis. There is no evidence of rapid progression, no
predisposing systemic diseases and no blood leucocyte
abnormalities. The pocket flora is characterised by a mixture of
gram negative microorganisms containing, among others Bacteroides
melaninogenicus ss intermedius, Eikenella corrodens, vibrios and
spirochaetes, but without a significant population of B.
gingivalis or Actinobaci1lus actinomycetemcomitans".
Adult periodontitis responds well to plaque removal and root
curettage and adjuncts such as antibiotic therapy are not needed.
Fibrosis and other manifestations of chronic long standing
inflammation may be present, but in many cases the gingival
tissues have not retreated apically as alveolar destruction
worsened. Preliminary data (Hirshfeld & Wasserman, 1978; Becker
et al, 1979) suggest that relatively quiescent adult periodontitis
may convert, at one or more sites, to a form of rapidly
progressive disease and that rapidly progressive disease may
revert spontaneously to the more slowly progressive adult form.
There is some evidence to suggest that HLA-A2, HLA-A10 or HLA-B5
may confer a degree of resistance to adult periodontitis (Goteiner
& Goldman, 1974; Amer et al, 1985; Tiwari & Terasaki, 1985).
1.1.3.4 Acute periodontitis
For the sake of completeness, it should be noted that there
are two main forms of acute periodontitis, pericoronitis and
periodontal abscess (Higgins et al, 1985). Pericoronitis, as the
name suggests, involves inflammation of the tissues around the
crown of a tooth and is most commonly associated with partially
erupted third molars. A periodontal abscess may occur as an acute
exacerbation of pre-existing chronic inflammatory disease or may
arise de novo in association with particulate matter forced into
the gum.
1.1.3.5 Other types of periodontitis
Another type of periodontitis is that observed following
repeated long-term episodes of acute necrotizing ulcerative
gingivitis, characterised by deep craters in the interdental bone,
either localised or throughout the mouth (Page & Schroeder, 1982)
The disease undergoes periods of exacerbation during which
greyish pseudomembranes composed of bacteria and necrotic tissue
form in the affected regions and the breath becomes fetid.
Periodontitis of this type has not been well studied.
1.1.4 PERIODONTAL PATHOGENS
The concept that periodontal diseases are bacterial in origi
is supported by experiments in germ-free animals (Irving et al,
1975; Listgarten et al, 1978a), responses to both mechanical
treatment and chemotherapy (Listgarten et al, 1978b; Slots et
al, 1979), histological evidence of bacterial invasion of the
tissues (Saglie et al, 1982; Slots et al, 1983), therapeutic
efficacy of plaque control (Axelsson & Lindhe, 1978; 1981) and
experimental gingivitis studies in man (Loe et al, 1965, Theilade
et al, 1966). The situation has been summed up by Page & Schroede
(1982): "Organisms present in microbial plaque in the region of
the gingival sulcus, or gingival or periodontal pocket, or
substances derived from them constitute the primary and possibly
the only extrinsic aetiological agents, participating in the
aetiology of inflammatory gingival and periodontal disease." It
is thus essential to know something of the organisation,
pathogenic potential and composition of microbial plaque,
especially subgingival, which both initiates and promotes the
disease process.
1.1.4.1 Organisation of subgingival plaque
Subgingival plaque is highly structured and organised yet, i
any given pocket, there are significant differences in microbial
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composition between one location and another and significant
changes in composition with time (Soames & Davies, 1974;
Listgarten et al, 1975). The build up of plaque on subgingival
surfaces has been studied by using removable epoxy crowns
(Listgarten et al, 1975). The surfaces were first colonised by
Gram-positive cocci which, on multiplication, formed columns.
Within one week, the coccoid plaque became covered by filamentous
organisms and within three weeks, these latter forms both invaded
and replaced the cocci. At the advancing front of the pocket, or
on the soft tissue side thereof, the flora was made up of plaque-
related, freely floating, unattached spirochaetes, small
unidentified cocci, Gram-negative rods, many of which were motile,
and unusual microbial aggregates referred to as 'corn-cobs'.
Bacteria have also been identified within the epithelium and
connective tissues at the apical terminus of advanced pockets as
well as at surfaces of and within alveolar bone (Michel, 1969;
Frank, 1980; Manor et al, 1984).
1.1.4.2 Pathogenic mechanisms
The possible means by which bacteria and the substances they
release cause periodontal damage may be summarised as follows
(Page & Schroeder, 1982):
(a) Rapid growth and apical extension of the area invaded by
microorganisms requires space which is created by displacement
through physical force (exudation) or enzymatic activity of the
junctional epithelium from the tooth surface (Schroeder &
Attstrom, 1980).
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(b) Some of the bacteria produce leucotoxins which hamper
neutrophil defence (Taichman & Wilton, 1980; Baehni et al, 1980).
(c) Bacterial components may interact with various host cells and
systems to activate acute inflammation and possibly immuno-
pathological processes which cause pathological tissue alteration
(Page & Schroeder, 1973, 1976; Smith et al, 1980).
(d) Some bacterial products can directly cause bone resorption
(Daly et al, 1980; Nowotny et al, 1982).
1.1.4.3 Microbial floras associated with periodontal
health and disease
In one of the earliest investigations in this field, Hemmens
& Harrison (1942) found no major differences between the
periodontal flora of normal and diseased human subjects. On the
other hand, Rosebury et al (1950) showed that certain organisms
such as spirochaetes, vibrios and fusiform bacilli were present in
the scrapings from periodontally diseased teeth in far greater
numbers than in those from periodontally normal teeth.
These latter observations were not supported by the studies
of Socransky et al (1963) or Gibbons et al (1963) who found no
significant differences of composition between floras of diseased
and healthy sites, although there was a difference in the total
amount of microbial deposit present. Examination of the ratio of
non-motile to motile organisms found in diseased as compared to
healthy sites was, however, more fruitful. In clinically normal
or recently treated pockets this ratio was found to be 40:1
(Listgarten & Hellden, 1978; Darwish et al, 1978; Rosenberg et al,
1981). In contrast, the ratio at diseased sites was shown to be
approximately 1:1 (Listgarten & Hellden, 1978). Numerous studies
have attempted to associate different floras with different
periodontal disease states, resulting in a large collection of
data, much of which is contradictory. However, the following
general points appear to be widely accepted.
Healthy Sites
Newman et al (1976) studied the flora of healthy pockets in
patients with localised juvenile periodontitis. The sites had a
predominantly Gram-positive and aerobic flora comprising mostly
Streptococcus sanguis, S. mitis, Staphylococcus, Propionibacterium
acnes and large numbers of Gram-positive filamentous rods of the
Actinomyces type. Studies by Slots (1979) and Tanner et al (1979)
have shown that Streptococci and facultative species of
Actinomyces, especially A. viscosus and A. naeslundi, along with
Rothia dentocariosa, account for up to 85% of the total cultivable
flora at clinically normal sites. Saccharolytic Bacteroides
species and Capnocytophaga have also been found (Spiegel et al,
1979).
Advanced periodontitis
In general, the flora at diseased sites with little
associated gingival inflammation is primarily Gram-negative and
anaerobic (Listgarten & Hellden, 1978). However, Tanner et al
(1979) found that B. melaninogenicus ss intermedius, pleomorphic
Bacteroides and Eikenella corrodens predominated. With greater
degrees of gingival inflammation, Bacteroides gingivalis and
Fusobacterium nucleatum accounted for up to 75% of the cultivable
flora (Slots, 1979) while Tanner et al (1979) showed the presence
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of anaerobic vibrios and pleomorphic Bacteroides also. Lai et al
(1981) and Holt et al (1981) have described the presence of
previously unidentified Gram-negative bacteria in advanced
periodontitis lesions.
Juvenile periodontitis
The idea that specific microorganisms may be associated with
particular clinical entities has recently been supported by serum
immunoglobulin studies of patients with generalised juvenile
periodontitis. Such individuals showed raised serum titres to
gingivalis (Mouton et al, 1981; Ebersole et al, 1982). Patients
with localised juvenile periodontitis, however, demonstrated low
titres to B. gingivalis but raised titres to Actinobacillus
actinomycetemcomitans (Murray & Genco, 1980; Listgarten et al,
1981; Ebersole et al, 1982; Ranney et al, 1982). Indeed,
individuals with localised juvenile periodontitis have elevated
total serum immunoglobulin levels (Lehner et al, 1975; Kaslick et
al,.1980; Chen et al, 1983) and high levels of specific anti A.
actinomycetemcomitans immunoglobulins in serum, saliva and
gingival crevicular fluid (Genco et al, 1980a; Murray & Genco,
1980; Listgarten et al, 1981; Ebersole et al, 1982; Ranney et al,
1982). Such elevated titres in patients with juvenile
periodontitis were shown to decrease after successful treatment
(Genco et al, 1980a).
Slots & Rosling (1983) showed that, unlike some other
periodontopathogens, A. actinomycetemcomitans could not be
eliminated from pockets by mechanical debridement alone.
According to Zambon (1985), this is probably due to the organism's
ability to invade gingival connective tissues, evidence for which
has been provided by the electron microscopic studies of Saglie et
al (1981a,b) and Gillett & Johnson (1982). Specific identification
of the organism was performed both by immunoperoxidase techniques
(Saglie et al, 1982a,b) and indirect-immunofluorescent staining with
species specific antisera (Christersson et al, 1983). Thus, Slots
et al (1983) showed 1 g per day oral tetracycline administered for
three weeks to be effective in eliminating A. actinomycetem-
comitans from periodontal sites. Combined conventional
periodontal therapy and systemic antibiotics resulted in decreased
gingival inflammation, gains in clinical attachment and
regeneration of angular osseous defects in studies by Lindhe
(1982) and Slots & Rosling (1983).
Much recent work has concentrated on A. actinomycetem-
comitans and its virulence factors which are capable of inhibiting
host defence mechanisms. These are:
(a) Leucotoxin, a heat stable protease sensitive product (Tsai et
al, 1984) which lyses human polymorphonuclear leucocytes (Baehni
et al, 1979; Tsai et al, 1979) and human monocytes (Taichman et
al, 1980) by Causing cell membrane perturbations. At healthy
sites only 7% of the small number of A. actinomycetemcomitans
present are leucotoxin producing while producers constitute 43-75%
in diseased subjects (Baehni et al, 1981; Zambon et al, 1983).
Resultant polymorph damage releases hydrolytic enzymes to
exacerbate local tissue damage (Zambon, 1985).
(b) Polymorphonuclear leucocyte chemotaxis inhibitor, which
impairs these cells' response to chemotactic agents (Van Dyke et
al, 1982) and may exacerbate the systemic neutrophil chemotactic
defect found in some localised juvenile periodontitis patients.
(c) Another soluble, heat labile factor, which suppresses
lymphocyte activation to mitogens and antigens (Shenker et al,
1982b), though its significance is uncertain.
(d) Catalase from the organism, which can inhibit oxidative
bacterial killing by degrading hydrogen peroxide of host immune
cells (Slots, 1982).
(e) Lipopolysaccharide from the organism, which participates in
the Schwartzman reaction, macrophage activation and platelet
aggregation (Kiley & Holt, 1980) and is a potent mitogen (Chen et
al, 1981), causing bone resorption in organ culture.
(f) Collagenase produced by most strains (Robertson et al, 1982;
Rozanis & Slots, 1982; Rozanis et al, 1983), which may combine
with that from lysed neutrophils to produce tissue damage.
(g) Another factor which inhibits growth and proliferation
of human fibroblasts (Shenker et al, 1982a; Stevens & Hammond,
1982) which, in conjunction with the collagenase, may not only
destroy tissue but also inhibit repair (Stevens & Hammond, 1982).
(h) Epitheliotoxin (Birkedal-Hansen et al, 1982; Kamen, 1983),
which may assist the organism in sulcular epithelial penetration
and connective tissue access.
Thus this organism is periodontopathic from many different
points of view. Some or all of these factors may also be produced
by other bacteria which have not, as yet, been as extensively
tested.
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1.1.4.4 Effects of sampling
As pointed out by Greenstein & Poison (1985) the act of site
microbiological sampling can introduce variability into studies
and clinical diagnoses. Mousques et al (1980) demonstrated that
repeated sampling of sites can affect their microbial composition
and Listgarten & Lewis (1967) showed that returning to sample
identical locations is difficult as the bacterial composition
varies in different regions of the same lesion. Furthermore,
collection of specimens at different pocket depths introduces
another variable, since there is evidence that the percentage of
spirochaetes and motile rods may be pocket-depth related (Armitage
et al, 1982; Savitt & Socransky, 1984). However, other workers
have shown that deep pockets do not necessarily contain increased
percentages of these morphotypes (Evian et al, 1982; Greenwell &
Bissada, 1984).
1.1.4.5 Conclusions
The importance of bacteria in the pathogenesis of periodontal
disease is beyond doubt. However, in view of the difficulties in
merely sampling sites, far less culturing, counting and
identifying the organisms recovered, it is not surprising that a
very large number of conflicting views as to the details of
microbial involvement have been put forward. The flora is
enormously complex and many of the bacteria are extremely
fastidious in their growth requirements. Nevertheless, further
understanding of the organisms and pathogenic mechanisms involved
in the different types of disease is desirable for rational
prevention and therapy.
1.1.5 HOST DEFENCE SYSTEM
The components of the mammalian host defence system in the
periodontium include the intact epithelial barrier; vessels of the
microcirculation with their neighbouring mast cells; factors from
the blood plasma, including specific and non-specific antibodies,
opsonins and the complement, clotting and plasminogen proteins;
the kinin system; and the peripheral blood leucoctyes including
the neutrophils, monocytes and lymphocytes. The various
components operate in concert; their activities are interrelated
and highly interdependent, and there are myriads of control
mechanisms, most of which are not well understood. The host
defence system component cells can also exert direct effects on
the resident cells such as fibroblasts and bone cells, thus
eliciting direct changes (Irving et al, 1979; Garant, 1979;
Narayanan et al, 1980).
It appears that activation of any component of the host
defence system, be it the immune response, acute inflammation, the
complement cascade, the phagocytic leucocytes, or various
combinations of these, creates the potential for a great deal of
tissue damage as well as for potentially life-saving protection
(Page & Shroeder, 1982). Normally the damage created can be
readily repaired and the price paid, in terms of tissue damage, is
small relative to the protection provided.
The factors determining whether or not tissue damage will
occur and, if so, how much, and the duration of the destructive
process are only poorly understood. It is known that chronic
inflammatory diseases, including periodontitis, continue so long
as the driving force remains present, and all tend to resolve when
the driving force, microorganisms, in the case of periodontitis,
is inactivated or removed. In addition to the nature of the
driving force, which components of the host defence system are
called into play, the exact manner in which they are activated,
and the magnitude of their participation, determines the type and
extent of the tissue damage. This is further complicated as it
can vary from one individual to another, from one disease state to
another and even from one stage of a given disease to another.
The roles of the polymorphonuclear neutrophilic granulocytes
and both cellular and humoral immune systems will be examined in
detail in subsequent chapters. It is, however, possible to say
that the host defence system at large, with its double-edged role
of protection and destruction, is perhaps the most important
element in periodontal disease initiation and progression. The
complex interrelationships of the different components make
separate study difficult, but perhaps attempting this is the only
way to advance our understanding of periodontal disease.
1.1.6 CONCLUDING REMARKS
A number of types of investigation of human periodontal
disease have been performed, including diagnostic,
epidemiological, therapeutic and both cellular and humoral
immunity studies. Most of these have provided data on small
numbers of patients in discrete populations, yet frequently the
findings have been deemed to apply to the human population at
large.
The most important and least soluble problem in using man to
study periodontal diseases stems from the many sources of
variation both between and within populations. Examples include
host genotype, oral flora, diet, concurrent therapy, standard of
oral hygiene and level of patient cooperation during treatment.
Furthermore, witholding treatment in order, for example, to
monitor disease progression would be unethical in man.
In experimental animals, it is possible both to manipulate
the different sources of variation and to observe the progress of
untreated disease. In addition, large enough samples to provide
unambiguous results are easily obtained. Thus, animal models in
periodontal disease research, where so many basic questions with
regard to host response, pathogenesis, epidemiology and therapy
remain unanswered, can be a powerful way of providing clues about
the human disease that would be difficult or impossible to
disclose in man.
1.2 PERIODONTAL DISEASE IN
EXPERIMENTAL ANIMALS
Pathological changes in the periodontal tissues of a variety
of experimental animals have been studied both to understand
certain aspects of disease aetiology and to test therapies that
have some promise in the control of disease. Naturally occurring
and induced disease have both been investigated. Species used
have included larger mammals such as dogs, sheep, cattle and
several non-human primates but, most commonly, rodents have been
studied. Although the gross anatomy of the dentition varies
greatly from one species to another, the structure and
organisation of the periodontal tissues are generally similar. As
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a consequence, with but minor exceptions, the essential features
of periodontitis are common to all mammals that have been
investigated.
1.2.1 SIZE AND TIME
Animal size is extremely important not only with regard to
costs of animal acquisition, maintenance, experimental design and
tissue processing, but also in understanding the pattern and
progression of the disease and interpreting experimental results.
Bacterial colonies and the neutrophil granulocytes they
attract occupy space. In large experimental animals such as dogs
and chimpanzees, the dimensions of the dentition fall within a
range similar to that for humans, but in other experimental
animals the teeth, alveolar bone and soft tissues are much
smaller. In rodents, where there are three molars in each
quadrant, tooth size ranges from that found in the pocket mouse to
that of the hamster. However, in all these animals the
interdental regions are very small. Thus, the interval between
approximal root surfaces of adjacent molars, although containing
the same structural elements as found in humans, organised in a
similar manner, measures only a fraction of a millimeter (Page &
Schroeder, 1982). Under these conditions, certain questions
become very important. What type and quantity of dental plaque
and how many cell layers can be accommodated? What is the range
of effectiveness of the bacteria and the substances they release?
What is the radius or range of tissue involvement relative to the
tissue volume available?
Size is also relevant for histological processing where,
particularly for small animals, preparations with minimum
distortion are required. Many classical histological procedures
fall short of such stringent demands (Page & Schroeder, 1982).
Time is also an important consideration in the individual history
of periodontitis in different animals. Pathological processes,
which in man and other long-lived animals may take years or
decades to develop, must necessarily develop much more quickly in
rodents such as mice with their short life span of sometimes less
than one year. Sulcular hair impaction which occurs to varying
degrees may be a precipitating factor (Baer & Lieberman, 1959,
1960).
1.2.2 MICE AS EXPERIMENTAL ANIMALS
Mice have a number of advantages over other experimental
animals. They are easy to procure and, provided they are acquired
from a reputable source, should be free from infection and
infestation. Many genotypes, even relatively unusual mutants, can
be purchased in Great Britain so eliminating the need for
quarantine.
The small size of the animals allows many of them to be
housed in identical conditions, thus, in quantitative experiments,
it is easy to study numbers large enough for unambiguous
statistical analysis. Also, when larger numbers of animals are
used, losses due to accident, disease or death are not as serious
as in small samples. Mice are easy to handle and are suited to a
wide variety of experimental procedures, such as germ-free housing
and rearing, administration of special diets and both
microbiological and therapeutic experiments. They also have a
short generation time, making breeding experiments much quicker
than in other animals. This also means' that a few young pairs
will quickly produce a thriving colony, so eliminating the need
for recurrent acquisition. Cost, of course, in these days of
stringent financial constraint, is a prime consideration in
setting up experiments and mice are valuable in that, apart from
the rarer genetic mutants, they are relatively cheap to buy,
transport, house and feed. More importantly, mice are regarded as
being sufficiently similar to man in relation to the anatomy of
the periodontium that they may be considered to show a disease
process analogous to that found in man.
Nevertheless, early investigators such as Mitchell (1954),
Costich (1955) and Konig & Muhlemann (1959) noticed that the
subepithelial inflammatory reaction seen in human diseased
periodontal tissue was usually absent. This is perhaps because
the crevicular epithelium is keratinised in rodents but not in
humans. Thilander (1961) reported that the keratinised epithelium
in rats blocked the passage of trypan blue and may therefore block
irritating or toxic materials from bacterial plaque. Trypan blue
penetrated the tissue and entered the crevice primarily at the
epithelial attachment, which was therefore considered to be the
site in rodents where materials passed through the epithelial
barrier. It has also been suggested by Socransky (1970) that the
rodent oral flora is simpler than that of man. This could be due
to the relatively simple and constant experimental diets consumed
by rodents or to physiological differences between species
controlling the implantation of bacteria. A simplified flora may
be considered an advantage when devising pathogen-free models but
it may be a limitation in terms of the total gingival ecology as
seen in humans.
A number of investigators (Fitzgerald et al, 1960; Jordan et
al, 1965; Gustafson, 1969) have described the phenomenon of hair
impaction in the interdental spaces of rodent molars. This is a
condition to which germ-free animals seem especially prone. In
conventional animals, such impaction may add to the tissue
irritation originating from plaque microflora and should therefore
be taken into account as a possible cause of localised periodontal
destruction.
However, the balance of advantages and disadvantages seems to
be that, provided the investigator is aware of the differences
between the mouse model and man, mice have a most important
contribution to make in the investigation of periodontal disease.
1.2.3 PHYSIOLOGICAL CHANGES IN MICE
Mice show a complex series of physiological alterations
involving the molar regions. Cohn (1957), reporting on RAP-albino
mice, stated that "as soon as functional occlusion is attained"
(M^ at 24 days, M2 at 25 days and at 35 days) "and all
through the life of the tooth, the crown is being worn down with
relative rapidity because of the enamel free areas on the cusps.
To compensate for the occlusal wear, there is a gradual deposition
of cellular cementum at the apical end of each tooth which keeps
the teeth in occlusion. The formation of this cellular cementum
is so pronounced in the mature molar, that there is a distinct
hypercementosis at each root tip." Gilmore & Glickman (1959) used
the same strain of mouse and showed that continuous bucco-occlusal
molar eruption occurred after a functional occlusion had been
attained and that the periodontal surface of the buccal plate
underwent resorption while the periosteal surface showed
apposition. The lingual plate showed the opposite changes. Again,
apical cement deposition was noted. The distance between the
alveolar crest and the amelocemental junction (ACJ) in mice
therefore increases with age for non-pathological reasons. Other
authors working around the same time did not appear to appreciate
these normal changes (Baer & Bernick, 1957; Baer & Newton, 1959;
1960), although Baer & Lieberman (1960) and Baer et al, (1963a)
showed that murine occlusal wear per unit time was dependant on
the abrasiveness of the diet. The histological specimens
appearing in the papers of both Baer & Bernick (1957) and Baer &
Lieberman (1959) showed apical cellular cementum deposition.
1.2.4 PERIODONTAL DISEASE IN MICE
1.2.4.1 Spontaneous periodontal disease in the wild
Spontaneously occurring periodontitis has been reported by
Sheppe (1965) for two deer mouse (Peromyscus) populations near
Vancouver, Canada. Advanced disease with both maxillary and
mandibular molar tooth loss was demonstrated in one species living
at higher elevations. The disease was endemic and confined to a
small geographical area. Other animals of the same species in
British Colombia and Washington State, USA were not affected.
Sheppe believed it to have an infectious origin, perhaps with
inherited susceptibility. This Peromyscus oreas species appears
to be the only one in which spontaneous periodontitis is known to
occur in mice in the wild. However, similar disease patterns do
occur spontaneously or can be experimentally induced in highly
inbred strains of laboratory mice (see below).
1.2.4.2 Importance of age
Baer & White (1961) determined the minimum age of disease
development in STR/N mice as between 30 and 50 days of age or
approximately with the onset of sexual maturity. They also
stated that the lesions increased in severity with age. It is
probable that this "bone loss" was a reflection of normal
physiological processes. Rateitschak & Reimers (1969) studied
STR/N mice aged 48 - 83 days on one of three different diets for
up to 450 days. Histological and ACJ-alveolar bone crest
measurements revealed that periodontitis had not developed in 90
day old animals or even in those 165 days old. However the data
confirmed previous observations (Gilmore & Glickman, 1959) that
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the distance between ACJ and alveolar bone crest, while increasing
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with age, was always around twice as great on the lingual
(palatal) aspects of the molars as on the buccal, and this was
consistent with physiological change. Only by 365 - 450 days was
periodontitis apparent and even then only moderate bone loss with
irregular shallow pocketing was found.
1.2.4.3 Variation in susceptibility between strains
Histology was the means by which Baer & Bernick (1957) first
described periodontitis in 10 - 24 month old C57BR/dcJN mice.
They noted that changes occurred regularly in the maxilla but
rarely in the mandible and that these involved the development, by
12 months, of crater-type pockets which, along with degradation of
bone septa both interdentally and in furcation areas, increased in
number and severity with age. Baer & Lieberman (1959; 1960)
examined three strains at 16 months of age (DBA/2JN, C57L/HeN,
STR/N) and a further 6 strains at age 12-24 months (SWR/N, B/HeN,
BRSUNT/N, C57BL/6JN, A/HeN, A/LN). The jaws were defleshed in
papain and bone loss scored 0-4 according to the number of
quarters of roots exposed. The maximum bone loss around any tooth
was taken as the score for that tooth. Strains STR/N and BRSUNT/N
developed lesions related to massive hair impaction. SWR/N,
BL/HeN, C57BL/6JN showed only moderate non-specific periodontitis
regularly and moderate hair impaction. The remaining two strains
(DBA/2JN, C57L/HeN) appeared to be relatively disease resistant.
It was also noted that, in all susceptible strains, the disease
was more severe in the maxilla than in the mandible and more
severe in females than males. The differences in susceptibility
were thought to be genetic but an experiment involving cross¬
breeding and backcrossing of susceptible STR/N and resistant
DBA/2JN mice did not provide evidence to support this hypothesis
(Baer et al, 1961).
Doykos et al (1967) studied the mouse mutant grey lethal (gl)
and showed that the homozygote had retardation of growth, general
inability to resorb bone and no tooth eruption as root formation
is halted after crown eruption. In some animals apparently
typical periodontitis with deep interdental craters, bone loss
and abundant microbial plaque was observed at 10 weeks of age
(Cohen et al, 1969). Sheehan et al, (1972) concluded that the
grey lethal mutant had a high genetic susceptibility to
periodontal disease.
BNL (Brookhaven National Laboratory, USA) mice aged 5-78
weeks were studied by Tonna (1972). Histological examination of
both gingival and periapical regions showed that inflammatory
infiltrate, which both developed more frequently and increased in
intensity with age, occurred at both sites. However, there was no
associated bone loss, and the inflammatory infiltrate remained
always within the gingival connective tissues. It was therefore
suggested that the BNL strain is resistant to periodontitis.
Spontaneous leukaemia in various mouse strains does not seem
to predispose to periodontitis. Leukaemic infiltrates have been
observed in pulp tissue and periodontal membrane spaces adjacent
to bone marrow spaces, but no periodontal damage developed in
either ARK-leukaemic or CFWw mice (Carranza et al 1965; Brown et
al, 1969; Flanagan et al, 1970).
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1.2.4.4 Sublethal X-irradiation
Sublethal X-irradiation up to 9500 rad, of Swiss-Webster mice
(Shapiro et al, 1960; Greulich & Ershoff, 1961) and Swiss and
C57BL mice (Burstone, 1950), resulted in severely disturbed tooth
development and rampant periodontitis with total loss of alveolar
bone, deep periodontal pocket formation and root exposure both at
interdental and inter radicular sites in older animals. The large
crater-like pockets were packed with bacterial deposits attached
at least in part to root surfaces. A latent period of several
months preceded the onset of periodontitis, which eventually came
to affect all animals surviving 100 - 300 days after the first X-
ray exposure. Ultimately, tooth exfoliation occurred leaving a
socket containing a large mass of bacterial plaque. Such events
did not occur in non-irradiated controls (Greulich & Ershoff,
1961). These results were interpreted as implying that bone
marrow damage and the resulting effects on phagocytic cells were
very important in disease susceptibility. In addition, Greulich &
Ershoff (1961) suggested that irradiation may have altered the
oral bacterial flora in some way, thus affecting disease
experience.
1.2.4.5 Histological features
Most investigators have described the inflammatory
periodontal lesion only superficially but they agree that, both
within the junctional epithelium or pocket epithelium and in
connective tissue subjacent or lateral to these epithelia,
leucocytes, mostly neutrophilic granulocytes, tend to accumulate
(Gilmore & Glickman, 1959; Greulich & Ehrshoff, 1961; Tonna, 1972;
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Messer, 1980). In older animals, a slight infiltration of
lymphocytes in a subepithelial position has frequently been
observed (Baer & Bernick, 1957; Rateitshak & Reimers, 1969; Tonna,
1972). The type of periodontal disease seen in various strains of
mice is characterised by the irregular occurrence, chiefly in the
maxillary molar region, of wide interdental and interradicular
craters filled with bacterial masses, hair and cellular debris.
In spite of ulcerations seen in the epithelium lining the crater¬
like pockets (Baer & Bernick, 1957; Shklar & Person, 1975) true
abscess formation has not been seen, even in severe lesions
developing after X-irradiation (Greulich & Ehrshoff, 1961).
1.2.5 BACTERIAL INVOLVEMENT IN MURINE PERIODONTAL DISEASE
1.2.5.1 Bone loss in germ-free mice
Germ-free white Swiss mice 39 days to 6 months and 12 - 30
months of age were examined by Baer & Newton (1959; 1960) and Baer
et al (1964) together with conventional mice of the same strain.
The results showed that the 'bone loss' for germ-free and
conventional mice was essentially the same in both age ranges.
Messer (1980) however, pointed out that Swiss-Webster mice, from
which Baer and colleagues' germ-free colony was derived, were
essentially periodontal disease resistant. The changes described
were again consistent with normal physiological change yet Baer &
Newton (1959; I960) interpreted the data as evidence of disease.
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By defining periodontal disease as the combination of alveolar
bone loss and apical proliferation of the epithelial attachment,
they concluded that disease occurred in germ-free animals without
the presence of inflammation and that "living bacteria are not the
primary etiologic factors in the type of periodontal disease which
occurs in germ-free mice".
1.2.5.2 Implantation of bacteria into the mouths of germ-free
mice
Gibbons et al (1964) successfully implanted human oral
bacteria, including a strain of Bacteroides melaninogenicus, into
the oral cavities of germ-free mice and Gibbons & Socransky (1966)
demonstrated, using a scoring method developed for rats (Gupta &
Shaw, 1956b) that gnotobiotic mice 110 - 145 days old orally
inoculated with human gingival bacteria lost more bone than did
germ-free controls. Thus the inoculated bacteria presumably
induced pathological damage that was superimposed on normal
physiological change.
1.2.5.3 The effect of chlorhexidine
Daily oral treatment of conventional male STR/N mice with
0.2% chlorhexidine, an antibacterial agent used in the management
of human periodontitis, resulted in a mean increase in the
ACJ to alveolar crest distance (on the lingual aspect of each
molar root) of 0.08 mm compared to 0.14 mm in untreated control
mice (Messer & Douglas, 1980). This finding provides further
support for bacterial involvement in pathological periodontal
change in the mouse.
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1.2.5.4 Induction of bone loss by Actinomyces viscosus
Early observations by Keyes (1946) revealed a condition in
hamsters characterised by gingival accumulations of plaque around
the molar teeth, resulting in soft tissue inflammation and
alveolar bone loss. Mitchell & Johnson (1956) demonstrated the
inhibitory effect of penicillin on this condition, implying
bacterial involvement. The infectious nature of the disease was
confirmed by demonstrating its transmissibility (Keyes & Jordan,
1964). In particular, while albino hamsters were not sufferers of
periodontal disease they could become so if plaque was transferred
to them from the mouths of affected golden and cream hamsters
(Jordan & Keyes, 1964). By using this model, it was possible to
show that the disease was induced by specific filament-forming
organisms isolated from infected hamsters. Cultural
characteristics and morphology (Howell, 1963) as well as
biochemical properties (Howell & Jordan, 1963) indicated the
similarity of this organism to certain actinomycetes. Because
inclusion in the genus Actinomyces was not recommended at that
time, the organism was named Odontomyces viscosus (Howell et al,
1965). Later, Georg et al (1969) proposed that the genus be
amended to include catalase-positive strains and the organism was
renamed Actinomyces viscosus.
Development of the rat model as an experimental system for
studying periodontal disease followed a pattern similar to that
traced for the hamster. Early observations on spontaneous
gingival disease noted masses of debris and plaque-like
accumulations in the gingival crevice (Konig & Muhlemann, 1959;
Stewart & Burnett, 1958; Thilander, 1961). The rice rat,
because of particular susceptibility to periodontal disease, has
proved well suited to this type of study (Gupta & Shaw, 1956a).
Again, administration of antibiotics decreased the severity of
periodontal disease (Gupta et al, 1957) thereby suggesting a
bacterial aetiology. As in the hamster, periodontal disease in
the rice rat was shown to be transmissible (Dick & Shaw, 1966) and
later the infectious agent proved to be a Gram-positive, rod-
forming organism (Dick et al, 1968). This description fits with
that of Actinomyces viscosus although no name was given to the
organism. Similar organisms have been found in the cervical
plaque obtained from humans, and various strains have been
isolated from human dental calculus (Gerenczer & Slack, 1969). In
addition, Jordan (1971) stated "in our laboratory we have
routinely isolated catalase positive, filament forming bacteria
from human material. Many strains are morphologically and
biochemically similar to the animal strains." It was the finding
of specific bacteria in animal models that prompted a search for
these organisms in humans. Actinomyces viscosus was consequently
regarded as a possible aetiological agent in human periodontal
disease by Jordan et al in 1972. Several other reports have
demonstrated the association of A. viscosus with dental plaque and
the ability of these bacteria to colonise tooth surfaces (Jordan &
Hammond, 1972; Loesche & Syed, 1978).
The human isolate of A. viscosus, strain T14V, was reported
to produce extensive plaque, root surface caries and bone
destruction characteristic of periodontal disease in germ-free
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rats (Hammond et al, 1976). Fitzgerald et al (1981) used this
same strain to induce periodontal disease in conventionally reared
BALB/c mice. This mouse model of periodontal disease forms the
basis of the current work and will be described in detail in a
subsequent chapter. As it had been shown that Actinomyces species
are especially potent lymphocyte stimulators and are thus
implicated as important agents in the periodontal disease process
(Ivanyi & Lehner, 1971a), Fitzgerald et al (1981) also studied
the immune response, both cellular and humoral, to the organism.
Their findings will be compared and contrasted with those of the
current work in subsequent chapters.
1.2.6 CONCLUDING REMARKS
The fact that animal models in general, and mice in
particular, have a valuable role to play in periodontal disease
research is recognised by many investigators, but this is only
true if the special physiological changes found in these animals
are fully appreciated. Most certainly, the many advantages found
in such an easily manipulated model should generate important
information it would not otherwise be possible to obtain.
1.3 OBJECTIVES OF THE STUDY
The overall objective of the present study was to investigate
the roles of different components of the host defence system in
determining susceptibility to periodontal disease in the mouse.
A number of approaches were envisaged:-
(a) Using mutants with specific disorders of the immune system.
A number of these are available including mutants with specific
defects of T-cells, B-cells, complement components and polymorpho¬
nuclear leucocytes and with diabetes.
(b) Studying naturally occurring disease in these mutants and,
particularly, disease induced by oral inoculation with live
A. viscosus.
(c) Studying the host response in terms of:
(i) Alveolar bone loss in gross defleshed specimens of the
jaws to assess periodontal disease experience. This could be
used to monitor disease progression with time in animals both
exposed and not exposed to A. viscosus.
(ii) Histological sectioning and staining of fixed jaw
specimens to investigate the tissue response. These studies
could be used to describe the presence of plaque, calculus,
hair or foreign body impaction, and the presence and degree
of inflammatory infiltrate, loss of epithelial attachment,
pocket formation and alveolar bone loss. Findings could be
related to alveolar bone loss in the gross specimens.
(iii) Polymorphonuclear leucocyte function tests, consisting
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of chemiluminescence studies to provide measures of general
cellular function and myeloperoxidase assays as a more
specific test of bactericidal potential. These tests would
be performed on peritoneal exudate neutrophils.
(iv) Lymphocyte transformation to indicate the importance of
the cellular component of the immune system. Splenic cells
could be used as a measure of responsiveness of the systemic
immune system and mesenteric lymph node cells as a measure of
responsiveness of the gut-associated immune system. In
addition, study of the stimulation and/or suppression induced
by each system on the other would be possible using co-
cultures.
(v) Serum immunoglobulin studies to determine the role of
the humoral components of the immune system. The levels of
non-specific immunoglobulins of the classes IgG, IgA and IgM,
and of specific anti-A. viscosus immunoglobulin in any mice
inoculated with this organism, could be studied.
(d) Microbiological studies to investigate the naturally
occurring oral flora and the results of oral inoculation with
live A. viscosus. As this organism is found only in relation
to teeth, estimation of carriage/colonisation would be
performed by removal of the molar teeth, grinding these in
growth medium, and plating out the resultant suspension.
From the results of these various investigations, it was
envisaged that it would be possible to reach some conclusions
as to the relative importance of different components of the
host defence system in controlling susceptibility to
periodontal disease in the mouse. In this way, it was hoped
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that new clues might be provided for solutions to the many




MATERIALS, GENERAL METHODS AND PRELIMINARY EXPERIMENT
2.1 MICE
A number of different genotypes were used in the experiments
described in subsequent chapters. Three inbred strains and three
mutants were involved. The inbred strains were BALB/c,
C57BL/6/01a (C57) and CBA/Ca/Ola (CBA), and the mutants beige
(bg), obese (ob) and X-linked immune deficiency (xid). The
choice of mice was made on the basis of ease of availability and
to provide a range of genotypes and defects of immune function.
2.1.1 INBRED STRAINS
The three strains selected have different origins and
consequently are genetically distinct. Each strain has been
maintained by brother-sister mating for at least 15 generations so
that members of the same strain can, for practical purposes, be
regarded as genetically identical.
BALB/c: The BALB/c mice were obtained from a breeding colony at
the Faculty Animal Area, University of Edinburgh. Progenitors of
these mice arrived there from Lac Ltd in 1972 (Olac Manual, OLAC
Ltd, Oxon, UK).
C57: These mice were purchased from OLAC Ltd. The original C57
mice were derived by Little in 1921 from a mating between female
57 and male 52 from Miss Lathrop's stock. Sublines 6 and 10 were
separated prior to 1937 and animals from Subline 6 were sent to
the Jackson Laboratory (Bar Harbor, Maine, USA), and thence to the
Agricultural Research Council (Compton, UK). OLAC first obtained
these animals in 1976 (Olac Manual).
CBA: Mice of the strain CBA were also purchased from OLAC Ltd.
The first CBA mice were derived in 1920 by Strong from a mating
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between a Bagg Albino female and a DBA male. The Ca subline was
sent to the Jackson Laboratory and thence to Haldane and to




The strain used was obtained from OLAC Ltd, Oxon, UK, and is
designated C57BL/6-bg/bg/01a. The mutation arose spontaneously at
Oak Ridge Laboratory (Tennessee, USA) and was back-crossed to
C57BL/6 in 1961 at the Jackson Laboratory (Bar Harbor, Maine,
USA). In 1980, the strain was sent to the OLAC Breeding Unit and,
in 1981, to OLAC isolators after caesarian section, where the line
has been maintained by brother-sister matings (Olac Manual, OLAC
Ltd).
Beige (bg) is an autosomal recessive mutation causing a
condition analogous to the Chediak-Higashi syndrome in man. It is
so-called because one of its effects is on coat colour. Humans
and experimental animals with this disorder are known to have a
number of defects. Included is defective granule formation in a
range of cell types (Padgett et al, 1970). In a survey carried
out by Oliver and Essner (1973), it was found that 15 out of 23
tissues of the beige mouse had giant lysosomes detectable by
histochemical localisation of acid phosphatase activity. Of
these, the greatest aberrations occurred in liver, brain, kidney
and granulocytes. In some tissues, such as kidney proximal tubule
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cells, the giant lysosomes reached a size of up to 11 microns in
diameter (Brandt et al, 1975) taking up most of the total cell
volume. The mechanism of formation of the giant lysosomes is
uncertain, although electron microscopic studies of developing
leucocytes suggest that an abnormally high rate of uncontrolled
fusion of normal lysosomes in younger cells occurs to form the
giant lysosomes in older cells. The basis for this is unknown,
although it could involve reported altered membrane composition or
microtubule function, both of which could affect lysosomal
biogenesis (Davis et al, 1971; Oliver & Essner, 1975).
An interesting alternative mechanism is suggested by the work
of Essner and Oliver (1974) who found that the specialised region
of smooth endoplasmic reticulum, which may be the site of
biosynthesis of lysosomes, was abnormally dilated in the
hepatocytes of beige mice. Abnormally enlarged nascent lysosomes
were detected in this region, indicating that the morphological
aberration may be the result of a defect at the site of
biosynthesis of primary lysosomes. In addition, the fact that
cholinergic agents correct the lysosome defect in rapidly dividing
beige cells such as fibroblasts, but do not in more slowly turning
over cells such as macrophages, is consistent with altered
morphology arising from defective biosynthesis (Oliver et al,
1976). If lysosomal biosynthesis is altered, however, it is
probably a qualitative rather than a quantitative defect, since
studies have shown normal rates of synthesis of at least one
lysosomal enzyme, beta-glucuronidase, in beige mice (Brandt &
Swank, 1976; Swank et al, 1978).
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Other defects found in the Chediak-Higashi syndrome in man
are decreased bactericidal capacity of granulocytes (Root et al,
1972), decreased fusion of lysosomes with phagosomes (Root et al,
1972), decreased chemotaxis (Gallin et al, 1975) and platelet
storage disease (Buchanan & Handin, 1977; Boxer et al, 1977).
Affected individuals suffer repeated bouts of infection and often
enter an advanced lymphoproliferative phase. As a result, few
survive their teens. In human Chediak-Higashi patients and in
beige mice, there is also a defect in cytolysis mediated by
natural killer (NK) cells (Roder 1979; Haliotis et al, 1980),
which normally spontaneously lyse tumour or virus-infected cells
in vitro without prior immunisation (Herberman & Holden, 1978;
Santoli & Koprowski, 1979). Roder and co-workers (Roder, 1979;
Roder & Duwe, 1979; Roder et al, 1979) showed that impaired
cytolysis was neither due to altered organ distribution or
frequency of target binding NK cells nor to a change in target
selectivity, and concluded that the NK defect seen in beige mice
involved the final lethal hit of the NK cell against its target.
A number of authors (Stutman et al, 1978; Paige et al, 1978;
Kumar et al, 1979; Burton, 1980; Burton et al, 1980, 1981; Lust et
al, 1981; Stutman & Cuttito, 1981) have shown that there is
heterogeneity among murine NK cells. One class of NK cell, NK^,
displays preferential cytotoxicity towards lymphoid tumour
targets, is sensitive to treatment with specific anti-NK antiserum
• • • 89and complement, and shows absent or reduced activity in Sr-
treated mice (Kumar et al, 1979; Burton, 1980; Burton et al, 1980;
1981). A second class of NK cell preferentially lyses adherent
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solid tumour targets and is resistant to treatment with specific
anti-NK alloantisera and complement. Normal activity of these
89
latter cells has been reported in Sr-treated mice and these
cells have been termed natural cytotoxic (NC) or NKg cells
(Kumar et al, 1979; Burton et al, 1981; Lust et al, 1981).
It has been shown that NKg cell activity is normal in beige
homozygotes (Burton et al, 1981; Lust et al, 1981; Stutman &
Cuttito, 1981). On the other hand, impaired NK^ activity of
spleen cells against lymphoma targets has been found in beige
homozygotes although this abnormality could be partially or wholly
overcome by prolonging the assay time (Bartlett & Burton, 1982).
The relatively unchecked growth of implanted tumours in beige
mice has suggested that NK cells carry out tumour surveillance in
normal individuals (Talmadge et al, 1980; Karre et al, 1980). As
for protection against viral infection, little was known about the
role of NK cells till the work of Shellam et al (1981) on the NK
reaction to murine cytomegalovirus (MCMV) was published. While
adoptive protection against MCMV can be conferred by T cells from
immune mice (Starr & Allison, 1977; Ho, 1980), the primary
cytotoxic T cell response is difficult to detect (Ho, 1980) and
significant cytotoxicity is not observed before the fourth day of
infection (Quinnan et al, 1980). Thus, while susceptible mice die
within 3-4 days of infection and mice of resistant strains survive
(Chalmer et al, 1977), protection of resistant mice by an early
non-T cell mechanism appears likely.
In support of an early protective role for NK cells, it has
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been shown that their cytotoxicity is rapidly enhanced during MCMV
infection and that they lyse MCMV-infected cells i_n vitro (Quinnan
& Manischewitz, 1979; Bancroft et al, 1981). A significant
positive correlation between resistance to lethal MCMV infection
and the level of NK cytotoxicity has been demonstrated at one day
after infection in a number of mouse strains (Bancroft et al,
1981). Shellam et al (1981) reported that NK deficient beige mice
were more susceptible to MCMV than heterozygous litter mates.
This increased susceptibility to viral infection in beige mice
strongly suggests that NK cells have a protective role in early
MCMV infection.
In 1976, Lavine et al demonstrated that mutant mink suffering
from the Chediak-Higashi syndrome showed a far greater severity of
periodontal bone loss than their non-mutant counterparts. At the
end of this publication, it was suggested that beige mice may be
similarly afflicted. This influenced the choice of beige mice for
the present study as it was anticipated that they would show a
high level of spontaneous disease.
2.1.2.2 Obese
The strain obtained from OLAC Ltd, Oxon, UK, is designated
C57BL/6-ob/01a. The mutation arose spontaneously in an outbred
multiple recessive stock prior to 1950 at the Jackson Laboratory
(Bar Harbour, Maine, USA). In 1978, these animals were sent to the
OLAC breeding unit after caesarean derivation (Olac Manual, OLAC
Ltd, Oxon, UK).
Obese (ob) is an autosomal recessive mutation which, on the
C57BL/6 background, causes marked obesity, hyperphagia, transient
hyperglycaemia and markedly elevated plasma insulin concentration
(10-50 times normal) associated with an increase in the number and
size of the beta-cells of the islets of Langerhans (Coleman,
1982). The obesity is of the hypertrophic-hyperplastic type, both
the size and number of adipocytes being increased (Johnson &
Hirsch, 1972). This is in contrast to most other rodent models of
obesity where adipocyte enlargement alone is responsible for the
massive fat stores (Coleman, 1982). Homozygotes of both sexes are
infertile and must be obtained either by mating heterozygotes or
by mating male heterozygotes to normal females into which ovaries
from mutant obese females have been transplanted (Coleman, 1982).
Biochemical studies have shown that the activities of most
insulin-dependent enzymes are increased, the rate of liver and
adipose tissue lipogenesis is more than twice normal, and that
marked insulin resistance is associated with a down-regulation in
the numbers of insulin receptors in several tissues (Chang et al,
1975; Soil et al, 1975). This loss of receptor sites is associated
with progressive hyperglycaemia and seems general in all obesity
mutants studied (Coleman, 1982). Down-regulation of receptor site
may be a mechanism whereby the mutants are protected against
lethal hypoglycaemia which would occur if the high concentrations
of circulating insulin were fully effective. Those enzymes
involved in gluconeogenesis that normally are decreased in the
hyperinsulinaemic state remain elevated in obese mice and probably
contribute to the hyperglycaemia. Increased gluconeogenesis
occurs early in development in several obesity mutants and may be
associated with the loss of insulin receptor sites in specific
target cells (Coleman, 1982).
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The obese mouse has many defects that suggest a hypothalamic
disorder. These include hyperphagia, hyperinsulinaemia,
infertility and defects in thermoregulation (Coleman, 1982).
Despite the hyperphagia, obese mice are remarkably efficient with
regard to utilization of food. Mutants can maintain weight and
deposit excess lipid even when food intake is restricted to 50% of
the normal mouse requirement. The factors causing this increased
metabolic efficiency are unknown but, when established, could have
major implications regarding how different modes of energy
utilisation contribute to the development of diabetes and
obesity.
Of the factors implicated in periodontal disease,
abnormalities of collagen and cell-mediated immunity have been
studied in obese mice. A deficiency of collagen formation during
wound healing has been reported (Goodson & Hunt, 1979), and skin
collagen has shown abnormal mechanical and chemical properties
(Enser & Avery, 1984). Thompson et al (1983) found resistance to
melanoma metastasis and an enhanced T-lymphocyte mitogenic
response, while Meade et al (1979) reported that the ability of
spleen cells to kill mastocytoma target cells was impaired in
obese mice. Similarly, Chandra (1980) reported that NK activity
was increased while Clark et al (1981) found that it was reduced
in these mutants. Further investigation of the immune responses
of obese mice is therefore indicated. There is some suggestion
that any abnormality of cell-mediated immunity may be the result
of the metabolically abnormal tissue environment rather than
intrinsic to the immune system itself (Meade et al, 1979; Chandra,
1980).
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2.1.2.3 X-linked immune deficiency
The strain obtained from OLAC Ltd, Oxon, UK, is designated
CBA/HN/Ola. The origin of strain CBA was as described above. The
H subline reached the National Institutes of Health, Bethesda,
USA, in 1966, where the X-linked immune deficiency (xid) mutation
was discovered (Olac Manual, OLAC Ltd).
Hemizygous males and homozygous mutant females are affected.
The defect is characterised by inability to mount an antibody
response to various helper T cell-independent (TI) antigens, low
immunoglobulin (Ig)M antibody responses to some helper T cell-
dependent antigens, as well as low serum IgM and IgG2 levels
(Amsbaugh et al, 1972; Scher et al, 1973; Amsbaugh et al, 1974;
Press, 1981; Scher, 1982a). B cells of xid mice express a low
ratio of IgM to IgD surface Ig (Finkelman et al, 1975) and are
extremely susceptible to the induction of immunological tolerance
(Metcalf et al, 1980). They also lack Lyb-3,5 and 7 alloantigens
which are normally expressed by mature B cells (Huber et al, 1977;
Ahmed et al, 1977; Subbarao et al, 1979). Mosier et al (1977)
proposed that TI antigens could be divided into two categories,
TI-1 antigens which elicit an immune response in xid mice and TI-2
antigens which do not.
B lymphocytes from normal mice comprise a mixture of mature
and immature cells (Scher, 1982b; Mond, 1982; Huber, 1982).
Immature B cells arise early in ontogeny, express a high density
of surface IgM, lack Lyb-3,5 alloantigens, respond to TI-1 and not
TI-2 antigens and reside largely in the spleen. Mature B cells
develop late in ontogeny, express Lyb-3,5 alloantigens and a low
density of IgM, respond to TI-2 and not TI-1 antigens and occupy
both spleen and lymph nodes (Sprent et al, 1985). Whether these
two subsets represent distinct lineages or different developmental
stages of the same lineage remains unclear. In attempting to
resolve this question, much emphasis has been placed on studying
the properties of xid B cells, which exhibit many of the
properties of immature B cells of normal adult mice. This has
given rise to the notion that xid mice are selectively devoid of
mature cells, the lack of these cells reflecting either a stem
cell defect in the mature B cell lineage or a block in the
differentiation of immature to mature B cells (Huber, 1982).
However, Sprent et al (1985) showed that, in terms of cell
distribution in the lymphoid tissues, homing properties, capacity
to recirculate and rate of turnover, the majority of xid B cells
are indistinguishable from the mature B cells of normal mice. On
the other hand, in terms of total numbers, these authors found
that xid mice contained only about one-third of the number of B
cells recovered from non-defective mice. Significantly though,
this quantitative deficiency of B cells in xid mice was no more
marked in lymph node or thoracic duct lymph than in spleen,
implying that the ratio of recirculating cells to sessile (or
spleen-seeking) cells in xid mice is no less than in normal mice.
Evidence for long-lived circulating B cells in xid mice has come
from recent studies by Chaudhuri et al (1983).
Work by Kiyono et al (1983) investigated the secretory immune
system in xid mice. Their experiments showed that the gut-
associated lymphoreticular tissue (GALT), such as Peyer's patches
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(PP), possessed unique populations of T cells which supported in
vitro responses in xid B cell cultures from both the spleen or PP,
and thus directed mature B cell populations present towards IgA
isotype specific responses. While the magnitude of the response
in xid mice was found to be lower than in similarly treated non-
xid controls, the work showed the xid secretory immune system to
be operative. This is clearly important in any experimentation
involving oral antigen administration.
2 1.3 MAINTENANCE AND CROSSES
All the mice were maintained at a constant temperature of
70°F and housed at a maximum of 10 animals per cage. Food and
water were given ad libitum except as stated otherwise in the
experimental schedule. A 12 hours light and 12 hours darkness
cycle was automatically controlled. Uninoculated mice and mice
inoculated with A. viscosus were kept in different rooms and the
infected animals' food bowls and water bottles were washed
separately to avoid cross-infection. All mice were weaned at
three weeks of age. Both a standard laboratory diet and a special
high carbohydrate/low fat diet were used (see Appendix).
Mice of the required genotypes were obtained as follows:
(a) BALB/c mice of the appropriate age were bought from a large
breeding colony at the Faculty of Medicine Animal Area
(University of Edinburgh).
(b) Both the C57 and bg/bg stocks were maintained first by
breeding pairs of the originally purchased animals and
subsequently by breeding pairs of their progeny.
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(c) +/bg heterozygotes were produced by mating C57 males with
bg/bg females.
(d) ob/ob mice were bought in the numbers required as the
maintenance of obese stocks posed special difficulties.
(e) To obtain the different xid genotypes, 10 xid/xid females,
xid/Y males and 10 female and 10 male CBA mice were
bought. Matings were as follows:-
(i) Female Male
Parents xid/xid +/Y(CBA)
Offspring +/xid (discarded) xid/Y(kept)
(ii) Female Male
Parents +/+ (CBA) xid/Y
Offspring +/xid (kept) +/Y (kept)
2.1.4 SUSCEPTIBILITY TO BACTERIAL PATHOGENS
A summary of previous work involving bacterial challenge of
certain of the mouse genotypes used in the present study or
related strains is shown in Table 2.1, though none of the
organisms investigated previously have been considered periodont
pathogens. In each case (except Hector et al, 1982), resistance
or susceptibility was judged according to whether or not the
animals died as a consequence of inoculation with the named
organism.
The clear conclusion is that there is variation in response
of different genotypes to the same organism and of the same
genotype to different organisms. There is some suggestion that
CBA has tended to be less susceptible than the other two inbred
strains, although this did not apply to infection by Candida
albicans.
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Studies of the progeny of crosses between strains susceptible
and resistant to certain organisms have suggested the existence of
autosomal dominant resistance genes (Wardlaw, 1970; Plant & Glynn,
1976; Gros et al, 1981; Brown et al, 1982). However, O'Brien et
al (1979,1981) showed that susceptibility to Salmonella
typhimurium infection can be X-linked.
Table2.1




























BALB/c C57BL/6 C57BL/10 CBA/CaHN xid(CBA/N)
+ + +
Intraperitoneal orintravenous Subcutaneous Intraperitoneal orintravenous
O'Brienetal,1979 Plant&Gly n,1976 O'Brienetal,1981






There are a number of pathogenic microorganisms that resemble
both bacteria and fungi. Some of these are included in the order
Actinomycetales and one genus in this order is Actinomyces,
whose members are non-sporulating, filamentous, anaerobic or
microaerophilic Gram-positive bacilli. These organisms are found
as commensals in the oral cavity, the predominant species being
Actinomyces israelii, the principal cause of human actinomycosis,
Actinomyces naeslundii and Actinomyces viscosus (Burnett &
Schuster, 1978). A. viscosus, in particular, has been implicated
in both human and animal gingivitis and periodontitis.
2.2.1.1 Colonisation
A study by Socransky et al (1977) showed that Streptococcus
sanguis and A. viscosus were predominant among the pioneer
colonisers of newly cleaned tooth surfaces. Dextrans from several
sources aggregated cells of some A. viscosus strains (Bourgeau &
McBride, 1976) and some A. viscosus strains attached to S. sanguis
by mechanisms that apparently did not involve dextrans (Mclntire
et al, 1978; Cisar et al, 1979). In vitro co-aggregation of
A. viscosus and Veillonella strains in the form of corn-cob and
bottle-brush aggregates is mediated by extracellular polymers
synthesised by A. viscosus (Newbrun, 1979).
Further information on A. viscosus colonisation and
aggregation comes from experiments on gnotobiotic rats. Rats
monoinfected with strain T14-Vi suffered periodontal damage as
assessed by bone loss while those infected with T14-AV did not
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(Brecher et al, 1978). Electron microscopic studies of involved
teeth showed much fewer T14-AV to be present than T14-Vi and
further examination of the cell surfaces of each strain showed
that T14-Vi possessed more surface fibrils than strain T14-AV. In
addition, the fibrils present on strain T14-Av were embedded in an
extracellular capsule (Powell et al, 1978). Perhaps the reduced
number of surface appendages and their occlusion in extracellular
material reduced the adsorption to, and subsequent colonisation
of, tooth surfaces by T14-AV and resulted in lower pathogenicity
relative to strain T14-Vi.
2.2.1.2 Gingivitis
Recent in vitro research into the surface adsorption of
A. viscosus seems to point to the involvement of at least two
antigenically distinct and functionally independent surface
fimbriae. Monospecific antifimbrial IgG and Fab fragments and
fimbrial deficient mutants of A. viscosus strain T14V have been
used to show that type 1 fimbriae mediate the adsorption of
A. viscosus strain T14V to saliva-treated hydroxyapatite surfaces
in vitro (Clark et al, 1984; Clark, 1985). The type 2 fimbriae
have been shown to mediate interbacterial aggregation between
A. viscosus strains and other plaque bacteria such as
Streptococcus sanguis (Cisar et al, 1979, 1981, 1983;
Kolenbrander, 1982; Revis et al, 1982).
While functional activities have been associated with each
type of A. viscosus fimbriae, these adhesions have not been
structurally characterised because isolated fimbriae are resistant
to complete dissociation (Cisar, 1986). Therefore, cloning of A.
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viscosus genes in Escherichia coli was initiated as an approach to
the identification of the fimbrial subunits. A type 2 fimbrial gene
was cloned by Donkersloot et al in 1985 and a type 1 fimbrial unit
was cloned by Yeung et al in 1987. It is hoped that these advances
will facilitate further studies to increase our understanding of
A. viscosus colonisation.
In the gingival crevice and periodontal pocket, there is a zone
of plaque that is directly attached to the tooth or calculus
surface. The organisms in this zone are mainly Gram-positive rods.
Included is A. viscosus, reflecting its role in early colonisation.
The development of gingivitis as such is, however, thought to be
caused by the bacteria associated with the subsequent increase in
supragingival and gingival margin plaque formation. The Gram-
positive filamentous rods, mainly Actinomyces species, including
A. viscosus, appear to be of major significance in this clinical
condition (Slots, 1977).
In experimental gingivitis, there is an increase in the total
mass of supragingival plaque as well as increased proportions of
members of the genus Actinomyces. This genus tends to be dominant
in supragingival plaque and frequently comprises 50% or more of the
total bacterial isolates.
The bacteriology of human experimental gingivitis has been
studied relative to plaque age (Syed & Loesche, 1978) and to plaque
and gingivitis scores (Loesche & Syed, 1978). These authors showed
that while streptococci dominated in early plaque, Actinomyces
species, including A. viscosus, dominated in older plaques and were
associated with gingival bleeding. These studies are important as
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they suggest that proportional changes in the subgingival
microflora may uniquely contribute to the development of gingival
inflammation.
2.2.1.3 Periodontitis
In chronic periodontitis, there is a large amount of attached
subgingival plaque (Listgarten, 1976) in which filamentous
organisms such as A. viscosus are numerous (Socransky, 1977);
Darwish et al, 1978). Experimental studies in gnotobiotic rats
and pathogen-free hamsters suggest a degree of specificity of
bacteriological involvement in the pathogenesis of this condition.
The pathogenic potential of certain Gram-positive bacteria which
formed plaque in gnotobiotic rats fed high sucrose diets was
tested, and certain microorganisms, including A. viscosus,
resulted in accelerated alveolar bone loss (Jordan et al, 1972;
Guggenheim & Schroeder, 1974; Irving et al, 1974; Crawford et al,
1978a & b). In 1981, Fitzgerald et al published their method of
inducing periodontal disease in conventionally maintained mice fed
a high sucrose diet by oral inoculation with live A. viscosus.
When the skin of humans with periodontitis was tested with
antigen prepared from A. viscosus, a positive hypersensitivity
reaction was produced (Nisengard et al, 1968). Lymphocytes from
patients with gingivitis and periodontitis exhibited a blastogenic
response to antigens prepared from A. viscosus while lymphocytes
from disease-free controls did not respond (Patters et al, 1976),
thus implicating this organism in the pathogenesis of periodontal
disease.
However, A. viscosus may not act in isolation. Recently it has
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been reported that it is necessary for plaque to contain Actinomyces
species and other Gram-positive bacteria for Bacteroides
melaninogenicus, an important periodontopathogen, to become part of
the resident oral microflora (Sidaway, 1979).
2.2.2 AIMS
A. viscosus was to be used to induce periodontal disease, along
the lines described by Fitzgerald et al (1981), in host mice of
different genotypes. Accordingly, there were three main aims of the
bacteriological work:
(a) Successful culture and identification of the organism by
morphological and biochemical means.
(b) Preparation of an antigen from the organism to be used in
subsequent immunological tests.
(c) Preliminary investigation of the antigen produced.
2.2.3 TECHNIQUES
2.2.3.1 Source and stock
The organism used was Strain 10951 of Actinomyces viscosus
obtained as lyophilised cultures from the National Collection of
Type Cultures, London (NCTC). Lyophilised cultures were
reconstituted with a few drops of Cooked Meat Broth (CMB: see
Appendix), then transferred to 10 ml of the same medium. After
aerobic incubation for 24 hours at 37°C these CMB cultures
remained at room temperature and served as stock cultures for
further tests.
2.2.3.2 Culture
As A. viscosus is described as microaerophilie, initial
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culturing was performed under both aerobic and anaerobic
conditions, with the latter carried out using anaerobic jars and
the Gas Pak system (Becton Dickinson UK Ltd), a disposable carbon
dioxide and hydrogen generator. Visual assessment of growth by
turbidity checks comparing the two modes of culture showed that
aerobic culture produced greater growth. Aerobic culture was
therefore used for all subsequent work. Both liquid- and solid-
phase culture was performed.
Liquid-phase culture was carried out by adding three drops of
CMB stock culture to proteose peptone yeast medium (PPY: see
Appendix) supplemented with 1 ml 2% sodium carbonate and 1 ml
3.75% cysteine hydrochloride per 50 ml PPY. This was then
incubated for 48 hours at 37°C. Each time such a culture was
produced, a purity check was carried out by plating one drop of
the culture on blood agar and examining all colonies in terms of
gross morphology and Gram staining.
Solid-phase Culture was carried out on two types of agar
plate:
(a) Blood agar, prepared by adding out-dated human blood to
Columbia agar base (Oxoid Ltd, London, UK) to a concentration
5% (v/v).
(b) Semiselective agar, produced as above with the addition of
10 mg colistin sulphate and 15 mg nalidixic acid per litre
agar base.
In both cases, 15 ml of agar was dispensed into each plate
and plates were either used fresh or stored for up to one day at
4°C. After plating out on either medium, incubation at 37°C
for 48 hours resulted in recognisable growth.
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2.2.3.3 Identification
A. viscosus NCTC 10951 was identified by a number of tests
used to monitor its presence throughout the various experiments
described in subsequent chapters:-
(a) Morphology on agar plates
Colonies on blood agar were flat, smooth, greyish in colour, and
approximately 2 mm in diameter. On the semiselective agar, they
were more domed in shape and were whiter in colour, but again of
size approximately 2 mm in diameter. On both media, alpha-
haemolysis was seen.
(b) Gram stain
Gram stain produced an appearance of Gram-positive bacilli.
(c) Biochemical tests
To perform these, a few drops of CMB stock culture were placed
in 20 ml supplemented PPY medium and incubated at 37°C overnight
to produce a working culture. From this, 1 ml aliquots were taken
to perform the following tests:
(i) Sugar Fermentation Tests:- Here the culture was added
to sugar containing tubes to produce a 1% final concentration of
ribose, raffinose, mannitol or glucose. A control tube containing
no sugar was also included and all tubes were incubated
aerobically for 24 hours at 37°C. After this time, tube pH
changes were recorded either by pH meter or by addition of 30 pi
0.01% bromothymol blue indicator. A pH decrease in excess of 0.5
pH unit or a change to yellow colour relative to control was
considered a positive result.
(ii) Urease test:- The culture was added to a tube containing
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urea to a final concentration of 1%. After 24 hours of incubation
at 37°C, the pH change was recorded either coloriraetrically or
by pH meter. Production of a blue colour or an increase in pH of
0.5 pH unit relative to control was considered a positive result.
(iii) Catalase test:- A few drops of 10% v/v hydrogen peroxide
were added to 1 ml of the culture. Bubble production indicated a
positive response.
(iv) Nitrate test:- 200 pg ml"''" potassium nitrate was added
to 1 ml of the culture and incubated aerobically at 37°C
overnight. The next day 0.2 ml of Nitrate Test Solution 1 was
added, followed by 0.2 ml of Nitrate Test Solution 2 (see
Appendix). The development of a red colour was taken to indicate
a positive result.
(v) Gas-liquid chromatography (GLC):- Cherry and Moss (1969)
described gas-liquid chromatography as a rapid and sensitive
technique for the analysis of certain microbial cell components or
their products that would aid taxonomists and clinicians. Certain
short chain volatile fatty acids are characteristic of many
organisms (eg. propionic, butyric, isobutyric, valeric and
isovaleric acids), although GLC profiles cannot alone identify an
organism to species level (Holdeman et al, 1977). A number of
authors have reported the effects of growth medium composition on
GLC profiles of metabolic fatty acids (Deacon et al, 1978;
Lombard, 1979; Turton et al, 1983a & b). However, as all the
organisms used in this study were cultured in supplemented PPY,
this problem was avoided. A 48 hour PPY culture of A. viscosus
was produced as described earlier, and five drops of 50% sulphuric
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acid were added to 5 ul of culture and well mixed. The culture
i
was then centrifuged at 1000 g for 15 minutes and the supernatant
collected for analysis of volatile fatty acids. Methyl
derivatives of non-volatile fatty acids were prepared according to
Holdeman et al (1977). Samples (1 pi) were then analysed by GLC
using a column of SPIZZO on chromosorb WAW (Supelco Inc,
Belefonte, Pennsylvania, USA) at a temperature of 147°C.
Gas flow rates were as follows:-
oxygen free nitrogen 35 ml min-'''
(the carrier gas)
hydrogen 35 ml min ^
air 525 ml min-'"
A Pye Unicorn 104 chromatograph with a flame-ionisation
detector (200°C) was used. Standard solutions containing
volatile and non-volatile fatty acids were injected into the
column for comparison prior to samples. The concentration of
a particular acid in a sample was calculated, from the size of
the corresponding peak traced on a recorder, by the following
equation:-
Concn. of acid = Peak height of test/Peak height of standard
The results of biochemical tests on A. viscosus NCTC 10951 are
shown in Table 2.2.
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Table 2.2 Results of biochemical tests on A. viscosus NCTC 10951
Sugar Fermentation:
Sugar pH Change 0.5 pH Unit Colour Change
Ribose -ve -ve
Raffinose +ve to yellow
Mannitol -ve -ve
Glucose +ve to yellow
Urease Test: pH increase 0.5 pH unit relative to
control and a colour change to blue
Catalase Test: Positive
Nitrate Test: Positive
GLC: The fatty acid end products of
metabolism for A. viscosus were:
Acetic acid 4.7 )
Lactic acid 18.8 ) moles ml"
Succinic acid 4.4 )
2.2.3.4 Comparison of Actinomyces viscosus recovery from
blood agar (BA) and semiselective agar (SSA) plates
Successful culture and identification of A. viscosus was
essential if disease induction via oral inoculation of the
organism was to be possible. If pure cultures of A^_ viscosus were
to be used exclusively, ordinary blood agar plates for solid phase
culture would have been adequate. However, it was envisaged that
recovery of A. viscosus from mixed flora would be required in
subsequent experiments, so use of a semiselective agar (SSA) to
facilitate this was deemed appropriate. The addition of colistin
sulphate and nalidixic acid does not permit the growth of many
Gram-negative organisms. Any such selective agar is often,
however, at least partially inhibitory to most other organisms. It
was therefore important to determine whether the inhibition would
be too great for adequate growth of A. viscosus NCTC 10951.
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A 48 hour culture of A. viscosus was prepared as previously
described and a bacterial count performed using a 0.1 mm depth
Thoma Ruling Cell Count Chamber (Hawksley Ltd, Lancing, UK).
This suspension underwent a 10"^ dilution, and 100 ul of this
was plated out on each of five blood agar and five SSA plates.
The plates were then aerobically incubated at 37°C for 48 hours
and the resultant colonies counted.
The original cell count of the 48 hour culture was 1.09 x
10^ cells ml-^". Thus, plating of 100 ul at a 10"^ dilution
resulted in plate reception of 1090 potential colony forming units
(cfu) per plate. The counts produced on each of the five plates







Mean + s.e. 845 + 42 ' 533 + 15
Mean as a proportion of plate reception:
for BA = 78% for SSA = 49%
There was thus a statistically significant difference in
colony forming ability between the two media. However, inhibition
by SSA was not too great to allow adequate growth of A. viscosus
and so, in all subsequent recovery experiments, the semiselective
agar was used. The use of blood agar was restricted to purity
checks of cultures.
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2.2.3.5 Preparation of an EDTA antigen extract from
A. viscosu8
This antigen was produced using a modification of the method
described by Poxton and Brown (1979). As often as required, two
litres of 48 hour A. viscosus culture in supplemented PPY medium
was prepared as previously described and, after purity checks, the
cells were washed three times in phosphate buffered saline (PBS)
with the first wash involving spinning the cells at 17,500 g for
10 minutes and the following two at 20,000 for 10 minutes. The
pellets produced after the third wash were resuspended in 2 ml
each of 10 mM ethylene-diamine-tetraacetic acid (EDTA) at neutral
pH and placed in glass tubes in a 45°C water bath for one hour.
This suspension was then centrifuged at 10,000 g for three minutes
and the supernatant containing the antigen extract transferred to
acid-washed Bijou bottles. The protein content of individual
EDTA extracts was estimated by the Lowry method (Lowry et al,
1951) using 2 mg ml"''" bovine serum albumin as the standard.
2.2.3.6 SDS PAGE of EDTA A. viscosus extract
In recent years, a technique that has received much attention
as an aid to taxonomic studies of bacteria is polyacrylamide gel
electrophoresis (PAGE). This procedure involves the separation of
cell extracts, usually proteins, according to molecular size by
the sieve-like effects of the porous acrylamide gel, and their
visualisation by staining with, for example, Coomassie blue,
silver or amido black. Such proteins are made soluble with sodium
dodecyl sulphate (SDS) which is the anionic detergent used to
resuspend samples before their application to gels and is also
included in electrophoresis buffers and gels themselves. SDS
dissociates proteins into monomeric polypeptides and coats them
with a uniform negative charge, thus promoting their migration
towards the anode during electrophoresis. The rate of migration of
these molecules, and therefore their final position in the stained
gel, is determined by their molecular weight and the gel pore
size. An additional function of SDS is to prevent re-aggregation
of polypeptides into their native configurations. Polyacrylamide
gels consist of acrylamide and methylene bis-acrylamide,
polymerised by the addition of ammonium persulphate and tetra-
methyl-ethylene-diamine. Two types of gel are used, gradient gels,
in which the concentration of acrylamide increases away from the
point of sample application or, more commonly, and as was used in
this study, homogeneous gels.
A modified version of the method of Laemmli (1970) was used
as described by Poxton and Brown (1979). Vertical slab gels (170
x 140 x 1 mm) consisted of a 10 mm 4% acrylamide stacking gel
above a 10% acrylamide separating gel. Samples of the EDTA extract
containing 100 ug protein per 100 ul single strength sample buffer
(containing SDS and boiled for three minutes) were added to a well
in the stacking gel and run under the following conditions.
60 V was applied to the gel to move samples through the stacking
gel (1-2 hours) followed by 150 V until the sample buffer front
(indicated by bromophenol blue) was approximately 2 cm from the
bottom of the separating gel (2-3 hours). Gels were then stained
with Coomassie blue (Poxton & Sutherland, 1976).
A photograph of an SDS PAGE separation of the EDTA
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A. viscosus extract is shown in Figure 2.1. Many bands are
present, confirming that the antigen was a crude mixture of
fragments.
Fig 2.1 SDS PAGE separation of the EDTA A. viscosus extract




This experiment confirmed a similar piece of work reported by
Fitzgerald et al in 1981. These authors found that oral
inoculation of A. viscosus resulted in colonisation of the teeth
only, and that recovery of the organism could be achieved by
grinding the molars of infected animals in growth medium and
plating out the resultant suspension. The experiment was carried
out in the present study:
(a) to practise the oral inoculation procedure;
(b) to determine appropriate dilutions and volumes of molar
suspensions to plate out for colony counting;
(c) to determine whether the age of mice at the time of
inoculation affected subsequent organism recovery;
(d) to confirm that the method used resulted in recovery of an
organism indistinguishable from that originally inoculated.
2.3.2 MATERIALS AND METHODS
The experiment was performed according to the schedule shown
in Figure 2.2.
Five BALB/c mice were obtained at the following ages:
3 weeks, 11 weeks and 19 weeks. All the mice were fed, ad
libitum, the special high carbohydrate low fat diet used in
subsequent experiments (see Appendix).
A 48-hour culture of A. viscosus in supplemented PPY medium
was prepared as described previously. The number of organisms
-1 • . 8
ml was then determined and the culture adjusted to 3.2 x 10
organisms ml-^". Seven days after instituting the special diet,
one 50 ul aliquot of the A. viscosus suspension, containing 1.6 x
10^ cfu, was placed in the mouth of each of the 15 mice using a
micropipette (Anachem Ltd, Luton, UK) with a fresh sterile
disposable pipette tip (Flow Labs, Rickmansworth, UK) for each
inoculation. The animals were left without water overnight and
the inoculation procedure repeated with fresh 48-hour cultures on
the two successive days. The mice were then given food and water
ad libitum.
Seven days after completion of the inoculation procedure, one
mouse per group was sacrificed by ether inhalation and its molars
were removed. The three molars from each quadrant of each mouse
were ground in 2 ml supplemented PPY medium using a tissue
homogeniser. Serial dilutions of each suspension were made to
-1 - 2 - 5
produce four working dilutions; 0, 10 ,10 , 10 J; and
200 pi of each of these was plated in triplicate on SSA. Plates
were incubated aerobically at 37°C for five days and examined
for A. viscosus growth. After this time, visual evaluation was
used to determine the appropriate dilution for the remaining mice
of each age group. The remaining four mice per group were
sacrificed by ether inhalation 12 days after completion of the
inoculation procedure. Molars were removed by quadrant and ground
in 2 ml of supplemented PPY as before. 200 pi of the appropriate
dilution suspension (as determined from the single mouse of each
group) was plated in triplicate on SSA and incubated aerobically
at 37°C for five days. Colony counts were then made and random
samples of colonies subjected to the identification procedures
described previously.
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5 mice at 3 weeks old (Group A) on special diet
5 11 (Group B)
5 19 (Group C)
7 days
♦
Oral inoculation with 1.6 x 10^ cfu A. viscosus (x3)
7 days
(1 mouse per group)
Molars ground in 2 ml growth
medium by quadrant
Incubated (AO2) on selective
agar
Diln: 0, 10"1, 10"2, 10"3
12 days












Serial dilutions from the single mouse of each group showed that
the appropriate dilutions by age at inoculation were:




Colony counts were as given in Table 2.3, and the differences
in recovery with age at inoculation are summarised in Figure 2.3.
The peak at 12 weeks was so extreme that a formal test of
statistical significance was not required.
The identification procedures showed that the organism
recovered was indistinguishable from that inoculated.
2.3.4 DISCUSSION
The A. viscosus recovery procedure necessarily resulted in a
culture of mixed oral floras on the agar plates. An incubation
time of five days proved to be required to produce adequate growth
of A. viscosus colonies on these plates compared with two days for
those receiving only a pure culture of A. viscosus. It must
therefore be assumed that the other organisms have a partially
inhibitory effect on A. viscosus growth. In all subsequent
recovery experiments plates were therefore incubated for five
days.
The identification procedures showed the organisms recovered
to be indistinguishable from that originally inoculated. This
confirms that the colonies cultured were truly A. viscosus and not
another related actinomycete and shows that new strains of the
organism did not develop in the mouse mouths with time.
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Table 2.3 Means of triplicate colony counts per mouse quadrant
for different ages at inoculation. UR, UL, LR, LL =
upper right, upper left, lower right, lower left.
O
cfu per quadrant (xlO )
Age at Mouse UR UL LR LL Mouse Mean
inoculation
(weeks)
4 1 2.36 2.22 2.36 2.23 2.29
4 2 2.23 2.25 2.12 2.42 2.25
4 3 2.30 2.26 2.08 2.38 2.25
4 4 2.37 2.44 2.07 2.38 2.31
Quadrant Mean 2.31 2.29 2.16 2.35 Overall Mean = 2.27 x 10-
cfu per quadrant (xlO )
Age at Mouse UR UL LR LL Mouse Mean
inoculation
(weeks)
12 1 1.44 1.40 1.45 1.45 1.44
12 2 1.42 1.50 1.39 1.42 1.43
12 3 1.38 1.41 1.32 1.35 1.36
12 4 1.44 1.37 1.40 1.44 1.41
Quadrant Mean 1.42 1.42 1.39 1.41 Overall Mean
cfu per quadrant (xlO3 )
Age at Mouse UR UL LR LL Mouse Mean
inoculation
(weeks)
20 1 1.78 2.08 1.69 2.30 1.96
20 2 0.83 1.05 1.04 1.57 1.12
20 3 1.63 1.18 1.59 1.95 1.59
20 4 0.78 1.34 1.54 0.88 1.14
= 1.41 x 10-
Quadrant Mean 1.26 1.41 1.46 1.67 Overall Mean = 1.45 x 103
Figure 2.3 Recovery of A. viscosus 12 days after inoculation with
1.6 x 107 cfu on each of three successive days at
different ages.
Recovery of A. viscosus was relatively low in animals
inoculated at four weeks, peaked markedly in those inoculated at
12 weeks and fell again in those inoculated at 20 weeks. This
result is similar to that described by Fitzgerald et al (1981) and
indicates that age-related host factors influence the colonisation
of A. viscosus. Brecher and van Houte (1979) reported a similar
effect in rats infected with A. viscosus, and the phenomenon has
also been described for other bacterial species (van Houte et al,
1977). The reasons for the age effect are obscure but may involve
previous colonisation of the tooth surface with bacteria that can
compete for the same site as A. viscosus. However, whichever the
cause, this result underlined the need in subsequent experiments
to use mice of the same age.
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2.4 MAIN EXPERIMENTAL SCHEDULE
The experimental schedule described here and summarised in
Figure 2.4 formed the basis of all the disease induction studies
for different mouse genotypes. It was developed from the work of
Fitzgerald et al (1981) and the results of the preliminary
experiment.
For each genotype examined, a maximum of 60 mice aged 4-6
weeks were divided into five groups of 12 mice each. The first
group received standard laboratory diet and no oral inoculations.
The second group received special diet alone. The remaining three
groups all received special diet and, after one week, oral
inoculations of live A. viscosus on each of three successive days
at one of three dosages: 1.6 x 10^ cfu, 1.6 x 10^ cfu or
q
1.6 x 10 cfu. For the sake of brevity, these
inoculation doses are designated simply as 10^ cfu, 10^ cfu
9and 10 cfu in all subsequent sections. All these inoculations
were performed as detailed previously. After inoculation, all
inoculated animals were given food and water ad libitum until the
end of the experimental period 12 weeks later, when all mice were
sacrificed by ether inhalation.
Two out of each group of 12 mice had their molars removed by
quadrant for A. viscosus recovery as described previously. For
the remaining 10 mice per group, the following procedures were
carried out:
(a) Immediately post mortem, blood was aspirated from the
inferior vena cava and samples from the 10 mice of each group
were pooled. The resultant serum was then stored at -60°C
for antibody studies.
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(b) The spleens and mesenteric lymph nodes were removed and
pooled by group to provide sufficient numbers of cells for
cellular immunological studies.
(c) The jaws of each mouse were dissected out and stored in
separately labelled bottles of buffered formol saline. The
right hemimandibles were subsequently defleshed and assessed
for bone loss, while the left hemimandibles were retained for
routine histological study.
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2.5 STATISTICAL ANALYSIS
All measurements were transferred to computer data files and
analysed using the following routines from SPSSx (SPSS Inc, 1983):
FREQUENCIES, CROSSTABS, BREAKDOWN, ONEWAY, ANOVA, MANOVA and
NONPAR CORR.





3.1 PREVIOUS METHODS OF ASSESSMENT
Various means of assessing periodontal disease experience in
animals from gross jaw specimens have been used. Some of these
are summarised below. All methods have been applied to defleshed
specimens.
(a) Method of Keyes & Gold (1955): The distance from the
amelocemental junction (ACJ) to the adjacent alveolar bone crest
was recorded for both the maxilla and mandible of Syrian hamsters.
Measurements were made both buccally and lingually at sites
corresponding to the positions of the molar cusps, and were
recorded to the nearest 0.2 mm using a dissecting microscope and a
graduated metal blade. The total count of 0.2 mm units at all
sites in the molar region was used as a means of expressing
periodontal destruction.
(b) Method of Gupta & Shaw (1956b): The degree of alveolar
resorption in both jaws of rice rats was expressed in terms of the
ACJ to alveolar crest distance at sites as used by Keyes and Gold
(1955), but in terms of arbitrary categories:
0 = No detectable bone resorption
1+ = Minor alveolar resorption with j of the root exposed
2+ = Appreciable bone loss with 7 to j of the root exposed
3+ = Moderate bone loss with j to | of the root exposed
4+ = Severe bone loss with essentially no remaining alveolar
support for the root
(c) Method of Gustafson (1969): The distance between the ACJ and
alveolar bone crest was measured in mink at five different sites
with a probe graduated at 0.2 mm intervals. The sites were:-
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(i) Buccal : distal surfaces of two premolars
(ii) Lingual: distal surfaces of 1st molar
(iii) Bifurcation of 1st molar root
(iv) Mesial part of bifurcation of 2nd molar root
(d) Method of Lavine et al (1976): The distance between the ACJ
and alveolar bone crest on the buccal side only was measured in
mink at the following sites:-
(i) Midbuccal and distobuccal of 1st premolars
(ii) Midbuccal only of maxillary 2nd premolar
(iii) Mesial and distal of mandibular 2nd premolar
(iv) Mesial and distal of mandibular 3rd premolar.
(e) Method of Messer et al (1982): The lingual aspect of mouse
right hemimandibles was lightly stained with 'Paragon' stain to
emphasise the ACJ. The distance from the ACJ to the alveolar crest
was measured for each root of each molar using a dissecting
microscope incorporating a micrometer scale. The length of root
exposed was then expressed as a percentage of the total root
length based on the average measurement obtained for each root
length from 30 extracted molars. Results were expressed either as
a mean score for all teeth or for individual roots.
Other variations on the theme exist, but in the current study
it was decided to introduce a slightly different form of
measurement, by which the whole area of exposed molar roots, on
lingual view of defleshed hemimandibles, was recorded. This had
the advantage of being a simple way of providing a single bone
loss score for each animal which did not rely on arbitrary scores
given after viewing specimens or on measurements made only at
specific designated points. It was thus hoped that the technique,
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details of which are described in Section 3.2, would provide
more accurate measure of periodontal bone destruction.
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3.2 METHOD OF ASSESSMENT USED IN THE
THE PRESENT STUDY
After sacrifice, the jaws were dissected out and the right
hemimandibles defleshed by placing them in individually labelled
water-filled boiling tubes which were then boiled for 10 minutes.
After boiling, the water was replaced by a 5% solution of papain
in isotonic saline and the tubes placed in a 37°C incubator for
48 hours. The method of defleshing was taken from Luther (1949).
The jaws were then removed, rinsed in clean cold water, carefully
brushed to remove tissue fragments, air dried at room temperature
and subsequently placed in van Gieson stain for approximately 10
minutes. Stain was taken up by cementum and bone but not by
enamel, thus throwing the ACJ into sharp relief. The lingual side
of the stained specimens was then viewed via a dissecting
microscope (Zeiss Ltd, West Germany) incorporating a grid
graticule composed of 0.25 mm sided squares (Graticule Ltd, Kent,
UK), at a fixed magnification of x25. At this magnification, the
image was divided into squares, the sides of which were equivalent
to 0.01 mm on the object. The area of exposed molar root surface
was measured by counting the number of squares bounded by the ACJ,
the lingual alveolar bone crest, the anterior border of the
anterior first molar root and the posterior border of the third
molar root, as illustrated in Figure 3.1.
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Figure 3.1 Lingual view of defleshed right hemimandible




3.3 NATURALLY OCCURRING BONE LOSS
Naturally occurring bone loss, as a consequence of the normal
oral flora, standard laboratory diet and advancing age, was
examined in bg/bg mice and non-mutant control C57 mice to assess
the range of periodontal disease experience that might be expected
for animals in which no active attempt had been made to induce
disease. The results are shown in Table 3.1. Analysis of
variance by genotype, age and sex for these groups of mice is
summarised in Table 3.2. There was a significant difference
between genotypes (with bg/bg mice showing more bone loss at all
ages), a significant age effect (with bone loss increasing with
age in both genotypes) but no overall difference between the
sexes. There were, however, significant interactions between
genotype and age, genotype and sex, age and sex and genotype, age
and sex. The nature of these interactions is illustrated in
Figure 3.2. The age effect was more pronounced in bg/bg mice than
C57 controls, bone loss tended to be greater in beige females than
males but less in C57 females than males, and the difference
between the sexes was most prounounced in the oldest age group of
bg/bg mice.
The increase in bone loss with age was consistent with the
physiological age changes described previously (1.2.3), and the
higher levels of bone loss in bg/bg mice, and more rapid
progression with age, were anticipated in view of this mutant's
defects of immune function. However, the massive periodontal
destruction described in the Chediak-Higashi mink (Lavine et al,
1976) was not found. The reasons for the genotype by sex
interaction shown in Table 3.2 and Figure 3.2 are unclear.
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Table 3.1 Mean bone loss (mm ) in beige mice and non-mutant C57




C57 n 10 9 9 10










(bg/bg versus C57), age and sex in uninoculated mice.
Source of variation ss DF ms F Significance
Main effects
Genotype 0.308 1 0.308 124.1 0.000
Age 1.887 3 0.629 253.1 0.000
Sex 0.006 1 0.006 2.5 0.122
2-way interactions
Genotype/Age 0.201 3 0.067 27.0 0.000
Genotype/Sex 0.011 1 0.011 4.6 0.036
Age/Sex 0.024 3 0.008 3.2 0.030
3-way interactions
Genotype/Age/Sex 0.023 3 0.008 3.1 0.032
Residual 0.151 61 0.002


















6 21 36 52
weeks
Fig 3.2 Bone loss in male and female beige mice and non-
mutant C57 controls at different ages.
C57 female (blue), C57 male (red),
bg/bg female (black), bg/bg male (green).
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3.4 INDUCED BONE LOSS
3.4.1 SIX WEEKS AFTER INOCULATION
Bone loss six weeks after inoculation was assessed to see
(a) whether bone loss could be related to inoculum size and (b)
how the absolute levels of destruction achieved in this time
compared with those found 12 weeks after inoculation. This
experiment was performed only in BALB/c mice and the results are
summarised in Table 3.3. Uninoculated controls and all three
inoculation groups showed significantly greater bone loss six
weeks after inoculation than uninoculated controls at the start
of the experiment. Mice inoculated with 107 cfu showed
significantly greater bone loss than the other three groups at
the same age, but neither of the other two inoculation groups was
significantly different from uninoculated controls at the same
age.
Table 3.3 Mean bone loss (mm ) in BALB/c mice at age 7 weeks
and 6 weeks after inoculation (age 13 weeks),












7 weeks n 10
Mean 0.580
s. e. 0.020
13 weeks n 8 8 9 10
Mean 0.721 0.760 0.836 0.747
s. e. 0.020 0.014 0.028 0.012
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3.4.2 TWELVE WEEKS AFTER INOCULATION
The results of all bone loss measurements made 12 weeks after
inoculation, with the exception of those for a special
immunisation experiment described in Chapter 9, are summarised in
Table 3.4. They illustrate three basic points:
(a) The standard errors are very small relative to the means,
implying that the variation within groups was small enough
to estimate group means with reasonable accuracy using samples of
around 10 mice per group;
(b) Differences between genotypes and inoculation groups were
generally large compared with the group standard errors, so that
many of these differences are statistically significant;
(c) For each genotype studied, maximal bone loss was always
associated with inoculations of 10^ cfu.
More detailed analysis is described below.
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Table 3.4 Mean induced bone loss in mm 12 weeks after inoculation,
n = number of mice.
DIET: NORMAL SPECIAL SPECIAL SPECIAL SPECIA!
INOCULUM: 0 0 106 107 109
BALB/c n 10 10 9 9 9
Mean 0.933 0.931 0.926 1.484 0.927
s. e. 0.030 0.011 0.036 0.024 0.040
C57 n 10 9 10 10 10
Mean 0.652 0.648 0.646 0.982 0.728
s. e. 0.008 0.009 0.023 0.011 0.009
+ /bg n 10 10 10 10
Mean 0.661 0.690 1.010 0.730
s. e. 0.020 0.023 0.023 0.012
bg/bg n 10 9 9 9
Mean 0.742 0.757 0.996 0.801
s. e. 0.012 0.017 0.014 0.011
ob/ob n 8 8 8
Mean 0.628 0.894 0.722
s. e. 0.011 0.013 0.009
CBA n 5 5 5 5
Mean 0.796 . 0.800 1.212 0.812
s. e. 0.012 0.008 0.009 0.009
+/x id n 5 5 5 5
Mean 0.790 0.800 1.206 0.810
s. e. 0.010 0.007 0.011 0.007
xid/Y n 5 4 5
t
5
Mean 0.704 0.702 1.362 0.710
s. e. 0.008 0.010 0.009 0.007
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3.4.2.1 Special diet alone
The effect of special diet as opposed to standard laboratory
diet was analysed in uninoculated mice using analysis of variance
by diet and by sex for the BALB/c and C57 strains separately
(Table 3.5). Neither diet nor sex showed a significant association
with bone loss in these strains and there was no diet by sex
interaction. The results indicate that induced bone loss was
dependent on the combined effect of special diet and inoculated
A. viscosus and that any difference between the sexes observed in
inoculated animals could not be attributed to the special diet alone.
Table 3.5 Analysis of variance for bone loss by diet and sex in
uninoculated BALB/c and C57 mice.
BALB/c















Diet/Sex 0.014 1 0.014 2.749 0.117
Residual 0.079 16 0.005
Total 0.094 19 0.005
C57

















Diet/Sex 0.000 1 0.000 0.349 0.565
Residual 0.011 15 0.001
Total 0.012 18 0.001
3.4.2.2 Inbred strains
Analysis of variance for the three inbred strains by strain
and inoculum size (Table 3.6) showed statistically significant
differences between strains and inoculation groups as well as a
significant strain by inoculum interaction. It was not possible
to test for a sex effect in this comparison as CBA was represented
by males only. Statistically significant differences between
strain/inoculum groups from one-way analysis of variance are shown
in Table 3.7.
BALB/c showed greatest bone loss, CBA intermediate bone loss
and C57 least bone loss overall. Within strains 10^ cfu did not
Q
increase bone loss above the control level, while 107 cfu
resulted in only a relatively small effect and only in C57 mice.
By contrast, 10^ cfu produced a marked increase in bone loss in
all three strains, the absolute value of the increase being
greatest for BALB/c and least for C57. This was the main source
of the significant strain by inoculum interaction (Table 3.6). The
relative increase in bone loss however was more similar between
strains, with the 10^ cfu groups for C57, CBA and BALB/c showing
respectively 1.51, 1.52 and 1.59 times the bone loss of their
corresponding uninoculated controls.
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Table 3.6 Analysis of variance for bone loss by strain and
inoculum size.
Source of variation ss DF ms F Significance
Main effects
Strain 1.905 2 0.953 219.5 0.000
Inoculum 3.236 3 1.079 248.6 0.000
2-way interactions
Strain/Inoculum 0.245 6 0.041 9.4 0.000
Residual 0.369 85 0.004
Total 5.755 96 0.060
Table3.7
Summaryofstatisticallysignificantdifferen es groups. BAL=LB/c,*P<0.05.
Genotype:C5757CBA Inoculum:106109106
MeanG no.Inoc 0.646C5710 0.652C 7 0.728C57109 0.796CBA 0.800CBA106 0.812CBA109 0.926BAL106 0.927BAL10 0.933BAL 0.982C57107 1.212CBA107 1.484BAL107
o
forb nel ss(mm)betweentrain/inoculum CBABALBALC57BAL 1091061091071077
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3.4.2.3 Beige
Analysis of variance for bg/bg, +/bg and non-mutant control
C57 mice by genotype, inoculum size and sex (Table 3.8), disclosed
statistically significant differences between genotypes, between
inoculum groups and between the sexes. There were also
significant interactions between genotype and inoculum, genotype
and sex and inoculum and sex. Statistically significant
differences between genotype/inoculum groups from one-way analysis
of variance are summarised in Table 3.9. Overall, C57 mice showed
least bone loss, +/bg intermediate bone loss and bg/bg most bone
loss, indicating that the beige allele was not fully recessive
with respect to periodontal destruction. At 10^ cfu, bg/bg and
+/bg were not significantly different from each other indicating
that, for this inoculum size, the beige allele was fully dominant
with respect to induced periodontal destruction. This association
between inoculum size and the difference between bone loss in
bg/bg and +/bg mice contributed to the significant genotype by
inoculum interaction shown in Table 3.8.
For each genotype, maximum bone loss was associated with
10^ cfu inocula, while inocula of 10^ cfu did not
significantly increase bone loss over that found in uninoculated
controls. In all three genotypes 10^ cfu resulted in
significantly more bone loss than that shown in uninoculated
controls. The bone loss associated with 10^ cfu was also
significantly more than that associated with 10^ cfu in bg/bg
and C57 mice.
The nature of the sex difference and the interactions of sex
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with genotype and inoculum are illustrated in Figure 3.3. In both
bg/bg and +/bg animals, females showed more bone loss than males
in uninoculated control groups and 10^ cfu and 10^ cfu
inoculated groups. At 10^ cfu, however, this was reversed for
both genotypes with males showing more periodontal destruction.
In C57 animals, bone loss was greater in males than females for
all groups except 10^ cfu which showed no sex differences.
The reasons for these differences are not known.
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Table 3.8 Analysis of variance for bone loss by genotype (bg/bg, +/bg
and non--mutant C57), :inoculum size and sex.
Source of variation ss DF ms F Significance
Main effects
Genotype 0.107 2 0.054 31.4 0.000
Inoculum 1.862 3 0.621 363.3 0.000
Sex 0.017 1 0.017 9.9 0.002
2-way interactions
Genotype/Inoculum 0.036 6 0.006 3.5 0.004
Genotype/Sex 0.021 2 0.010 6.0 0.003
Inoculum/Sex 0.018 3 0.006 3.5 0.019
3-way interactions
Genotype/Inoculum/
Sex 0.020 6 0.003 1.9 0.083
Residual 0.159 93 0.002
Total 2.240 116 0.019
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Inoculum: c i & to*
Fig 3.3 Bone loss (mm2) in C57, +/bg and bg/bg male and
female mice 12 weeks after inoculation.
Male (black), female (red).
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3.4.2.4 Obese
Analysis of variance for ob/ob and non-mutant control C57
mice by genotype, inoculum size and sex showed statistically
significant differences between genotypes and between inocula, but
not between the sexes. The only significant interaction was that
between genotype and inoculum size (Table 3.10). Table 3.11
summarises the statistically significant differences between
genotype/inoculum groups from one-way analysis of variance.
Contrary to expectation, bone loss was less in ob/ob mice than in
C57 controls for all inoculum sizes and for uninoculated controls,
although this difference was statistically significant only at
10^ cfu, which presumably contributed to the genotype by
inoculum interaction. For each genotype, maximum bone loss was
again associated with 10^ cfu, and this was significantly
greater than in either the uninoculated or 10^ cfu groups. Bone
loss associated with 10^ cfu was also significantly greater than
in uninoculated controls. These results imply that homozygosity
for the obese allele does not alter susceptibility to bone loss
compared with C57 controls, either for naturally occurring loss or
that induced by lO^cfu. At 10^ cfu, however, ob/ob mice
appear to be relatively resistant to induced disease.
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Table 3.10 Analysis of variance for bone loss by genotype (ob/ob and
and non-mutant C57), inoculum size and sex.
Source of variation ss DF ms F Significance
0.020 1 0.020 20.8 0.000
0.873 2 0.436 447.8 0.000
0.002 1 0.002 2.3 0.140
0.017 2 0.009 8.7 0.001
0.000 1 0.000 0.0 0.844
0.000 2 0.000 0.1 0.891














Total 0.954 53 0.018
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Table 3.11 Summary of statistically significant differences for bone
loss (mm^) between genotype/inoculum groups for ob/ob and
non-mutant C57 control mice.
* = P < 0.05.
Genotype: ob/ob C57 ob/ob C57 ob/ob C57




0.723 ob/ob 109 * *
0.728 C57 109 * *
0.894 ob/ob 107 * * * *
0.982 C57 107 ★ * * * *
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3.4.2.5 X-linked immune deficiency
The results for these animals are given in Tables 3.12 and
3.13. They show that for uninoculated controls and for 10^,
lO'7 and 10^ cfu groups, there was no statistically significant
difference between + /xid females and CBA (+/Y) males, but there
were significant differences between xid/Y males and +/xid females
and between xid/Y and CBA (+/Y) males. However, whereas at 10^
cfu xid/Y showed significantly greater bone loss than +/xid and
CBA (+/Y) as might be expected, at 10^ and 10^ cfu and for
uninoculated controls xid/Y showed significantly less bone loss
than +/xid and CBA (+/Y) This reversal was responsible for the
significant genotype by inoculum interaction shown in Table 3.12.
It is consistent with relative susceptibility to bone loss
conferred by the X-chromosome derived from the CBA/Ca strain in
uninoculated animals, and at 10^ and 10^ cfu, with the xid
allele assuming importance only at 10^ cfu which, as for all
other genotypes, produced maximum bone loss.
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Table 3.12 Analysis of variance for bone loss by genotype (xid/Y,
+/xid and non-mutant CBA) and inoculum size.
Source of variation ss DF ms F Significance
Main effects
Genotype 0.013 2 0.006 16 0.000
Inoculum 2.682 3 0.894 2274 0.000
2-way interactions
Genotype/Inoculum 0.153 6 0.026 65 0.000
Residual 0.018 47 0.000
Total 2.866 58 0.049
2
Table3.13Summaryofstatisticallysignificantdiffer n esfol( m)betw en genotype/inoculumgroupsf rx d/Y,+/xidan -mutantCBAc ntrolmice. *=P<0.05. Genotype:xid/Yi /xid/Y+/xidCBA/ i+ xidCBAxi/Y Inoculum:106109106109107107 MeanG no.Inoc 0.703xid/Y106 0.704xid/Y 0.710xid/Y109 0.790+/xid 0.796CBA 0.800+/xid106 0.800CBA106 0.810+/xid109 0.812CBA109 1.206+/xid107 1.212CBA107 1.362xid/Y107
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3.4.3 DISCUSSION
Comparing the uninoculated BALB/c mice aged seven weeks and
13 weeks in Table 3.3, it is apparent again that bone loss
increases with time as a natural phenomenon. Comparing the
inoculated BALB/c mice aged 13 weeks with their uninoculated
controls (Table 3.3) shows that, even six weeks post-inoculation,
there was more bone loss associated with 10^ cfu than with
106 or 10^ cfu. The differences between groups, however, were
much smaller than those found 12 weeks after inoculation (Table
3.4), so this latter time was used exclusively in all subsequent
bone loss experiments.
To analyse the bone loss results further, they were
standardised by using the ratio of bone loss found 12 weeks after
inoculation to that found in uninoculated controls of the same age
and genotype. These ratios are shown in Figure 3.4. For each
genotype, the same pattern was found with the ratio for 10^ cfu
being least, that for 10^ cfu greatest and that for 10^ cfu
approximately down to the 10^ cfu level. In view of the
clumping of ratio-s around unity for 10^ and 10^ cfu, there is
little that can be said about differences of response between
genotypes. However, at 10^ cfu, xid/Y mice showed by far the
greatest ratio and bg/bg clearly the lowest.
Taking into account the neutrophil and NK cell defects of
beige mice (2.1.2.1), it is logical to conclude that the functions
of these cells are not important in protection against induced
disease. In X-linked immune deficient mice, there are marked B-























































3.4 Ratio of bone loss found 12 weeks after inoculation
with A. viscosus to that found in uninoculated mice
of the same age and genotype (C) sexes combined.
reduced capacity (2.1.2.3). The secretory immune system would
therefore seem to be significantly involved in the host response
to A. viscosus.
The response of the third mutant, obese, to 10^ cfu, was
little different from that of C57 controls, therefore, any
components of the immune system defective in these animals
(2.1.2.2) are not important in protection against induced disease.
Monitoring of polymorphonuclear leucocyte (PMN) function, the
cellular immune system, and both nonspecific and specific anti-A.
viscosus immunoglobulin production might help to explain the
differences of response to 10^ cfu found in these genotypes.
The fact that 10^ cfu inoculations did not result in
significantly more bone loss than controls could be ascribed to
insufficient numbers of organisms to elicit the required changes
in the host for bone destruction to occur. Increased bone loss
Q ...
associated with 10 cfu could be explained by assuming that this
inoculum size did elicit the required host changes. The fact that
10^ cfu produced significantly lower levels of bone loss than
10^ cfu, and that these were sometimes not significantly greater
than those in controls, suggests the action of some immunological
mechanism, primed by inoculum size, which influenced the degree to
which destruction occurred. One such possibility is tolerance.
This phenomenon is best explained as follows.
Normally, administration of a foreign antigen to an animal
results in an antibody response. An antigen, however, does not
always stimulate detectable antibody and, in certain
circumstances, highly immunogenic antigens can produce a state of
unresponsiveness which is permanent. This unresponsiveness is
specific for the initiating antigen and administration of further
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doses does not break the unresponsive state. This non-response is
known as tolerance. The most obvious example is the absence of an
immune response to self-antigens in the immunologically mature
adult. In some manner, the developing lymphoid system learns that
the antigens encountered in fetal life and in the early stages of
development are self-antigens. There appears to be some form of
genetic control over immune responses, the net effect of which is
the termination of any 'self-directed' immunocompetent cell line,
or at least of its effects. In experimental animals, tolerance
can be induced by giving large doses of antigen (1 mg g~^ body
weight). This 'high zone tolerance' is dependent on T and B cell
unresponsiveness and is usually transient. Injections of less
than 1 mg g-^" body weight can induce 'low zone tolerance', which
appears to be persistent and associated with T cell
unresponsiveness (Amos, 1981). Thus, in the present study, 10^
cfu perhaps corresponded to low zone tolerance, and 10^ cfu to
high zone tolerance. Investigation of T and B cell function could
clarify the situation.
The route of administration of antigen is also very
important. Using oral administration of bovine serum albumin
(BSA) to rats, Thomas and Parrott (1974) showed that tolerance
could be induced by that route. These authors suggested that,
although large quantities of BSA were administered orally, most
would be digested and the amount absorbed would thus be small.
They suggested that, in this case, the tolerance induced was low
zone tolerance.
One main problem with the oral route of administration as
used in the current work is the question of whether the swallowed
macromolecules retain antigenic properties after digestion.
Rothberg (1969) demonstrated that, after 'digestion' of BSA with
pepsin, a moiety remains which retains the molecular weight and
the antigenicity of native BSA. Crumpton (1967) and Atassi and
Saplin (1968) showed that proteolytic digestion of large molecules
can result in products which share antigenic determinants with the
native antigen. Therefore, the induction of tolerance via the
oral route could be due to absorption of either small quantities
of the native protein, or of fragments of the protein bearing
antigenic determinants in common with the native protein. The
latter possibility is particularly attractive in view of the
demonstration by Ada and Parish (1968) that digestion products of
flagellin are toleragenic in adult rats, while the whole molecule
is strongly immunogenic. Thus, it can be assumed that some
antigenic determinants are left on the A. viscosus organisms after
ingestion and digestion.
Oral or intragastric administration -of antigens is known to
cause the appearance of circulating antibodies which frequently
are predominantly of the IgA class (Heremans, 1974). Some of this
antibody is made locally in the immunised gut wall (Vaerman &
Heremans, 1970; Vaerman et al, 1973), but an additional fraction
originates in extraintestinal lymphoid tissues, particularly the
spleen. Andre et al (1975) found that if mice were given a
four-day course of intragastric placement of sheep red blood
cells, specific antibodies, mainly of the IgA class, were
produced. However, if the dosage was repeated 2-3 weeks later,
there was a complete absence of response and it took several
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months for systemic reactivity to renewed intragastric challenge
to be restored to the level of the primary response (Andre et al,
1973). Reports from different authors (Andre et al, 1974; Walker
et al, 1972, 1973) indicate that immunisation by the digestive
route leads to impaired enteric absorption of macromolecular
antigens. Andre et al (1974) showed that rats which received a
single dose of 200 mg human serum albumin by gastric intubation
had a greater than 50% reduction in capacity of the gut to absorb
intact albumin and that secretory IgA present in the enteric lumen
at that time was responsible for the effect. This led to the
suggestion that it was reduced absorption not tolerance that was
induced in animals given oral antigens.
However, Andre et al (1975) showed that orally immunised
animals did not respond to rechallenge with the same antigens by
the digestive route or by injection of the challenging dose
intraperitoneally, thus clearly demonstrating that there was true
tolerance. In addition, it was found that serum from
intragastrically immunised mice contained a very active toleragen
which was capable i^n vivo of conferring tolerance to non-immune
recipient mice and in vitro of paralysing the activity of antibody
producing cells (Andre et al, 1975). This toleragen seemed to
consist of immune complexes with IgA as the antibody. These
authors concluded that such a mucosal type of immune response
takes place in the gut wall itself and that, to some extent, it
may extend to distant lymphoid tissues such as the spleen. They
suggested that the portal lymphoid tissue of the liver also be
considered as it is in direct continuity with the lamina propria
of the gut and, like the latter, is a preferred site of IgA
production (Dive et al, 1974). In addition, it is exposed
directly to enterically absorbed antigen carried by the mesenteric
venous blood. Thus, if the mechanism of tolerance via IgA immune
complexes is correct, this would explain systemic
hyporesponsiveness by antigen given orally (Chase, 1946; Cantor &
Dumont, 1967) or injected into the portal circulation (Battisto &
Miller, 1962; Mayer et al, 1965), as well as the suppression of
these effects when the liver is bypassed by a portocaval
transposition (Cantor & Dumont, 1967). It has been suggested that
IgA antibody-ingested antigen complexes might persist for a long
time. However, Swarbrick et al (1976) demonstrated that passive
transfer of IgA antibodies promotes rapid elimination of antigen
and increases rather than reduces the antibody response to
subsequent immunisation.
The form in which antigen is administered appears to be
important also. Cox & Taubman (1984), studying salivary IgA
production, found the response to be greater if the antigen was in
particulate rather than soluble form. In the current work whole
bacteria were used, and it was hoped that this would lead to good
immunoglobulin responses.
Conclusions based on bone loss data therefore confirmed the
need in the present study for investigations of PMN function and
both humoral and cellular components of the immune system.
The findings emphasised the probable relevance of the secretory
immune system in general and of IgA levels in particular, and the
need to study cells from both spleens and mesenteric lymph nodes
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to elucidate the inoculum size dependent response. The hypothesis
6 9
that 10 cfu induced low zone tolerance and 10 cfu induced
high zone tolerance is considered again in subsequent chapters in






Histology has been used by a number of investigators as an
indicator of both the presence and severity of natural and
experimental periodontal disease in different mouse genotypes.
Examples include leukaemic mice (Brown et al, 1969; Flanagan
et al, 1970), pocket mice (Shklar & Person, 1975), albino mice
(Gilmore & Glickman, 1959) and diabetic mice (Elgeneidy et al,
1974). Many of the histological features seen in periodontitis in
animals have been assessed in attempts to measure the progress of
the disease. The features noted in such
investigations can be listed as follows:
(a) Epithelium, mucosa and submucosa
(i) Presence or absence of keratinised layer on gingival
epithelium
(ii) Epithelial proliferation, both site and degree
(iii) Apical growth of epithelial attachment
(b) Periodontal membrane
(i) Changes in orientation of periodontal fibres or signs
of their degeneration
(ii) Increased thickness of periodontal membrane
(iii) Number and size of blood vessels
(c) Bone
(i) Presence of either localised or generalised resorption
(ii) Whether bone loss is horizontal or vertical
(iii) Position of ACJ relative to bone crest
(iv) Number and distribution of bone incremental lines
(v) Relative numbers of osteoblasts and osteoclasts
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(d) Cement
(i) Signs of cement resorption
(ii) Extent and distribution of secondary cement formation
(iii) Number and distribution of cemental incremental lines
(e) Tooth
(i) Presence or absence of occlusal abrasion
(ii) Presence or absence of root cavitation
(f) Inflammation
Position, degree and nature of any inflammatory
infiltrate
(g) Plaque/calculus
Presence and position of plaque/calculus
(h) Foreign bodies
Presence of hair or food impaction
Examination of most of these' features was attempted for all
genotypes used in the current study.
As already discussed (1.2.3), it is important when studying
murine periodontal disease that age changes are not misinterpreted as
disease. In this context, Gilmore and Glickman (1959) showed that
cement thickness increases with age in the mouse so that the
increasing distance between ACJ and alveolar crest is not wholly
pathological in origin. These authors also noted that the gingival
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wall of the gingival sulcus is lined by keratinised oral
epithelium which extends below the level of the base of the sulcus
where it lies lateral to and is contiguous with the enamel
epithelium. At all stages, the base of the sulcus is located at
the most coronal level of the enamel epithelium (see Figure 4.1).
With age, however, the most coronal portion of the enamel
epithelium undergoes progressive atrophy leading to the formation
of a thin cuticle with the base of the sulcus shifting towards the
ACJ. These authors also noted that some degree of inflammation
was a constant finding in the connective tissue beneath the base
of the sulcus, associated with irritation from food debris and
calculus. The degree of inflammation was shown to increase with
the age of the animal. Epithelial changes accompanied the
increase in inflammation with epithelial proliferation occurring
apically and laterally in the form of elongated finger-like
projections. This hyperplasia was originally confined to the
enamel epithelium and was predominantly apical but, as the
inflammation increased, proliferation of the oral epithelium was
observed also. This then led to formation of a pocket below
which bone crest resorption was visible, though this was found
essentially only in old animals.
The histological component of the current work was not
intended to be either conclusive or exhaustive. It was included
to complement the other aspects of the study and to see if it was
possible to relate bone loss findings to histological
manifestations of disease.
4.2 MATERIALS AND METHODS
After sacrifice, left hemimandibles were placed in
individually labelled sample bottles containing neutral buffered
formalin. These specimens were subsequently decalcified in formic
citrate solution (see Appendix) for 14 days at room temperature,
trimmed down to the molar segments and embedded in paraffin wax.
Approximately sixty 5 pm sections were then cut buccolingually in
the coronal place from the first molar end of each block and these
were stained alternately with haematoxylin and eosin (H & E) van
Gieson and azure stains (see Appendix). H & E gave a general
overview of the histological appearance, azure was particularly
useful for studying bone and cement, while van Gieson, which
stains collagen, was of value in studying the orientation and
integrity of the periodontal ligament fibres. Specimens from each
genotype/inoculum group of the main study and from each of the
different groups in the immunisation experiment (see Chapter 9)
were examined, together with uninoculated beige mice at ages 6,
21, 36 and 52 weeks (10 mice per age group). An attempt was made
to assess the features listed above, with the exception of the
relative numbers of osteoblasts and osteoclasts.
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4.3 RESULTS
No consistent pattern could be discerned relating
histological appearance to either genotype or inoculation group.
In some sections the base of the gingival sulcus was lying at the
ACJ. This was associated with either minimal neutrophil
infiltration (Figures 4.2; 4.3) or with greater numbers of these
cells migrating through the epithelial attachment and adjacent
connective tissue (Figures 4.4; 4.5). In other sections the
epithelial attachment was lying entirely on the cementum but in no
case was there evidence of dense inflammation (Figure 4.6). In
only a few apparently random sections was there evidence of active
bone resorption with osteoclasts (Figure 4.7). Figures 4.8 to
4.10 are of representative sections from beige mice aged 6 weeks
to 52 weeks.
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Fig 4.1 Buccolingual section through the lingual gingival sulcus
in a 5 week old RAP mouse. The base of the sulcus,
indicated by the arrow, is at the most coronal level of the
enamel epithelium. Magnification x440. Stained H & E
(reproduced from Gilmore & Glickman, 1959).
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Buccolingual section through the buccal gingival sulcus in
the lower left first molar region of a 10^ cfu inoculated
xid/Y mouse showing the base of the epithelial attachment
located at the ACJ and associated with minimal inflammation.
Magnification xl20. Stained H & E.
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Fig 4.3 Higher power view of specimen shown in Figure 4.2
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Fig 4.4 Buccolingual section through the buccal gingival sulcus in
the lower left first molar region of a lO'7 cfu inoculated
CBA mouse showing the base of the epithelial attachment
located at the ACJ and associated with noticeable
inflammation.
Magnification xl20. Stained Van Gieson.
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Fig 4.5 Buccolingual section through the buccal gingival sulcus in
the lower left first molar region of a 10^ cfu inoculated
xid/Y mouse showing the base of the epithelial attachment
located at the ACJ. Neutrophils can be seen migrating
through the sulcus epithelium.
Magnification x300. Stained H & E.
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Fig 4.6 Buccolingual section through the lingual gingival sulcus in
the lower left first molar region of a 10 cfu inoculated
BALB/c mouse showing the epithelial attachment lying on
cementum but without a dense inflammatory infiltrate.
Magnification xl20. Stained H & E.
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Fig 4.7 Section of crestal bone from the first mandibular molar
region of a 10^ cfu inoculated C57 mouse showing active
bone resorption with osteoclasts (indicated by arrows).
Magnification x300. Stained H & E.
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Fig 4.8 Buccolingual section through the lingual gingival sulcus in
the lower left first molar region of a 6 week old
uninoculated beige mouse showing the base of the epithelial
attachment located at the ACJ.
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Fig 4.9 Buccolingual section through the buccal gingival sulcus in
the lower left first molar region of a 36 week old
uninoculated beige mouse showing the epithelial attachment
partially located on cementum.
Magnification xl20. Stained H & E.
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Fig 4.10 Buccolingual section through the lingual gingival sulcus in
the lower left first molar region of a 52 week old
uninoculated beige mouse showing the epithelial attachment
largly located on cementum.
Magnification xl20. Stained H & E.
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4.4 DISCUSSION
It was surprising that no consistent histological pattern
emerged which could be related to the bone loss findings of either
the main study or the immunisation experiment, though a more
detailed quantitative assessment could have been more informative.
The reasons for this are not clear but one possibility is that
periodontal destruction is essentially cyclic in nature (Socransky
et al, 1984), resulting in histological findings that were not
comparable, even in age, strain and treatment matched mice.
The results for beige mice at different ages were consistent
with the findings of Gilmore and Glickman (1959) in that both the
degree of inflammation and loss of epithelial attachment increased
with time. However, the severity of both these features was less
than shown in the 1959 publication, possibility due to the
difference of genotype.
In conclusion, the histological findings, rather than helping
to explain the bone loss results, have posed new questions, in
particular with regard to the value of histological parameters in
assessing experimental periodontal disease in the mouse. The
investigators who first developed the A. viscosus mouse model
(Fitzgerald et al, 1981; Fitzgerald & Birdsell, 1982) have not
published any histological findings so no comparison with the
current work is possible.
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CHAPTER 5
RECOVERY OF A. VISCOSUS
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5.1 INTRODUCTION
Fitzgerald et al (1981) demonstrated that previously
inoculated A. viscosus was recoverable only from the teeth and
that, while there was a 'dramatic rise' in the number of organisms
recovered over the first four weeks after oral inoculation, a
plateau was reached after six weeks. These authors also found
that the level of colonisation was 'similar' regardless of the
initial inoculum and were unable to recover A. viscosus from
uninoculated animals. In the present study, the level of
colonisation of the teeth by A. viscosus was assessed at the end
of the experimental period only, 12 weeks after oral inoculation.
5.2 MATERIALS AND METHODS
Recovery of A. viscosus was.performed as described in Section
2.3, on two mice of each genotype (with the exception of +/xid)
and each inoculum group.
5.3 RESULTS
A. viscosus was never recovered from uninoculated mice and
always recovered from inoculated mice.
Analysis of variance for recovery count showed that variation
between quadrants and between mice was not significantly greater
than that between repeat measurements within quadrants for each
genotype/inoculum group. Subsequent analysis was therefore
restricted to differences between genotypes and inoculum groups
only. This analysis is summarised in Table 5.1. Statistically
significant differences between inoculum groups were found, but
only for BALB/c, C57 and ob/ob. No consistent pattern emerged
and, furthermore, these differences were trivial compared to the
thousand-fold range in number of organisms inoculated. On the
other hand, statistically significant differences between
genotypes were found for all inoculated groups, with BALB/c
showing consistently low counts that were always significantly
lower than +/bg, bg/bg and CBA. The significance of comparisons
between genotypes over all inoculum groups is summarised in Table
5.2. Spearman rank correlation coefficients over the seven
genotypes between mean recovery count (over all inoculated groups)
and bone loss in uninoculated controls and in mice inoculated with
6 7 9 • •
10 , 10' and 107 cfu were all negative but statistically
non-significant (-0.32, P = 0.48; -0.26, P = 0.62; -0.43,












Mean A. viscosus recovery counts in cfu x 10^
per quadrant for the different genotype/inoculum groups,
and the results of one-way analysis of variance between
inoculum groups within genotypes and between genotypes
within inoculum groups.
n = number of mice x quadrant x triplicate (2x4x3)
counts.











































F 4.6 12.6 8.8
Significance 0.001 0.000 0.000
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Table 5.2 Summary of statistically significant differences for
A. viscosus recovery between genotypes (for all
inoculated groups). Means are number of cfu x 10^.
* = P < 0.05.











Inability to recover A. viscosus from uninoculated animals
confirmed that this organism was not a normal oral commensal in
the mice examined.
The differences in colonisation level between genotypes over
all inoculum groups (Table 5.2) show that the mutant genotypes
tended to have higher recovery counts than the three inbred
strains. There is therefore some indication that immunological
mutants may tend to support higher levels of colonisation of the
teeth by A. viscosus than non-mutant genotypes. However, although
counts for both +/bg and bg/bg were significantly higher than for
C57 controls, ob/ob and xid/Y did not show significantly higher
counts than their respective C57 and CBA controls. Whether such
differences are mediated through immunological mechanisms or
simply through, for example, differences in tooth surface area or
habits such as hair chewing is, at present, a matter for
speculation. In terms of disease experience, the lack of
significant correlation between bone loss and A. viscosus recovery
count over the seven genotypes indicates that differences between
genotypes for bone loss were unlikely to have had their basis in
differences of colonisation level.
The 10 and 1000-fold differences in initial inoculum size
were not reflected in the final level of colonisation by
A. viscosus. It can therefore be concluded that, over the range
of inoculum size used, colonisation of the teeth ultimately
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stabilised at essentially the same level for each genotype. The
final level of colonisation was therefore not related to bone
loss. Consequently, it seems likely that the consistently high
bone loss associated with inoculations of 10^ cfu (Figure 3.4)
was the result of host response to the initial inoculum. This
hypothesis is discussed in subsequent chapters.
One further point of interest is that while the final
absolute numbers of A. viscosus recovered did not show consistent
differences between inoculum groups, the actual area of tooth
surface available for colonisation was greatest in 10^
inoculated animals due to the high level of bone loss. Assuming
the same efficiency of recovery for all inoculum groups, the
number of organisms per unit area of available tooth surface in
this inoculum group must therefore have been less than in the
6 9.10 and 10 inoculated groups. There is no obvious explanation
for this, but it is possible that some of the host defence and/or
destructive processes in the lO'' group, such as extracellular
enzyme release from gingival fluid polymorphs, antibodies in
saliva and gingival fluid or lymphokine production, could be
responsible.
It is thus apparent that results presented here for the seven
genotypes are comparable with the findings of Fitzgerald et al
(1981) for BALB/c. The present study shows, in addition, that a
more or less consistent pattern of A. viscosus recovery may be






Polymorphonuclear leucocytes (polymorphs) are found in the
gingival tissues and saliva of both healthy and diseased mouths.
However, as in other infections having an acute inflammatory
component, the host response to subgingival plaque microorganisms
is characterised in part by a marked increase in the number of
these cells. Among them, numerically the most important are the
neutrophil granulocytes (neutrophils) which constitute
approximately 98% of polymorphs and approximately 70% of all blood
leucocytes.
Polymorph cytoplasm contains two types of lysosomal granule.
First, there are the azurophilic or primary granules, so-called
because of their blue appearance when stained with Wright's stain
and because they are the first granules to appear during
neutrophil maturation. They contain lysozyme, acid hydrolases,
neutral proteases such as elastase, cationic proteins,
myeloperoxidase, acid mucopolysaccharide and beta-glucuronidase.
Second, there are the specific or secondary granules, so-called
because they are found only in neutrophils and appear after
primary granules. They contain lysozyme, lactoferrin, B12 binding
protein and neutral proteases such as collagenase. In the mature
neutrophil, the specific granules are the most numerous (Murphy,
1976a)
It is generally accepted that extracellular lysosomal enzyme
release is associated with tissue damage. Two possible mechanisms
of such 'degranulation' are phagocytic release and secretion
(Baggiolini et al, 1978), both of which depend on fusion of
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lysosomes with the plasma membrane. Phagocytic release is
triggered by the ingestion of particulate matter and, the larger
the particle, the greater the number of lysosomal granules
released (Miller et al, 1984). Convincing evidence of a true
secretory mechanism for specific granules is still lacking but, as
pointed out by Miller et al (1984), it is tempting to hypothesise
that it does exist since lysozyme, lactoferrin and collagenase are
often found extracellularly. Release of lysosomal granules may be
triggered in vitro by complement-derived chemotactic factors
released by bacteria (Murphy, 1976b). Lysosomal enzymes are also
released following polymorph death (Murphy, 1976b).
6.1.1 ORAL POLYMORPHS
It has long been known that neutrophils are present in human
saliva and it has been reasonable to assume that these are
ultimately derived from blood leucocytes. Nevertheless, early
work was unable to demonstrate a correlation between salivary and
blood leucocyte counts in healthy subjects and those with both
haematological and non-haematological malignancies (Stephens &
Jones, 1934). Calonius (1958), however, compared salivary
leucocyte counts from patients with both normal and inflamed
gingiva, carious teeth and edentulous mouths. Counts were highest
in subjects with gingival inflammation and lowest in edentulous
cases, suggesting that salivary leucocyte count might be useful in
assessing gingival pathology. Confirmation of the relationship
between tooth presence and salivary leucoctye count was provided
by Lantzman & Michman (1970) who compared counts before and after
tooth extraction. They found that a drop in salivary leucocyte
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numbers, sometimes to zero, occurred following extraction,
suggesting that the gingival crevice is the main source of these
cells.
Loe (1961) sealed the orifice of the healthy gingival crevice
in dogs and demonstrated a build up of neutrophils and epithelial
cells within the crevice, indicating that epithelial desquamation
and neutrophil migration into the crevice are continuous processes
in the healthy state. An ultrastructural study of clinically
normal crevicular tissues in beagle dogs has demonstrated
neutrophils not only in the lamina propria but also migrating
through the basal lamina and within the epithelium itself (Garant
& Mulvihill, 1971a). In germ free rats, neutrophils have been
seen routinely within the intercellular spaces of the crevicular
epithelium at all levels of attachment (Yamasaki et al, 1979).
Thus, the passage of neutrophils into the gingival crevice cannot
be attributed to the presence of microbial plaque alone, implying
that, at least under certain circumstances, their presence is
physiological rather than pathological. It has been suggested that
the possibility of chemotactic attraction to food antigens should
not be ignored (Taubman et al, 1981). Nevertheless, recruitment
of neutrophils to the crevice is generally believed to be largely
mediated either by bacterially derived chemotactic factors or
through activation of the complement system (Tempel et al, 1970;
Lindhe & Hellden, 1972; Mary et al, 1972; Hellden & Lindhe, 1973;
Kraal & Loesche, 1974; Taichman & Baehni, 1977).
The relationship between neutrophils and gingival pathology
has been the subject of a number of investigations. Payne et al
(1975), in studies on the early stages of experimental gingivitis
in man, demonstrated a statistically significant increase in the
numbers of neutrophils in the junctional epithelium after 2-4 days
compared with clinically normal gingiva. Theilade et al (1966)
found that the number of neutrophils increased with the
development of gingivitis but rapidly decreased again with the
reinstitution of oral hygiene measures. Work by Garant &
Mulvihill (1971b) demonstrated the presence of many neutrophils
within dilated intercellular spaces of chronically inflamed
crevicular epithelium of beagles. Many neutrophils were disrupted
with apparent extrusion of lysosomal granules and the crevicular
epithelium displayed decreased numbers of intercellular contacts.
These findings suggested that increased neutrophil emigration
leads to increased antigen exposure to the underlying connective
tissue.
The Orogranuloctye Migratory Rate (OMR), as measured by
counting the number of leucoctyes in 12 sequential 30-second oral
saline rinses (Klinkhamer & Zimmerman, 1969), has been proposed as
a useful indicator of gingivitis. While it is true that patients
with gingival inflammation do tend to have higher OMRs than those
with healthy gingivae (Woolweaver et al, 1972), the value of OMR
as an index of severity of periodontal disease in an individual
patient seems limited (Hase & Reade, 1979). Golub et al (1981)
and Singh et al (1982) used an in vitro chemotaxis assay for
crevicular polymorphs which employed casein as a chemoattractant.
They found the influx of polymorphs in patients with both
gingivitis and chronic periodontitis to be greater than that of
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polymorphs in controls. It is hoped that this assay may prove to
be an important diagnostic aid for studying polymorph migration in
both periodontal and systemic diseases.
6.1.2 PROTECTIVE ROLE
According to Miller et al (1984) the increase in number of
polymorphs with increasing gingival inflammation can be viewed as
a host protective response against bacterial plaque. In studies
of mono-infected rats (Garant, 1976) a polymorph wall was seen to
form between plaque and host tissue and, while plaque bacterial
phagocytosis was not a prominent feature, the wall was thought to
prevent bacterial products from entering the tissues. Electron
microscopic studies of neutrophils and plaque microorganisms by
Baehni et al (1977), Taichman et al (1977) and Tsai et al
(1978) demonstrated that not only were the polymorphs in close
association with the plaque mass, but that pseudopodal extensions
from the polymorphs penetrated the mass. The polymorphs
contacting the plaque showed a decrease in number of lysosomal
granules and phagocytosis was noted when the cells contacted
individual organisms.
More direct evidence for a protective role for polymorphs
comes from studies of disorders of polymorph function. Attstrom &
Schroeder (1979) demonstrated increased apical extension of
subgingival plaque in neutropenic dogs and suggested that
polymorphs may prevent the progress of subgingival plaque
formation. Human sufferers of Chediak-Higashi syndrome (CHS) have
an increased susceptibility to infection which is associated
with granulocytopenia (Blume et al, 1968), an abnormality of
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granuloctye chemotaxis (Clark & Kimball, 1971), a delay in the
killing of phagocytosed bacteria, particularly staphylococci (Root
et al, 1972), and an abnormal distribution of enzymes in leucocyte
lysosomes (Wolff et al, 1972). In those cases with oral status
evaluation, severe gingivitis, caries and varying degrees of oral
ulceration have been noted (Tempel et al, 1972; Hamilton &
Giasanti, 1974) and, of ten cases for whom intraoral radiographs
had been taken, seven showed severe early periodontal destruction
resulting in premature tooth loss.
Beige mice were found to have increased susceptibility to
infection caused by Staphylococcus aureus, Streptococcus
pneumoniae and Candida albicans (Elin et al, 1974). Specific
studies to further characterise beige mouse leucocyte function
were undertaken by Gallin et al in 1974. Using peritoneal exudate
cells from black control (NIH stock C57B6/6N) and beige (NIH stock
C57B1/6/6JBg) mice, these authors found that the beige leucocytes
showed significantly reduced chemotaxis and decreased bactericidal
capacity against Staphylococcus aureus and some 'group D
streptococci', though this latter finding was not statistically
significant after 90 minutes. The killing of Escherichia coli by
beige leucocytes "appeared to be less effective than that of
normal cells" but the phagocytic uptake of these organisms by
cells of both genotypes was not significantly different, leading
these workers to conclude that the abnormality in CHS leucocytes
was related to a defect in early intracellular killing. It is
interesting, however, that granulocytopenia, a characteristic
findings in CHS in man (Blume et al , 1968), is not a feature of
beige mice (Bennett et al, 1969).
Other conditions where impaired neutrophil function and
increased periodontal disease occur together are chronic
granulomatous disease (Simchowitz et al, 1980), localised juvenile
periodontitis (Cianciola et al, 1977; Clark et al, 1977; Lavine et
al, 1979; Vandesteen et al, 1981; Van Dyke et al, 1981) and other
aggressive early onset periodontal diseases (Page et al, 1983a &
b). Patients with Job's syndrome were shown to have depressed
polymorph chemotaxis (Hill et al, 1974), and Van Dyke et al (1985)
observed that such patients exhibited severe gingivitis and
alveolar bone loss. Bissada et al (1982) and Cianciola et al
(1982) have demonstrated that, among juvenile diabetes mellitus
sufferers, a subpopulation exhibiting reduced neutrophil
chemotaxis exists. Also, polymorphs from diabetics with severe
periodontal disease have been shown to have a reduced chemotactic
response relative to diabetics with mild periodontal disease or
non-diabetics with periodontal disease (Manouchehr-Pour et al,
1981). Polymorphs from patients with inflammatory bowel disease
appear to have altered glucose metabolism, possibly through
interaction with circulating immune complexes. When faced with
severe gingival challenge (eg necrotising ulcerative gingivitis),
these patients may have difficulty in containing the local
infection resulting in rapid loss of alveolar bone (Lamster et al,
1978; 1982).
These findings all seem to point to defective polymorph
function as being associated with increased disease experience,
thus suggesting that the neutrophil is essentially protective.
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6.1.3 DESTRUCTIVE ROLE
As summarised by Miller et al (1984) "it is the extracellular
release of lysosomal granules by the recruited polymorphs that has
been suggested to be in part responsible for tissue destruction
observed in periodontal disease".
Jensen et al (1966) showed that the application of oral
Veillonella endotoxin to human abraded skin windows resulted in
immediate migration of neutrophils to the treated site and peak
phagocytic activity in 4-6 hours. It is possible for endotoxin to
produce similar effects in the gingiva, perhaps via complement
activation. Endotoxin has been shown to pass through intact
crevicular epithelium (Schwartz et al, 1972) and its presence in
gingival exudate has been found to correlate with the degree of
clinically and histologically detectable inflammation (Simon et
al, 1970; 1971). Taichman et al (1966) reported that intradermal
injection of normal rabbits with human plaque resulted in
localised abscesses and histological signs of neutrophil mediated
phagocytosis of bacteria, degranulation, increased vascular
permeability and haemorrhage. On the other hand, a similar
injection into leucopenic animals resulted in no local signs but,
after 24 hours, signs of septicaemia were noted. This implies
that leucocytes, while being essential for local defence, can
cause tissue damage by local enzyme release.
In support of this concept, various oral bacteria have been
shown to cause neutrophil degranulation (Baboola & Powell, 1972;
McArthur et al, 1976; Taichman & McArthur, 1976; Baehni et al,
1977; Taichman et al, 1977; Tsai et al, 1978). Pooled human
supra- and subgingival plaque incubated with human polymorphs
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showed a dose dependent relationship with lysosomal enzyme release
(Taichman et al, 1977). The addition of fresh autologous serum
augmented enzyme release in response to both supra- and
subgingival plaque but was not an absolute requirement. Indeed,
Passo et al (1980) demonstrated that A. viscosus could be killed
by polymorphs without serum. This serum enhancement however
implies a modulating effect by complement components.
Immune complexes associated with A. viscosus and
Streptococcus mutans have been found to trigger polymorph
degranulation (McArthur et al, 1976). Rizzo & Mitchell (1966) and
Ranney & Zander (1970) showed that experimental gingivitis and
periodontal inflammation could be induced by local formation and
deposition of immune complexes in animal studies, and complement
components and antibody against plaque antigens have been found in
diseased human tissues (Berglund, 1971; Taubman, 1974). Clagett &
Page (1978), however, were unable to find significant amounts of
immune complex in periodontally diseased dogs or humans using
imraunofluorescent techniques. Thus the role of the immune complex
is as yet unclear.
Free lysosomes have been detected in the intercellular spaces
of chronically inflamed human gingiva (Freedman et al, 1968).
Thilander (1963) found that application of a leucocyte horaogenate
to healthy human marginal gingiva resulted in widening of the
intercellular spaces of pocket epithelium in much the same way as
caused by bacterial hyaluronidase. Such widening may facilitate
passage of destructive substances into the connective tissue.
Ohlsson et al (1974) demonstrated free extracellular
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polymorph co1lagenases and elastase in the crevices of inflamed
human gingiva and, while they were detected at healthy sites, they
were found at only 15% of the concentration at diseased sites,
most of the collagenase and elastase at healthy sites being bound
to serum protease inhibitors. Another study (Kowashi et al, 1979)
showed a significant increase in free collagenase and neutral
protease concentrations in gingival washings from inflamed human
gingival crevices after 21 days of no tooth brushing, with a
concomitant increase in numbers of polymorphs. While it is true
that polymorph collagenase is immunologically similar to
epithelial and connective tissue collagenase, the presence of
collagenase in periodontal disease, along with inflammatory cell
infiltrate and collagen loss, suggests that it is primarily of
neutrophil origin (Miller et al, 1984).
Schroeder & Lindhe (1980) investigated the pathology of
destructive experimental periodontitis in dogs and found that
rapid alveolar bone destruction was the consequence of intense
acute inflammation and junctional epithelial ulceration. A
chronic inflammatory infiltrate was noted with low osteoclast
density at the bone surface. This experiment thus implies that
the role of polymorphs in alveolar bone loss is an active one.
6.1.4 POLYMORPH FUNCTION
The functions of polymorphs are related to their ability to
engulf and destroy microorganisms, ingestion of foreign particles
being associated with a marked increase in the uptake of oxygen
(Sbarra & Karnovsky, 1959). This is referred to as the metabolic
or respiratory burst because normally the cell is relatively
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dormant metabolically. It is generally accepted that the primary
oxidase responsible for the respiratory burst is located on the
outer surface of the polymorph plasma membrane (Briggs et al,
1975; Goldstein et al, 1977; Dewald et al, 1979). Initiation of
the respiratory burst occurs on membrane stimulation prior to
ingestion and degranulation (Rossi et al, 1972). Studies by
Korchak and Weissmann (1978) have provided evidence that
alteration of polymorph membrane potential may be the triggering
stimulus. Activation of the hexose-monophosphate shunt, the
other major component of the respiratory burst aside from the
primary oxidase of phagocytosis, has been thought to be related to
nicotinamide adenine dinucleotide phosphate dehydrogenase (NADPH)
oxidase and NADPH-linked lactic dehydrogenase (Evans & Karnovsky,
1962), as well as the glutathione cycle (Karnovsky et al, 1971).
The details of the possible complex interrelationships of these
pathways are summarised in Klebanoff & Clark (1978).
The products of the respiratory burst include superoxide
anions (O2), hydrogen peroxide (l^C^), singlet oxygen
('02) and hydroxyl radicals (OH). These toxic oxygen
derivatives not only kill microorganisms but also attack tumour
cells and parasites (Klebanoff & Clark, 1978). In association
with the oxygen burst, following bacterial ingestion,
degranulation occurs. The studies of Cohn & Hirsch (1960)
demonstrated that lysosomal enzymes sequestered in lysosomes are
then discharged from granules into phagocytic vacuoles or
secondary lysosomes.
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The systems within polymorphs that are responsible for
antimicrobial action are either oxygen dependent, such as the
myeloperoxidase system, or oxygen independent, such as lysozyme,
lactoferrin and neutral proteases. The myeloperoxidase (MPO)
system requires halide and hydrogen peroxide as well as the enzyme
myeloperoxidase. This enzyme catalyses the reaction of hydrogen
peroxide and chloride to generate the potent oxidant hypochlorous
acid which is powerfully microbicidal agent. The MPO system has
been found to be less effective when any of the three components
are missing (Rosen & Klebanoff, 1979). In addition, enzymes that
may be produced by ingested bacteria, such as catalase, can limit
the capacity of the system by decreasing available hydrogen
peroxide (Murphy, 1976b). The four by-products of the respiratory
burst (hydrogen peroxide, superoxide anion, hydroxyl radicals and
singlet oxygen) appear to have their own antimicrobial activity
augmented by myeloperoxidase and halide (Murphy, 1976b). MPO
binds to target microorganisms and this has been shown to be
important for myeloperoxidase-mediated killing of both bacteria
(Selvaraj et al, 1978) and fungi (Wright et al, 1983) in vitro.
It is thought that increased microbicidal activity of the target-
bound enzyme may result from the generation of hypochlorous acid
in close proximity to the microbial substrates (Wright & Nelson,
1985).
A sensitive way to measure the respiratory burst is based on
the finding that stimulated phagocytes generate photons of light
which can be detected as chemical luminescence or chemi-
luminescence (CL) (Fromtling et al, 1981; De Chatelet et al,
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1982). This light emission has been shown to depend both on
superoxide and myeloperoxidase-catalysed reactions and is a
measure of phagocytic as well as metabolic activity in the
stimulated cells (Trush et al, 1978). There are two main light
amplifiers in common use in CL studies, luminol (5-amino-2, 3-
dihydro-1, 4 pthalazinedione) and lucigenin (10,10-dimethyl-bis-9,
9-biacridinium nitrate). Muller-Peddinghaus (1984) found that
lucigenin appeared to react mainly with the superoxide anion, the
first of the generated reactive oxygen species, while luminol
appeared to react mainly with hydrogen peroxide and the singlet
oxygen. This author suggested that lucigenin records cell
activity via the respiratory burst more reliably than does luminol
which depends on the generation of the chain reaction intermediate
H2O2 and on its three main catalysts, catalase, MPO and
glutathione. However, many laboratories use both these
amplifiers. In vitro stimulation of polymorph CL can be achieved
by fungi, bacteria, particulate antigen such as zymosan or soluble
agents such as PMA (phorbol-12-myristate-13-acetate).
6.1.5 SCOPE OF PRESENT STUDY
Polymorphs from mice of various genotypes used in the present
study were tested to see whether polymorph function could be
related to the level of naturally occurring and induced disease.
The tests used were an MPO assay and CL using zymosan and PMA as
stimulators and both luminol and lucigenin as light enhancers.
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6.2 MATERIALS AND METHODS
6.2.1 POLYMORPHS
Polymorphs were harvested from peritoneal exudate of mice of
the following genotypes, BALB/c, C57, + /bg, bg/bg, ob/ob and CBA.
All mice were 7 week old uninoculated males. Peritoneal exudate
cells were obtained according to the method of Gallin et al
(1974). Mice were given an intraperitoneal (IP) injection of 4 ml
sterile 10% sodium caseinate (Koch-Light Ltd, Colnbrook, Berks,
UK) in isotonic saline and, immediately prior to harvesting the
peritoneal exudates 16 hours later, all the animals were given a
2 ml IP injection of 20 p ml"'" heparinised saline (heparin from
Sigma Chemical Co Ltd, Poole, UK). The animals were then
sacrificed by cervical dislocation, the peritoneal cavity opened
and the exudate aspirated.
The exudates were spun at 2500 g at 4°C for 5 minutes and the
pellet resuspended in 10 ml cold sterile phosphate buffered saline
(PBS) (Flow Labs, Rickmansworth, UK). 100 pi of each cell
suspension was placed in 300 ul of cell counting fluid and a count
was ujade for each in a Neubauer Counting Chamber (Weber Ltd,
England). The cell concentrations were then adjusted to 5 x 10^
ml"'" for both MPO and CL assays. Differential counts were made
by placing 50 pi of a 5 x 10^ cells ml"'" cell suspension and
300 pi cold PBS in a cytospin (Shandon Southern Ltd, Runcorn, UK).
The resultant slide was stained with Leishman's stain, viewed via
a dissecting microscope (Zeiss Ltd, Wellwyn Garden City, UK), and
the numbers of different cell types present were counted.
Viability testing was carried out using trypan blue exclusion, by
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mixing equal volumes of cell suspension and 0.5% trypan blue in
0.9% saline. After 5 minutes the numbers of stained and unstained
cells were counted. The unstained cells were considered viable.
6.2.2 MYELOPEROXIDASE ASSAY
This test was performed on three separate occasions, each
time using cells from one mouse of each of the six genotypes. On
each occasion 200 jjl of the fresh 5 x 10^ ml ^ cell suspension
was spun at 10,000 g and resuspended in 200 jul acetate buffer (see
Appendix). This was stored at -20°C till the next day when the
cells were thawed and then frozen and thawed 3 times followed by
centrifugation at 10,000 g for 25 minutes. The supernatant was
decanted and used for the assay. To 1 ml of acetate buffer was
then added 0.05487g of 2,2'-azino-di (3 ethylbenzthiazoline
sulphonic acid) (ABTS) and this was diluted 1:97 in acetate






First, the H202 and cell supernatant/acetate buffer were
placed on opposite sides of the cuvettes. Only then was 0.97 ml
of the acetate buffer/ABTS added vigorously to each cuvette and
the optical density (OD) measured at 412 nm for 3-5 minutes in a
spectrophotometer (Pye Unicara, Cambridge, UK, model SP8200).












in the acid conditions and its activity was recorded by a colour
change in the ABTS. MPO activity was calculated by the following
equation:
OP x storage volume x 1
32.4 assay volume no of cells stored (in millions)
with units = units/10^ cells/minutes. (Klebanoff, 1965).
6.2.3 CHEMILUMINESCENCE ASSAYS
These tests were performed in duplicate on three separate
occasions. On each occasion cells from one mouse of each of six
genotypes were tested. The stimulants used were prepared as
follows.
(a) Zymosan (Sigma Chemical Company, Poole, UK): this was
incubated for 30 minutes at 37°C in 10% autologous or AB serum and
spun and washed once. The zymosan was then resuspended in Hank's
Balanced Salt Solution (HBSS) (Flowlabs, Rickmansworth, UK) to a
concentration of 20 mg ml-"'' and stored frozen (-40°C) till
required. The working concentration of 10 mg ml"''' was achieved by
the addition of HBSS.
(b) PMA (Sigma Chemical Company, Poole, Dorset): this was
prepared by dissolving 5 mg PMA in 2.5 ml dimethyl sulphoxide
(Sigma Chemical Company, Poole, UK) (DMSO) to give a 2 mg ml"'"
stock solution which was divided into 10 p. 1 aliquots and then
stored frozen (-40°C). When required, aliquots were thawed and
HBSS added to give the required working concentration of 20 ug
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The enhancers were prepared as follows
-3
(a) Luminol. Stock at a concentration of 10 M was
prepared by adding 0.0177 g luminol (Sigma Chemical Company,
Poole, UK) to 1 ml DMSO and this was then diluted to 100 ml
in HBSS. The stock solution was diluted in HBSS to the working
-5
concentration of 4 x 10 M.
(b) Lucigenin. This was prepared by adding 0.05105 g
lucigenin (Sigma Chemical Company, Poole, UK) to 1 ml HBSS and
then adding a further 100 ml of HBSS to produce a stock solution
-3
at a concentration 10 M which was stored at -20°C. This was
also the working concentration.
To perform the assay, stimulant, HBSS and enhancer were added
to the assay tubes not more than 30 minutes before the test was
read. The cells were added at the last moment before reading
began. The tubes contained the following:-
Reagent Volume Concentration Final Concentration
when added
HBSS 100 pi
Cells 200 pi 5 x 106 ml"1 1 x 106 ml"1
-5 -6
Luminol 200 pi 4 x 10 M 8 x 10 M
or Lucigenin 200 pi 15 x 10"^M 3 x 10 M
-4
Zymosan 500 pi 10 mg ml"1 5 pg ml"1
or HBSS 400 U1
u
r
The light emitted was detected and measured using an LKB 1251
+ PMA 100 l 20 pg ml 1 2 pg ml 1
luminometer (LKB Instruments Ltd, South Croydon, UK).
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6.3 RESULTS
6.3.1 POLYMORPH FUNCTION TESTS
The mean per cent polymorphs among peritoneal exudate cells
and mean per cent viability of these cells are shown for each
genotype in Table 6.1. Tables 6.2 and 6.3 respectively show mean
MPO activity and chemiluminescence for each genotype. There was a
consistently negative association between chemiluminescence and
MPO.activity over all genotypes, one correlation coefficient being
significantly different from zero (Table 6.4). A nested analysis
of variance (Table 6.5) for myeloperoxidase activity and
chemiluminescence showed that there were statistically significant
differences between genotypes for both tests. For
chemiluminescence, there were also statistically significant
differences between stimulants and between enhancers, but the
variation between mice was not signficantly greater than that
between duplicate measurements within mice. Reference to Table
6.3 shows that zymosan tended to induce higher chemiluminescence
values than PMA, and that lucigencin was a much more potent
enhancer than luminol.
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Table 6.1 Mean per cent polymorphs among peritoneal exudate cells
and per cent viability of peritoneal exudate cells
(n = 3 mice per genotype).
Genotype Mean % Polymorphs + se Mean % Viability + se
BALB/c 74 + 2.5 93 + 2.6
C57 78 + 2.4 96 + 2.0
+/bg 75 + 2.5 95 + 2.2
bg/bg 76 + 2.5 96 + 2.0
ob/ob 75 + 2.5 97 + 1.7
CBA 74 + 2.5 98 + 1.4
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Table 6.2 Mean myeloperoxidase activity in units as defined in
Section 6.2.2.
(n = 3 mice per genotype).
Genotype Mean MPO + se (xlO^)
BALB/c 5.97 + 0.27
C57 1.10 + 0.11
+/bg 6.07 + 0.37
bg/bg 13.27 + 0.71
ob/ob 11.06 + 0.05




GenotypeZymosan/LuminolZym san/LucigeninPMA umi olPMA/L cigenin BALB/cMean+se33.850.40141.500.1245 35+0 86 .95.2 t512140423546 C57Mean+se26.300.0875.95123 .53+0 243 3719 t512140423546 +/bgMeanse26.680.12115. 5+0 4440.32.076 83 t512140456468 bg/bgMean+se4.880.033 .470.056+20. 1.0 t5121560564 ob/obMean+se16.080.5668.770 240. 3+0.2033.320 t5121560564 CBAMean+se19.570.0129.880.1647 4+0 0. 8.10 t5121560564
Ln
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Table 6.4 Spearman rank correlation coefficients (rg) for
the association between chemiluminescence and mye¬
loperoxidase activity.
P values are two-tailed probabilities.
Zymosan/Luminol Zymosan/Lucigenin PMA/Luminol PMA/Lucigenin
rg -0.83 -0.60 -0.14 -0.60
0.04 0.21 0.79 0.21
Table6.5
Nestedanalysisofv riancef rpolymorphfunctionte ts.*in atesen minatorrFratios.
TestSourceofVariationssDF
ms




















Significance ofF 0.000 0.000 0.000 0.000 0.460
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6.3.2 POLYMORPH FUNCTION AND BONE LOSS
Figure 6.1 illustrates two relationships between bone loss
and MPO activity. Bone loss is expressed both as that found in
uninoculated controls and as the ratio of that induced by 10^
cfu to the control level. The Spearman rank correlation and its
associated two-tailed probability are given for each relationship.
Similarly, Figures 6.2 - 6.5 illustrate the association between
bone loss and chemiluminescence. For Figures 6.1 - 6.5 the
correlation of polymorph function with 10^/control bone loss was
consistently stronger than that with control bone loss.
Correlation coefficients for MPO activity were negative while
those for chemiluminescence were positive, three of the four
















6.1 The relationship between bone loss and MPO activity
(units/10
cells/minute x 10"^)


















Fig 6.2 The relationship between bone loss and zymosan/
luminal chemiluminescence.


















Fig 6.3 The relationship between bone loss and zymosan/
lucigenin chemiluminescence.
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Fig 6.5 The relationship between bone loss and PMA/lucigenin
chemiluminescence.
control bone loss: rg = 0.66, P = 0.1610^/control bone loss: rg = 0.94, P = 0.005
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6.4 DISCUSSION
All the tests described in this chapter were performed on
uninoculated mice. Thus, the results show only the capacity of
polymorphs from animals of the different genotypes to respond to
standard stimuli and enhancers.
The use of peritoneal exudate polymorphs had the advantage
that the cells were easily obtained and that the yield was high.
However, there was a possible disadvantage in that the cells had
already responded to a chemotactic stimulus before testing and may
therefore have undergone some metabolic and functional changes.
The mean percentage of bg/bg polymorphs obtained (Table 6.1)
did not differ significantly from that of the other genotypes.
Thus, in view of the chemotaxis defects detailed by other authors
in these mice (Gallin et al, 1974), any such defect must have
affected all cell types. In addition, the cell condition was good
as attested to by the high viability.
The standard errors for all the measurements made were small
relative to their means indicating that sample size was adequate
for statistical analysis. MPO activity was generally low (Table
6.2), consistent with the findings of Higgins et al (1978).
6.4.1 DIFFERENCES BETWEEN GENOTYPES
Both types of polymorph function test showed significant
differences between genotypes. The increase in MPO acitivity from
C57 through +/bg to bg/bg is consistent with a gene dosage effect
for the mutant allele. It is known from previous work by Brandt
et al (1975) and Kimball et al (1975) that lyso somes from beige
mice and CHS patients are very susceptible to mechanical breakage.
MPO is an enzyme found in primary lysosomal granules and, even
though secondary granules are more numerous in mature polymorphs
(Murphy, 1976a), it is still logical that MPO levels may be higher
in animals carrying the beige gene due to possible disruption as a
result of washing and/or spinning procedures.
For chemiluminescence, on the other hand, +/bg showed either
a similar or greater response than C57 but bg/bg by far the lowest
response of all genotypes. It has been suggested in the past that
the formation of large lysosomes in CHS patients and animal
analogues may be related to altered membrane properties. Oliver
et al (1976) reported cytochemical evidence for a possible lipid
defect in beige cells and Chi et al (1975) found that the lamellar
bodies of type II pneumocytes of beige mice had a three-fold
increase in surface active phospholipid. As previously stated, it
is generally accepted that the primary oxidase responsible for the
respiratory burst in polymorphs is located on the outer surface of
the polymorph plasma membrane (Briggs et al, 1975; Goldstein et
al, 1977; Dewald et al, 1979). Chemiluminescence measures the
respiratory burst, thus it may be that the presence of the
homozygous beige gene results in some membrane change, possibly in
amount or position of the primary oxidase, which may in turn
affect the respiratory burst and thereby chemiluminescence.
No consistent relationship was found between the responses of
ob/ob and C57 polymorphs in the different stimulant/enhancer
groupings. There was, however, a tendency towards a negative
association between chemiluminescence and MPO activity over all
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genotypes (Table 6.4). As it was shown by Trush et al (1978) that
light emission depends on both superoxide and myeloperoxidase
catalysed reactions, the reasons for this negative association are
therefore obscure.
Differences of polymorph function between mouse strains have
also been described by Lamster et al (1979). These workers
investigated the ability of polymorph supernatants to enhance the
blastogenic response of mouse splenocytes to phytohaemagglutinin-P
(PHA). BALB/c, A/J and C57BL/6J strains were tested. BALB/c and
A/J mice had active supernatants capable of enhancing the
blastogenic response to the mitogen, and splenocytes that
responded to active supernatant in the presence of PHA. C57BL/6J
mice, conversely, did not produce an active supernatant, and
splenocytes from these animals failed to respond to active
allogeneic supernatant in the presence of mitogen. These findings
provide further evidence for genetic variation in polymorph
function.
6.4.2 DIFFERENCES BETWEEN STIMULANTS AND ENHANCERS
The chemiluminescence produced by zymosan/luminol was less
for all genotypes (except bg/bg) than that produced by
PMA/luminol, while the chemiluminescence of zymosan/lucigenin was
always greater than that of PMA/lucigenin. Differences between
stimulants and enhancers therefore appear to exist.
The time taken to reach peak chemiluminescence (Table 6.3)
shows that a peak was attained more rapidly with luminol than with
lucigenin. This result is consistent with that of Muller-
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Peddinghaus (1984). However, whereas that author found that
luminol produced the greater absolute chemiluminescence, in the
current work lucigenin produced the greater chemiluminescence in
11 of the 12 genotype/stimulant combinations. As pointed out by
Muller-Peddinghaus, lucigenin reacts with the first of the
generated reactive oxygen species, the superoxide anion radical
(O2). The shorter time to peak with luminol, which reacts with
the chain reaction intermediate H2C>2> is therefore to be
expected. The cause, however, as to why the absolute value was
almost always higher in lucigenin enhanced chemiluminescence is
unknown.
6.4.3. ASSOCIATION BETWEEN POLYMORPH FUNCTION AND BONE LOSS
The most important finding is that a high MPO activity
appears to be associated with protection from periodontal
destruction induced by A. viscosus inoculation, whereas high
chemiluminescence activity appears to be associated with high
levels of destruction (see Figures 6.1-6.5). The biological
significance of these findings is unknown but they do appear to
agree with previous work showing polymorphs to have both a
protective and destructive role in the pathogenesis of periodontal
disease.
For both MPO activity and chemiluminescence, the association
with 10^/control bone loss gave a more definite pattern of
results than with control bone loss. This suggests that certain
differences of polymorph function between genotypes may only be
disclosed following bacterial challenge. A number of previous
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investigations have a bearing on this hypothesis.
Lamster et al (1980) examined mouse polymorphonuclear
leucocyte-rich (PMNLr) cells, produced as a result of
intraperitoneal injection of either 2 ml 1% glycogen in sterile
saline (g cells) or 2 ml thioglycollate (th cells). The metabolic
activity of both g and th cell groups was determined by measuring
glucose utilization in the hexose monophosphate shunt. It was
found that g cells had significantly lower metabolic activity and
could depress both primary cell-mediated and secondary humoral
immune responses. Conversely, th cells had high metabolic
activity and stimulated both these responses. The mechanisms by
which inflammatory cells modify the immune response is not
definitely known, but a number of salient points have emerged.
Nakayama et al (1978) showed that PMNLr cells could enhance
cytolysis of tumour cells by allogeneic spleen cells, but that
PMNLr cells alone had no effect. It was thought that some factor
or factors released by PMNLr cells was responsible for the
activity observed.
A variety of neutral proteases released from polymorphs have
been shown to enhance immune function (Nakamura et al, 1976;
Schmidt et al, 1978; Havemann et al, 1978; Bretz, 1978). The
release of these enzymes seems to be correlated with metabolic
activation of the polymorphs (Murphy, 1976b). Therefore, the
stimulatory effects of the th cells in the study by Lamster et al
(1980) could be at least partially accounted for by protease
activity. The suppressive effect of the g cells in the same study
may be attributable, as pointed out by the authors, to a different
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polymorph released substance such as prostaglandin (PGE). Human
polymorphs have been shown to release PGE1 when exposed to zymosan
(Zurier & Sayadoff, 1975) and PGE is released from rabbit
peritoneal polymorphs during phagocytosis (McCall & Youlten,
1973). The difficulty encountered in studying the effects of PGE
in vivo relates to its relatively short half life. Strom et al
(1977), however, have demonstrated that PGE derivatives, which
have a longer half life, could suppress both in vivo and in vitro
immune responses to alloantigens, causing prolongation of kidney
allografts in rats, and reduction of in vitro lymphocyte-mediated
cytotoxicity in mice.
The findings of Lamster et al (1980) argue against the
interaction of polymorphs and immune cells as being specific for B
cells, as had been proposed (Vischer et al, 1976; Bretz, 1978),
since both lymphocyte-mediated cytotoxicity and complement-
dependent cytotoxicity were modified by the acute inflammatory
cells. The basic question of why different stimulants recruit
inflammatory cells with different spontaneous metabolic activity
has not been answered, but this finding underlines the importance
of making sure all cells for comparative testing are treated in
the same way.
6.4.4 CONCLUSION
The observed differences of polymorph function go some way
towards explaining why different levels of bone loss, both
naturally occurring and in response to A. viscosus inoculation,
were found in the different genotypes.
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Although no record of murine polymorph MPO activity or
chemiluminescence on challenge with A. viscosus has appeared in
the literature, Baron & Proctor (1984), using chemiluminescence as
a measure of the response of BALB/c peritoneal exudate polymorphs
to Salmonella typhimurium, showed that both polymorphs and
specific anti-Salmonella antibodies acting in concert were
required to effect polymorph-associated bactericidal activity.
These authors also showed that polymorph activity alone does not
play a major role in protecting unvaccinated, sensitive mice from
disease caused by this organism. This again leads to the
suggestion that the humoral immune system is extremely important
in the murine response to bacterial challenge.
Both the MPO and chemiluminescence findings have thus
generated interesting ideas, but proving or disproving them is not
possible without performing polymorph function tests using either
whole A. viscosus cells, or an extract thereof, as the stimulant.
Such tests could also be performed on the cells of animals
inoculated with 10^, 10^ and 10^ cfu A. viscosus, to






Investigations into the role of lymphoctyes in the
pathogenesis of periodontal disease, from a number of points of
view and using different techniques, have resulted in a mass of
information, much of which is contradictory. However, these
cells, with their potent immunoregulatory functions, are clearly a
most important component of the host defence system.
7.1.1 THE BLASTOGENIC RESPONSE
The blastogenic response is an increase in lymphocyte
numbers through cell division following some form of stimulation.
In a series of reports, Ivanyi and Lehner (1970; 1971a,b; 1974)
showed that cultures of peripheral blood mononuclear cells from
patients with gingivitis and mild or moderate periodontitis,
incubated in vitro with homogenates of a panel of bacteria from
periodontal pockets or supragingival microbial plaque, exhibited
blastogenesis whereas those from disease-free control subjects did
not. By contrast, cells from patients with severe periodontitis
did not respond blastogenically, although lymphokine production
was found to be increased. These are soluble factors, derived
from lymphocytes, which function as mediators of immune reactions
(Ivanyi et al, 1972). Ivanyi et al (1973) determined that
patients with severe disease carried serum factors which blocked
the blastogenic response, while serum from patients with chronic
gingivitis or mild to moderate periodontitis contained factors
which enhanced the blastogenic response. These factors appeared
to be immunoglobulins specific to the antigen activating the
mononuclear response.
Church and Dolby (1978), in contrast to previous workers,
examined the relationship between the dose of dentogingival plaque
and the in vitro lymphoproliferative response in periodontally
diseased individuals. The results of this work suggested that
lower concentrations of plaque are needed to produce peak response
values in severely diseased patients, implying that plaque
elimination is more important for severely diseased individuals
than for their less affected counterparts.
A positive correlation between the degree of periodontal
disease as measured by the Russell Index (Russell, 1956) and
spontaneous cell-mediated cytotoxicity (P^ 0.001) was reported in
1985 by Tsoumis et al. The in vivo significance of this is
obscure, but patients with Chediak-Higashi syndrome, who often
suffer rapidly progressive periodontal disease (Tempel et al,
1972), have impaired eel 1-mediated cytotoxicity (Katz et al,
1982). Apparently, cell-mediated cytotoxicity is influenced by
and may play a role in oral disease.
It is possible that HLA type is important in determining
lymphocyte responsiveness, as Amer et al (1986) demonstrated
impaired lymphocyte responsiveness to phytohaemagglutinin in HLA-
B8 and/or DR3 subjects.
7.1.2 THE ROLE OF T-CELLS
In the early 1970's, a blastogenic response to antigen
preparations by peripheral blood mononuclear cells in culture was
considered to be an in vitro correlate of a delayed
hypersensitivity reaction and only T-cells were thought to produce
lymphokines. Thus, an important role for T-lymphocytes and
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delayed hypersensitivity in the pathogenesis of chronic gingivitis
and periodontitis was postulated (Page & Schroeder, 1982). This
idea was supported by the observation of Ivanyi and Lehner (1977)
that levamisole, a drug which stimulates eel 1-mediated immune
responses, resulted in the development of gingivitis and
aggravated the severity of established chronic gingivitis. Work
by Wilde et al (1977) further supported this hypothesis in showing
that typical early lesions in both rat and monkey gingivae could
be induced by placing antigen at the gingiva! margin after
sensitising the animals' skin to the same antigen. Sensitisation
could also be transferred from one animal to another by
lymphocytes and not by serum.
However, Mackler et al (1974) demonstrated that plaque
bacterial products caused both B and T-cell activitation and that,
of the two cell types, B-cells were the better lymphokine
producers. Furthermore, the histological studies of Seymour and
Greenspan (1979) and of Mackler et al (1977; 1978a,b; 1979) showed
periodontitis to be characterised by a predominance of B-cells and
plasma cells rather than T-cells and macrophages, suggesting a
prominent role for B-cells.
7.1.3 INTERACTIONS BETWEEN T AND B-CELLS
The interrelationships of different cell types in
periodontal disease have recently been studied by Baker and
Tondreau (1985). These investigators, using peripheral blood
lymphocytes from patients with 'moderate' disease only, examined
the proliferative responses of B and T-cell populations,
separately and in combination. The lymphocytes were exposed to
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cell walls from seven types of oral bacteria to determine the
antigenic response, and to phytohaemagglutinin (PHA), pokeweed
mitogen (PWM), 1ipopolysaccharide (LPS) and streptolysin-0 (SLO)
to determine the mitogenic response. They found that mononuclear
cells, together with a recombined subpopulation consisting of four
parts purified T-lymphocytes and one part B-lymphocytes, responded
significantly to all the stimulants. Purified T-lymphocytes alone
responded significantly to PHA and PWM, but were unresponsive to
oral bacteria and SLO until cultured with 2% autologous
macrophages, indicating that the T-cell responses to oral bacteria
were macrophage dependent. B-cells alone were poorly responsive
to all the stimulants, but the responses to all stimulants except
PRA increased significantly after the addition of 10% mitomycin-C-
treated T-cells, showing that B-cell proliferation in response to
these stimulants was T-cell dependent.
The dependence of T-cell proliferative responses to oral
bacteria on macrophages had previously been reported by Stashenko
(1982) who also found that 10% macrophage concentrations gave
maximum T-cell proliferation while concentrations in excess of 20%
were suppressive.
Many B-cell mitogens, including PWM (Levinson et al, 1983),
LPS (Miller et al, 1978; Lopatin et al, 1980a), staphylococcal
peptidoglycan (Levinson et al, 1983) and Actinomyces viscosus
(Lopatin et al, 1980 b & c) have been shown to require T-cell help
in order to stimulate optimal human B-cell proliferation in vitro.
The recent work of Baker and Tondreau (1985) confirmed these
earlier findings. The evidence as a whole, therefore, suggests
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that examination of one subpopulation of lymphocytes alone cannot
provide all the answers to questions about lymphocyte function in
periodontal disease.
7.1.4 IS GINGIVAL LYMPHOCYTE ACTIVATION ANTIGENIC OR
MITOGENIC?
If gingival lymphocytes are activated specifically by
bacterial antigens (monoclonal activation) rather than non-
specifically (polyclonal activation), specific antibody
would be produced in diseased gingival tissues and immune complex
deposition would occur. Such complexes can activate complement
and so could interact with polymorphs and monocytes to initiate
and perpetuate tissue destruction. If such specific sensitisation
is reflected by lymphoid cells in the blood, responsiveness of
peripheral blood mononuclear cells to plaque related antigens
should vary with the periodontal disease status of the cell donor.
On the other hand, if lymphocyte activation is polyclonal large
amounts of nonspecific immunoglobulin would be produced, with
little or no immune complex formation. It should then be unlikely
that host disease status would be reflected in responsiveness of
peripheral blood mononuclear cells. It must be noted, though,
that both mitogenically (polyclonally) activated cells and their
antigenically (monoclonally) activated counterparts produce
lymphokines which may be key factors in tissue destruction (Page &
Schroeder, 1982).
At a cellular level, several studies have shown that T-cell
poliferative responses to mitogens are less macrophage-dependent
than T-cell proliferative responses to antigens (Cline & Swett,
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1968; Levis & Robbins, 1977; de Vries et al, 1979). The purified
T-cells in the Baker and Tondreau study (1985) responded
relatively well to the mitogens PHA and PWM in the absence of
macrophages, although addition of macrophages did enhance the
responses. The same T-cells were poorly responsive to the antigen
SLO and oral bacteria and these responses were highly dependent on
the presence of macrophages. This finding suggests that T-cell
responses to oral bacteria are antigenic rather than mitogenic.
On the other hand, many oral bacteria are known to activate
polyclonal immunoglobulin production in human peripheral blood B-
lymphocytes (Smith et al, 1980; Bick et al, 1981; Mangan et al,
1983). Furthermore, A. viscosus has been shown to activate
polyclonal DNA synthesis in human B-cells, provided there is a
source of activated T-cells (Lopatin et al, 1980b,c; 1981). Engel
and co-workers (1977) demonstrated that A. viscosus homogenate
contained substance(s) which caused spleen cells from conventional
and germfree mice to undergo increased DNA synthesis. This
mitogenic effect was apparently exerted primarily on B-cells as
spleen cells from nude mice or T-depleted spleen cells from
conventional mice responded as strongly as conventional (T + B)
spleen cells and mouse thymocytes did not respond at all.
These findings were confirmed by Burckhardt et al (1977) who
found that an extracellular heteroglycan and a sonicated cell
supernatant of A. viscosus were mitogenic to mouse B-cells. The
next step was to find, isolate and purify the mitogenic
fraction(s).
Kimura et al (1983) isolated a murine B-cell mitogenic
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component from both A. viscosus and A. naeslundii cell walls.
However, Halfpap et al (1985) extracted various cell components
from two strains of A. viscosus and tested the response of murine
splenocytes to each one. They found that the mitogens produced by
A. viscosus appeared to be either associated with whole cells and
released by physical methods, such as passage through the French
Pressure Cell, or were released into the medium during growth. The
data strongly suggested that the mitogenic activity was not
dependent on a major cell wall component because the most active
fractions were soluble macromolecules released by physical
methods. Such soluble preparations were substantially more active
than were cell walls or peptidoglycan produced by any of the
disruption methods used. Furthermore, complete solubilization of
the cell walls with M-N-acetylmuramidase according to the method
of Brown et al (1982) did not release activity that might have
been masked in the intact cell wall. It is possible that the
absence of mitogenic activity for A. viscosus peptidoglycan may be
attributable to the unique structure of the peptidoglycan
crossbridge as described by Schleiffer and Kandler (1972). In
conclusion, Halfpap et al (1985) suggested that subsequent efforts
in trying to identify murine B cell mitogens from A. viscosus
should be directed towards components that could be sheared from
the cells by the forces generated by passage through the French
Pressure Cell under conditions in which cell lysis is minimal.
This evidence that B-cell proliferative responses to oral
bacteria may be mitogenic still leaves unanswered whether T-cell
proliferation and T-helper activation occur antigenically or
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mitogenically. According to Baker and Tondreau (1985), a study
using cord-blood lymphocytes is planned. Such cells are thought
to be immunologically naive and, even though earlier studies
(Horton et al, 1972; 1976; Baker et al, 1976; Chen & Doroszczak,
1980) failed to detect a proliferative response in them to oral
bacteria, work by Donaldson et al (1983) showed that this lack of
responsiveness could be overcome by altering the cell culture
density.
Some authors (Chen & Doroszczak, 1980; Lopatin et al, 1980a;
Stashenko, 1982) have pointed out that the kinetics of human
peripheral blood lymphocyte DNA synthesis in response to oral
bacteria, resembles an antigenic rather than a mitogenic
response. DNA synthesis is maximal after six or seven days of
culture, both for specific antigens and for oral bacteria, whereas
mitogens such as PHA give maximal DNA synthesis after three days
in culture. However, a six to seven day maximal DNA synthesis
response is also typical of human lymphocyte responses to T-cell
dependent B-cell mitogens such as LPS (Miller et al, 1978) and
Staphylococcus aureus peptidoglycan (Dziarski et al, 1980).
Consequently, kinetic studies are not reliable criteria for
distinguishing between antigenicity and mitogenicity. Thus, at
present, the antigenic versus mitogenic activation question
remains unresolved.
7.1.5 THE PERIPHERAL MONOCYTE BLASTOGENIC RESPONSE AND
PERIODONTAL DISEASE
Numerous investigators have repeated and extended the
original experiments of Ivanyi and Lehner (1970). The first of
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these were Horton et al (1972) who found a positive correlation
between the peripheral monocyte blastogenic response to substances
from microbial plaque and the presence/severity of gingivitis and
periodontitis. A similar positive correlation was reported by
Baker et al (1976) and additional confirmatory observations were
reported by Horton et al (1973, 1976), Patters et al (1976),
Lang & Smith (1977) and Smith & Lang (1977). Kiger et al (1974)
found no correlation between blastogenesis and disease status but
there was a positive correlation between the capacity of a
patient's cells to respond to plaque bacterial preparations and
their capacity to respond to other non-plaque antigens, thus
suggesting that responsiveness is an individual characteristic
unrelated to the presence of inflammatory periodontal disease.
Another approach has been to study cell responsiveness in
subjects with experimental gingivitis. Lehner et al (1974) found
a positive correlation between mononuclear cell responsiveness and
the onset and severity of inflammation. The data have been judged
inconclusive as the increase was small and the variance large.
There were positive responses in this study to a purified protein
derivative and Lactobaci1lus acidophilus, two stimulants not in an
way aetiologically related to gingivitis, and this was taken to
imply that plaque accumulation in humans has an adjuvant effect in
that it may enhance immune responsiveness to all antigens.
Patters et al (1977, 1979) assessed mononuclear cell
blastogenic responsiveness during a 12-week period of intensive
tooth cleaning followed by a period of developing gingivitis.
While no change was detected in PHA induced blastogenesis, the
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stimulation index scores dropped in response to A. viscosus and
F. nucleatum during tooth cleaning but rose in six out of eight
subjects during the period of developing gingivitis. Lang and
Smith (1976), using blood cells from patients developing
gingivitis, found that the maximum response to PHA rose
approximately four-fold and the dose required to obtain maximum
I
blastogenesis dropped from 5 pg ml~^ to 1 ^ig ml""'".
Responsiveness returned to normal after reinstitution of oral
hygiene measures.
Suzuki et al (1984) presented data comparing 16 healthy
controls and 20 periodontally diseased subjects. After a full
clinical and radiographic examination of each patient, mixed
lymphocyte cultures from peripheral blood were set up with
homogenised cultures of B. gingivalis, F. nucleatum or
A. viscosus, or with the mitogens LPS or PWM as stimulators. A
range of cell and activator concentrations and incubation times
was used. Under these conditions, cultures of activated patient
cells did not differ significantly from activated control cells
with any of the bacterial preparations. However, responsiveness
of cultures from diseased subjects activated with both PWM and LPS
was significantly lower than that of cultures of control cells.
Stashenko et al (1983) compared the clinical findings and
cellular responsiveness of 33 diseased subjects and 11 healthy
controls. The cell cultures used were T-cells plus 10% monocytes
only and were tested against a panel of sonicates of 12 species of
microorganism, including A. viscosus, and PHA. No statistically
significant differences were found between the pooled results from
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diseased subjects and those from controls. When all the subjects
were grouped according to their T-cell response profile by cluster
analysis, 'generalised high responder' and 'generalised low
responder' groups were identified. Low responders were found to
have significantly more redness and bleeding on probing than high
responders. No differences were found, however, with respect to
plaque, attachment level, pocket depth or bone loss. Patients not
falling into the high or low responder groups had intermediate
proliferative responses and moderate amounts of inflammation.
These apparently conflicting findings make the role of the
blastogenic response in periodontal disease difficult to assess.
Lymphocyte studies have also been performed to try to shed
some light on the role of the immune response in the control of
collagen turnover. In 1982, Mammo et al showed that the cellular
immune response to Type 1 collagen was higher in patients with
periodontal disease than in their non-diseased counterparts. The
work of Johnson and Ziff (1976) and Wahl et al (1978) showed that
activated lymphocytes are capable of producing fibroblast
stimulating factors while Anastassiades and Wood (1981) showed
such cells to produce fibroblast inhi-biting factors. Al-Dallal et
al (1985) demonstrated the supernatants of mixed lymphocyte
cultures to contain mediators with opposing in vitro growth effect
on gingival fibroblasts at different times during culture. This
last work thus supports the dual regulation shown by the findings
of the previous three authors. Postlethwaite et al (1984)
reported a similar phenomenon in relation to collagen production
by fibroblasts.
It is not surprising, therefore, that this area of study is
still regarded as largely mysterious and uncertain territory.
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7.1.6 THE PRESENT STUDY
In the present study, experiments were designed to assess
the response of both splenic and mesenteric lymph node (MLN)
lymphocytes to both specific stimulation by the EDTA A. viscosus
extract and mitogenic stimulation by PHA. The splenic cells were
chosen to monitor the systemic immune system response and MLN
cells to monitor the response of the gut-associated immune system.
The effect of macrophage suppression on the different
cell/stimulation combinations was tested by the addition of
indomethacin and vitamin E which block any such suppression
(deShazo et al 1981).
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7.2 MATERIALS AND METHODS
The material for lymphocyte studies was obtained from
approximately 10 mice of each genotype/inoculation group 12 weeks
after inoculation with A. viscosus, according to the schedule
described in Section 2.4).
7.2.1 LYMPHOCYTE TRANSFORMATION
Immediately postmortem, spleens and MLNs were dissected out
in a laminar flow hood (Envair UK Ltd, Rossendale, UK) and
immediately placed in sterile RPMI 1640 Dutch modification with
Hepes medium (1640) (Flow Laboratories Ltd, Rickmansworth, UK).
Tissues of each type from mice of the same genotype/inoculum group
were then pooled.
The spleens were chopped finely in a sterile tissue culture
dish with a sterile disposable blade. Using a fresh sterile
disposable pipette for each group, 2 ml sterile 1640 was added and
the tissue and medium mixed to release the lymphocyte rich cell
population. The suspension was made up to 10 ml in a sterile
centrifuge tube with fresh 1640 and allowed to settle for 5
minutes. All tube contents except' the solids at the bottom of the
tube were then layered over 5 ml premixed Ficoll Hypaque (Flow
Laboratories Ltd, Rickmansworth, UK) in a fresh sterile disposable
centrifuge tube. The tubes were then centrifuged at 200 g for 10
minutes. The supernatant, containing lymphocyte rich leucocytes,
was removed immediately and washed twice in 1640 and the pellet,
composed primarily of red blood cells, was discarded.
The MLNs were carefully trimmed free of fat, chopped finely
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and resuspended in the manner described for spleens. The
suspension containing the lymphocyte rich leucocytes was then
washed twice in 1640. Pooled cells from each source were then
counted in a 0.1 mm depth Neubauer Cell Counting Chamber (Weber-
Werkzueg K G, Steinheim, West Germany) and cell viability was
assessed by trypan blue exclusion. All cell suspensions were
then adjusted to an appropriate working concentration as described
below.
Spleen and MLN cells were cultured in sterile 96-well flat-
bottomed microtitre culture plates (Flow Laboratories Ltd,
Rickmansworth, UK). The cultures, in triplicate, contained 2 x
10^ cells in a final volume of 0.2 ml consisting of 1640
supplemented with final concentrations of 5% fetal calf serum, 2
mM L-glutamine, 100 U ml~^ penicillin, 100 jig rnl"^"
streptomycin (all from Flow Laboratories, Rickmansworth, UK), and
5 x 10"5 M mercaptoethanol (Sigma Chemical Company, Poole, UK).
For each genotype, cells were used either purely from one
inoculum group or as 50/50 co-cultures from two inoculum groups.
Co-cultures were designated, for example, as 10^/10^.
Lymphocyte proliferation was induced by PHA (Sigma Chemical
Company) or by the A. viscosus EDTA antigen extract (2.2.3.5),
both at a final concentration of 5 |ig ml-"'". Cultures were
incubated at 37°C in a humidified atmosphere of 5% CO2 in air.
Incubation continued for three days for the mitogen (PHA) tests
and six days for the antigen (A. viscosus) tests, with 0.5 jiCi
H-thymidine GA (Amersham International pic, Amersham, UK) added
to each well for the last 24 h of incubation. The cell cultures
from each well were harvested using a cell harvester (Titertek,
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Flow Laboratories Ltd, Rickmansworth, UK). The filters containing
the harvested cells were then immersed in vials containing 3 ml
scintillation fluid (Fisons Scientific Apparatus, Loughborough,
UK) and the radioactivity counted in a liquid scintillation
counter (Packard Tri-Carb Ltd, Caversham, UK). Readings were
expressed as counts per minute (cpm).
Experiments with cells from different genotypes were
performed on the dates given below. Only on 22.1.86 were cells of
two different genotypes collected on the same day.
Genotype Date







7.2.2 MACROPHAGE MEDIATED SUPPRESSION
Microtitre lymphocyte cultures were set up as described
above, except that each well also contained a final concentration
of 50 g 1"^ of both indomethacin and vitamin E (Flow
Laboratories Ltd) abbreviated here as I/E. All cultures in
triplicate were then incubated for the appropriate time according
to whether stimulation was mitogenic or antigenic, with labelling,
harvesting and counting as described above. Macrophage




In all cell preparations, viability was 98% or better as
measured by trypan blue exclusion.
Tables including the number of observations, mean cpm and
standard error for each group used in the analysis are given as an
appendix to the main text of this chapter (Section 7-5).
7.3.1 DIFFERENCES BETWEEN RUNS ON DIFFERENT DAYS
For BALB/c, where the same lymphocyte transformation tests
were repeated on four different days, one-way analysis of
variance showed that for all 24 inoculum/cell/stimulation groups
(uninoculated, 10^, 10^, 10^/MLN, spleen/unstimulated, PHA,
A. viscosus) that were tested on all four occasions, there were
highly significant differences in blastogenic response between
days (P<^0.0001 for 23 groups, P = 0.004 for one group).
7.3.2 DIFFERENCES BETWEEN GENOTYPES
Owing to the differences between runs for the same genotype
(BALB/c) on different days, strictly valid comparison between
different genotypes tested on different days could not be made.
The only genotypes tested on the same day were BALB/c and CBA (on
22.1.86). Of the comparisons that could be made between these two
genotypes within inoculum/cell/stimulation groups (uninoculated,
10^, 10^, 10^/MLN spleen/unstimulated, PHA, A. viscosus) -
all with and without I/E combined) eight showed a statistically
significant difference between genotypes with CBA always having
the higher blastogenic response (P<0.05 by one-way analysis of
variance).
Although comparison between genotypes tested on different
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days is not strictly valid, an overall relationship between xid/Y,
CBA and the other genotypes emerged. Of the 24 inoculum/cell/
stimulation groups (uninoculated, 10^, 10^, 10^/MLN,
spleen/unstimulated, PHA, A. viscosus), xid/Y showed the lowest
blastogenic response in 19 and CBA the highest in 13.
7.3.3 DIFFERENCES BETWEEN INOCULUM GROUPS
One-way analysis of variance failed to reveal any consistent
pattern of differences between inoculum groups within genotypes,
cell-types and stimulants (with and without I/E combined).
The inconsistency of the results is illustrated by the testing of
BALB/c cells from uninoculated controls and 10^-inoculated
animals on four different days. Considering only 8.1.86 (Table
7.1) there appears to be a difference between inoculum groups that
is dependent on the source of the cells. However, this was not
confirmed by results on the other three days.
7.3.4 DIFFERENCES BETWEEN MLN AND SPLEEN CELLS
Spleen cells tended to show a higher blastogenic response
than MLN cells in unstimulated cultures, while in both PHA and
A. viscosus stimulated cultures, with the exception of +/bg, MLN
cells tended to show a higher response (Table 7.2).
7.3.5 DIFFERENCES BETWEEN STIMULANTS
Stimulation with PHA or A. viscosus resulted in significantly
higher blastogenic responses than in unstimulated cultures for a
large proportion of genotype/inoculum groups. PHA was a more
potent stimulant for BALB/c, bg/bg, ob/ob, CBA and xid/Y, while




Of the 32 statistically significant differences between
cultures with and without I/E (Table 7.4), six showed a lower
blastogenic response and 26 a higher blastogenic response with
I/E, a significant preponderance of higher responses (chi-squared
= 12.5, df = 1, P <0.001). Significantly higher responses with I/E
occurred predominantly with A. viscosus stimulation and in bg/bg
mice. Twenty three of the 26 significantly higher responses
occurred in mice with the C57 background.
7.3.7 CO-CULTURES
Statistically significant differences of blastogenic response
between co-cultures and both their component cultures are
summarised in Table 7.5. Of the 33 comparisons of 10^/10^ co-
cultures with both 10^ and 10^ pure cultures, four showed
significantly higher responses. Of the 33 comparisons of
10^/10^ co-cultures with both 10^ and 10^ cultures, only
one showed a significantly higher response. There was no instance
of a co-culture showing a significantly lower blastogenic response
than both its component cultures.
Table7.1
Summaryofstatisticallysignificantdifferencesofblastog nicresponsebetw en uninoculatedand107inocula dBALB/cmiceondifferentys(w thnd withoutI/Ecombined). MLNSpleen UnstimulatedPHAA.visUnstimulatedPHAA.vis
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Table 7.2 Differences in blastogenic responses: MLN - Spleen (with and without
I/E combined). P<0.05






t P t P t P
Uninoculated -2.79 0.008 3.78 0.000 -0.55 0.586
10'" -3.24 0.002 0.50 0.620 1.01 0.318
10? -2.72 0.009 0.12 0.901 0.39 0.702
10q -2.06 0.043 3.99 0.000 2.24 0.031
10b/10+ -4.78 0.000 -2. 56 0.018 0.74 0.466
10b/10q -1.85 0.069 -1.08 0.289 0.57 0.573
Uninoculated -3.11 0.005 1.64 0.141 -2.90 0.008
10b -0.72 0.477 -1.17 0.253 -0.50 0.631
10* 0.40 0.700 0.83 0.433 1.64 0.131
10q 1.69 0.109 0.90 0.393 2.88 0.015
iou7io> 2.16 0.046 0.71 0.483 2.83 0.017
10b/10q 1.96 0.069 0.48 0.638 3.01 0.012
Uninoculated - _ _ _ _ -
10fa -6.44 0.000 -18.25 0.000 -1.01 0.338
10* -3.79 0.003 -7.29 0.000 -0.41 0.687
10H -5.83 0.000 -9.20 0.000 -2.34 0.044
10b/10T - - - - - -
10<o/10q - - - - - -
Uninoculated -1.09 0.287 7.91 0.000 1.54 0.154
10b 0.39 0.703 10.05 0.000 3.33 0.008
10* -0.94 0.357 8.94 0.000 2.25 0.048
10* -1.99 0.060 1.36 0.238 3 • 64 0.019
lO^/lO* 1.25 0.244 6.01 0.001 4.26 0.002
10b/10q 0.21 0.838 25.54 0.000 5.96 0.000
Uninoculated -2.08 0.064 7.98 0.000 3.11 0.011
106 - - - - - -
10 *" -11.80 0.000 8.79 0.000 0.32 0.752
10 q -0.91 0.386 19.40 0.000 -0.94 0.388
iob/io* - - - - - -
iob/iocl - - - - - -
Uninoculated _ _ _ _ - _
10b -6.82 0.000 -0.12 0.910 -0.47 0.647
10* -1.49 0.150 5.87 0.000 3.31 0.008
10^ 1.20 0.241 7.36 0.000 6.86 0.000
10^/10+' -1.90 0.071 5.20 0.000 1.74 0.112
10"7l0q -2.11 0.047 4.99 0.001 0.56 0.629
Uninoculated -0.45 0.668 -0.34 0.737 0.60 0.564
10b -1.54 0.138 1.71 0.119 -0.41 0.692
10 * 1.05 0.303 0.54 0.599 -1.03 0.387
10 1.64 0.115 -1.74 0.112 -1.65 0.185
10*710*" 1.95 0.064 1.18 0.291 0.51 0.621
10710* -2.11 0.063 -0.65 0.530 -0.05 0.965
Table7.3 GenotypeInoculum
Differencesinblastogenicrespo se:ty sf P0.05 MLN Unstim.-PHAUnstim.-A.visPHA-A vi tP




























































































stimulation(withandwit utI/Ecombi ed). SPLEEN Unstim.-PHAUnsti . A.visPHA-A vi tP -3.340.004 -4.500 000 -3.550.002 -3.490.003 -6.810 000 -8.370 000 -4.100 002 -3.240.008 -2.320 039 -5.700.000 -3.120 008 -3.940.002 -5.450.000 -4.600 000 -3.990.004 -3.010 12 -5.100.000 -4.970 000-4.290 001 -4.120 001 -4.410 000 -3.150.005 -4.050 01 -4.080 01 -10.520.0 0 -8.020 00 -4.720 001 -7.480.000 -4.320 001 -6.090.000 -16.810.000 -6.550.002 -14.720.000 -6.580 002 -15.490.000 -15.670.000




GenotypeInoculum bg/bg ob/ob CBA xid/YUninoculated 10b 10+ io°\ \̂/1nl10^/10 10L/10S Uninoculated 10b 10T 10 10L/10f 10^/10^ Uninoculated 10° 10* 10'^ 10b/10+ 10^/10^ Uninoculated 10° 10* 10^ loVlO* 10s






7.530.001 5.700.002 4.180 009
10.410.000 12.770.000 12.150.000
-8.230.000 -3.740.014 -2.690.038





































































































































































































































































































































-0.04971 0.61547 1.330 201 1.100 278 0.26797
-1.400 170 0.62544 -1.000 367 0.67515 2.290 037 -0.75462 -0.25807 0.19854 -2.070 65 -0.21837 0.64538 -0.67522 0.25806
1.250 52 1.130 275 0.34735 1.050 307 0.12903 1.190 252 3.590.005 0.35.734 1.520 159 0.64537 3.090.011 0.23.820 4.150 014 2.750.051 1.470.214 5.080 07 8.260 001 0.87.434






bg/bgUninoculated 10b 101 ioCA lO^/lO1 io^/IO'1 ob/obUninoculated 10u 10+ 10 10/'
0.85 1.04 0.44 1.85 1.71 1.95
0.413 0.324 0.670 0.093 0.149 0.080
4.800 0 9 3.560 024 8.360 001
•0.98 0.17 ■0.93 12.52 -0.90 •0.92
0.382 0.823 0.403 0.006 0.417 0.408
-1.120 3 5 -1.530.201 -1.870.134
10L'/10
CBA xid/Y
Uninoculated 10^' 101 10^ lO^/lcP Uninoculated 10^ 10~* 10^ 10W10"* io^/IO^
0.43 0.99 0.23 0.67 1.46 0.26 0.52 0.48 0.52 0.72 0.83
0.674 0.344 0.824 0.517 0.174 0.813 0.613 0.644 0.615 0.486 0.425
1.69 0.32 0.34 0.04 1.81 1.90 1.68 1.05 1.10 0.11 1.59
0.166 0.767 0.752 0.972 0.145 0.130 0.168 0.351 0.332 0.914 0.186
SPLEEN
A.viscosusUnstimulatedPHAA.viscosus tPttPt -5.170.00 -7.910.00 13.690.000 4.680.009 -2.710.054 -2.070.108 -3.480 097 -0.32763 -3.770.020 -2.200 092 0.27803 -0.84446 -0.96393 0.12912 -2.700 117 -4.270 013 -1.200 97 -1.700 165 2.040 112 -1.740 157-0.49633 -0.74477 -0.23824 -0.28798 -0.29777 -0.10926 13.310.000 0.119 9 -1.680 242 -0.19850 -0.29780 -1.080 305 0.51624 2.030.070 0.09933 0.52614 -0.5875 -0.5498 -0.79448 -0.67516 0.5967-1.190.366 -2.450.070 -2.330.080 -0.01992 -0.97389 -1.770.151 -8.270 001 -8.760 001 -4.620 010 -2.250.088 -0.01992 -0.38724 0.60581 -0.51638 -1.470 217 -1.140 317 -1.980 118 -1.470 215 -0.19861 0.28795 -2.110 03
4.110.0 5 7.010.002 6.530 003 2.350 079 9.530.001 3.290.030 3.660 02 2.830.110o 1.000 423 0.45677 0.73.504 2.120 01 0.80470 2.770.050 0.36738 2.400 074 0.68.532 0.81463 1.780 219 2.420 073 1.840 140







The high level of viability of cells indicates that the
extraction procedures did not cause irreversible damage to either
MLN or spleen cells. A disappointing feature of the results,
however, was the difference between corresponding lymphocyte
transformation tests for the same genotype on different days,
making valid comparisons between runs on different days
impossible. However, for each genotype, different inoculum
groups, both cell types and all three stimulation groups (with and
without I/E) were tested on the same day, so that comparisons
between inoculum groups, cell types and stimulants within
genotypes, as well as the assessment of macrophage suppression,
were valid.
7.4.1 DIFFERENCES BETWEEN GENOTYPES
The only strictly valid comparison was that between BALB/c
and CBA, where CBA showed a significantly higher blastogenic
response than BALB/c. The reasons for this are not clear, but such
differences are to be expected between inbred strains.
The generally low blastogenic response of xid/Y was
consistent with the B-cell defect known to occur in this mutant.
As discussed previously (2.1.2.3), xid/Y mice mount antibody
responses to T-cell dependent antigens, thus suggesting that the
T-cells are functionally operative. PHA is a T-cell mitogenic
stimulant, and a detectable response would therefore be expected
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in mixed cell populations. The reason for unresponsiveness in the
majority of inoculum/cell/stimulation groups is not clear. It may,
however, have been caused by lack of recognition of the
stimulants, or T-cell function may not have been completely
normal. It is apparent that this effect, by being present in all
stimulation groups, is not A. viscosus mediated. In this genotype,
in particular, study of separated B and T-cell populations would
be valuable.
7.4.2 DIFFERENCES BETWEEN INOCULUM GROUPS
The fact that no consistent pattern of blastogenic response
was associated with inoculum group, and thus with bone loss, can
be interpreted in two ways. First, the function of the MLN and
spleen cells, as measured by lymphocyte transformation, may not be
of central importance in the pathogenesis of periodontal disease.
Second, the tests themselves may not be accurate enough to detect
relevant differences between inoculum groups, either because they
were performed on mixed cell populations or because the techniques
themselves were too crude.
7.4.3 DIFFERENCES BETWEEN MLN AND SPLEEN CELLS
The tendency for higher blastogenic responses by unstimulated
spleen cells than by unstimulated MLN cells (Table 7.2) could have
been caused by intrinsic differences between these two cell
populations. This is supported by the finding that PHA stimulation
tended to result in a higher blastogenic responses by MLN cells
than by spleen cells. As PHA is a T-cell mitogen, it may be
inferred that T-cells constitute a higher proportion of MLN than
of spleen cells. It is possible, though, that the different cell
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extraction procedures used for each organ type (Section 7.2.1) may
favour the retention of one cell type rather than another.
The fact that A. viscosus stimulation also tended to produce
higher blastogenic responses from MLN cells may be due to the
following. Oral inoculation must have resulted in the swallowing
of some proportion of the initial inoculum of A. viscosus. The
antigens thus ingested would therefore first be processed by the
gut-associated lymphoid tissue of which MLN cells are a
constituent part. It is possible that the systemic immune system,
as represented by the spleen cells, may only receive excess
antigen 'spilled over' from the gut-associated immune system. If
this was the case, even with an intrinsically higher blastogenic
response of spleen as compared to MLN cells, the response to the
antigenic challenge posed by A. viscosus extract might have been
greater in the MLN cells as the antigen exposure would have been
greater. The logical conclusion would be that, as the initial
inoculum dose of A. viscosus increased, so the 'spill over' effect
to the systemic immune system would increase, and thus the
blastogenic response of spleen cells to A. viscosus stimulation
would increase directly with initial inoculum dose.
Unfortunately, evidence for this was not forthcoming but, as
previously mentioned, this could have been caused by the
experimental techniques themselves.
7.4.4 DIFFERENCES BETWEEN STIMULANTS
As discussed earlier in this chapter, PHA is T-cell
mitogen whereas the A. viscosus extract was a mixture of non-
covalently bound surface antigens. As expected, stimulation by
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either of these tended to produce a higher blastogenic response
than found in unstimulated cultures. A. viscosus extract induced
a greater blastogenic response than PRA in both C57 and +/bg
cultures (Table 7.3), but not in cultures from other genotypes.
It is possible that these genotypes have an intrinsically greater
B-cell population which responds to B-cell mitogens in the
A. viscosus preparation. Alternatively, this could perhaps be
ascribed to some unknown genetic difference and to the fact that
the A. viscosus extract was more particulate in nature. It is
possible that this difference in blastogenic response could have
been associated with the C57 background, though neither ob/ob nor
bg/bg showed the same effect. The presence of a homozygous mutant
gene, however, may have overriden any influence of genetic
background. For the other genotypes, BALB/c, bg/bg, ob/ob, CBA
and xid/Y, where blastogenic responses were greater in response to
PHA stimulation, the proportional contribution of T-cells may have
been greater.
7.4.5 MACROPHAGE SUPPRESSION
Only a small proportion of comparisons between cultures with
and without I/E showed statistically significant differences
(Table 7.4). However, among these there was a significant
preponderance of higher responses with I/E, especially with
A. viscosus extract stimulation and in cultures from bg/bg mice.
The findings therefore suggest that macrophage suppression does




The co-culture experiments were included to detect T-cell
suppression or help. The fact that no co-culture showed a
significantly lower blastogenic response than those of the
constituent pure cultures, and that five co-cultures showed a
significantly greater response than those of their pure
components, could be regarded as weak evidence of T-cell help
(Table 7.5). This evidence, however, is based on only five
results out of a total of 66. It is possible, therefore that,
although statistically significant, these results may not have a
biological basis.
7.4.7 GENERAL DISCUSSION
The results of the experiments described in this chapter may
be summarised as follows.
(a) The inter-run variation in blastogenesis was too great to
allow comparison of experiments performed on different days.
(b) No consistent differences between inoculum groups, and thus
related to bone loss, were apparent.
(c) With no stimulation, there was a tendency for a higher
blastogenic response in spleen cells than MLN cells. With
stimulation by either PHA or A. viscosus the reverse was found.
This supports the idea that A. viscosus inoculations led to
greater stimulation of the gut-associated lymphoid tissue than
the systemic immune system.
(d) The effect of each stimulant on blastogenesis seemed to be at
least partly determined by genotype but the findings were
unrelated to levels of induced periodontal disease.
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(e) There was weak evidence for the presence of both T-cell help
and macrophage suppression, although again this was unrelated to
levels of induced periodontal disease.
In commenting on the somewhat inconclusive nature of the
lymphocyte findings, it could be said that the source of cells
used was not appropriate. However, although immunological aspects
of the microenvironment of the gingival crevice are probably most
relevant, this area in the mouse is too small to provide
sufficient numbers of cells for experimentation. In any case,
this does not obviate the value of examining immunocompetent cells
representative of the systemic and gut-associated immune systems,
as in vitro systems can be manipulated to favour relevant clones
of cells.
Unseparated lymphocyte cultures, as used in the current work,
contain a diversity of functionally distinct populations of
immunocompetent cells, and proliferation is only an index of the
product of numerous cell-cell interactions. Variation in the
proportions of different cell populations could thus contribute to
the variability of the results, even within triplicates treated in
a similar fashion. Separation of lymphocyte cultures into their
different cell component types was not performed, mainly through
lack of time, as the removal and storage of serum and jaw
dissections all had to be performed on the same day as the spleen
and MLN dissections and cell preparation, counting and plating.
The results are thus a composite of B and T-cell responses and it
is not possible to ascribe greater importance to either group of
cells. However, the results suggest that future study of
separated B and T-cells would be valuable.
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One of the most surprising results was the lack of positive
evidence for the modulating effect of macrophages. This was
unexpected as it is generally accepted that macrophages have a
major role in the immune response, both as essential accessory
cells and as regulatory cells that can either enhance or suppress
immune reactions. Activated macrophages can suppress lymphocyte
proliferation in vitro by prostaglandin and oxygen radical
production (deShazo et al, 1981).
The current findings do not necessarily imply that
macrophages are not important in periodontal disease. Mononuclear
phagocytic cells (macrophages and monocytes) are present in normal
and inflammed gingiva, both in human and animal periodontal
disease (Zachrisson, 1968; Pearshall & Weiser, 1970; Payne et al,
1975). These cells arise from blood monocytes (Ebert & Florey,
1939) which are chemotactically attracted to the inflammatory site
by numerous substances such as complement (Snyderman et al, 1972),
bacterial products (Ward, 1968} and lymphokines (Ward et al,
1970), and then become activated tissue macrophages (Ebert &
Flohey, 1939).
It has been shown by Richman et al (1979) that A. viscosus
activates macrophages in vitro. Such macrophages can phagocytose
cellular debris that polymorphs cannot (Pearshall & Weiser, 1970)
as well as synthesise and release lysosomal enzymes (Page et al,
1973; Wahl et al, 1974). It has been suggested that the breakdown
of collagen during inflammation is a consequence of the release of
lysosomally derived enzymes which activate collagenase (Houck et
al, 1968). Other enzymes such as beta-glucuronidase or N-acetyl-
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beta-galactosidase, could hydrolyse the mucopolysaccharides of the
connective tissue ground substance and also the extracellular
matrix of the epithelium. Furthermore, it has been suggested that
macrophages could play a role in bone resorption (Khan et al,
1978) and that macrophage-derived cells could phagocytose collagen
fibrils exposed after osteoclastic activity (Rifkin & Heijl,
1979). The presence of activated macrophages within inflammed
gingiva would probably indicate an attempt to remove the
irritants. On the other hand, macrophages could participate in
the destruction of the periodontium through the release of
lysosomal enzymes during activation. As an extension of the
current work, it would perhaps be worthwhile to investigate the
macrophage presence in induced disease by cytochemical techniques
such as those described by Charon et al (1981).
Fitzgerald et al (1981) detected a significant
lymphoproliferative response to A. viscosus antigens in cervical
node cells from animals inoculated with 10^ cfu but not in cells
Q
from animals inoculated with 107 cfu. Stimulation with LPS, a
B-cell mitogen, gave the same result, implying that B-cells were
predominantly the responding cell type. This finding is not
consistent with the results of the current work. Engel et al
(1977) showed that A. viscosus homogenate contained substances
which caused splenic lymphocytes from both germ-free and
conventional mice to undergo blastogenesis. These workers also
showed that the mitogenic effect was primarily directed to B-
cells, as spleen cells from nude mice, or T-depleted spleen cells
from conventional mice, responsed as strongly as a normal mixture
of T and B-cells. T-cells alone did not respond mitogenically to
A. viscosus. Fitzgerald and Birdsell (1982) reported similar
results, suggesting a predominant B-cell response in 10^ and
10^ inoculated animals as compared to controls. These authors
suggested that either the proportion of B-cells increases in
draining lymph nodes and spleen of infected animals, or that the
organs of infected mice contained a larger number of B-cells which
were able to proliferate better in response to LPS than cells from
uninoculated mice. It has been shown by Gronowitz & Couthino
(1975) that different types of B-cell mitogen exist. Dextran
sulphate acts on immature cells to turn them into pre-antibody
producing intermediate cells while LPS acts on intermediate cells
to turn them into antibody producing mature cells. It is possible
that A. viscosus inoculations may induce immature B-cells to
change into intermediate stage B-cells which are more LPS
responsive. This could account for the higher response observed
with LPS without postulating an increase in the proportion of B-
cells. It is generally accepted that B-cells and plasma cells are
the dominant cell types found in periodontally diseased tissue.
Fitzgerald and Birdsell (1982) also showed that concanavalin
A (ConA) stimulation of cells from both 10^ and 10^ inoculated
mice resulted in a greater blastogenic response than such
stimulation of control cells which showed little or no response.
Thus, because ConA is a T-cell mitogen, the implication is that A.
viscosus inoculation affected T-cells also, leading Fitzgerald and
Birdsell (1982) to conclude that A. viscosus non-specifically
alters the immune system.
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The current work adds little in terms of either opposition to
or support for these previous findings. Further work is required
and, if a lymphocyte study is to be seriously undertaken, T and B-
cell separation must be performed. Perhaps recombination of these
two cell types in different proportions would provide further
information. So far, the role of T-cell regulation of B-cells has




Tables showing the number of observations(n), mean
blastogenic response (cpm) and s.e. for each genotype/inoculum
group.
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Periodontally diseased tissue contains higher levels of
immunoglobulins than healthy tissue (Brandtzaeg, 1972; Clagett &
Page, 1978). Much interest has therefore been centred on both
their source and specificity.
8.1.1 SOURCE
It has been shown by many investigators that periodontitis
patients are frequently seropositive for certain microorganisms in
their gingival plaque (Mergenhagen et al, 1965; Genco et al, 1974;
Listgarten et al, 1981; Doty et al, 1982; Ebersole et al, 1984;
Tew et al, 1985b). The early assumption was that antibodies
arrived in the gingival crevice as a serum transudate. However,
more recent work (Tew et al, 1985a; Tynelius-Bratthal1 & Ellen,
1985) has demonstrated that certain specific immunoglobulins such
as anti-Bacteroides gingivalis, anti-Actinobacillus
actinomycetemcomitans and anti-A. viscosus are found at higher
concentrations in gingival crevicular fluid than in serum,
implying at least some local production. Local production is
likely to be related to the observation that B-cells are the
dominant infiltrate component in periodontal disease (Mackler et
al, 1978a & b). It therefore seems reasonable to suppose that
plaque-induced B-cell to plasma cell transformation occurs with
subsequent local antibody production. However, the relative
contributions of circulating and locally produced antibody to the
immunoglobulin found in crevicular fluid are not known.
8.1.2 SPECIFICITY
While recent work has demonstrated that high levels of
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specific antibody may be produced in response to periodonto-
pathogens such as Actinobacillus actinomycetemcomitans and
Bacteroides gingivalis (Tew et al, 1985b; Tynelius-Bratthal1 &
Ellen, 1985), earlier work showed crevicular fluid antibodies to
be largely non-specific (Brandtzaeg & Tolo, 1977; Clagett & Page,
1978). These authors thought that this bulk non-specificity was a
result of the innumerable antigenic determinants in plaque. Also,
if significant quantities of specific immunoglobulin were
present, immune complex deposition would be anticipated. However,
Berglund (1971) found only small amounts of immune complexes and
Clagett and Page (1978) were unable to demonstrate any.
Various other studies have a bearing on lack of specificity.
Banck & Forsgren (1978) found that 18 of 30 bacterial species
tested induced mitogenesis in human B-lymphocyte cultures and
Miller et al (1978) and Kunori et al (1978) showed that
lipopolysaccharide (LPS), a component of all Gram-negative
bacteria, has a potent mitogenic effect on the B-lymphocytes of
human peripheral blood. Furthermore, Smith et al (1980), using
the plaque-forming cell assay, found that human B-lymphocytes
activated in vitro with preparations of suspected
periodontopathogens produced antibody to unrelated antigens, in
this case sheep red blood cells. Similarly, Mangan and Lopatin
(1981) demonstrated that human lymphoid cells activated with a
soluble fraction from Actinomyces viscosus, produced antibody
unrelated to the activating substance. Thus, it appears that
activation of B-cells, either within the gingival tissue or in
vitro, with gingival crevicular debris or plaque bacteria, results
in the production of immunoglobulins with a broad spectrum of
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specificities (polyclonal activation). Such findings are not
exclusive to humans, as Actinomyces viscosus, Actinomyces
naeslundii, Actinomyces israelii, Bacteroides melaninogenicus,
Fusobacterium, Actinobacillus actinomycetemcomitans and
Capnocytophaga all evoke a strong mitogenic response in murine B-
cells (Burckhardt et al, 1977; Engel et al, 1977; Diggens &
Clagett, 1979; Smith et al, 1980; Carpenter et al, 1981; Chen et
al, 1981; Mangan & Lopatin, 1981).
8.1.3 IMMUNOGLOBULIN LEVELS IN RESPONSE TO TREATMENT
Only recently have antibody levels to specific oral plaque
bacteria been studied before and after periodontal treatment in
man. Naito et al (1985) studied previously untreated
periodontitis patients and examined the serum levels of IgG
antibodies to seven different bacterial species, not including
A. viscosus. These authors found that after treatment the
response to Bacteroides gingivalis increased, that to Eikene1la
corrodens decreased while the responses to the others did not
change. Tynelius-Brathal1 and Ellen (1985) studied the crevicular
and salivary anti-A^ viscosus and anti-A. naeslundii levels after
treatment of gingivitis. They found tendencies for crevicular IgG
and salivary IgG and IgA anti-A. viscosus levels to rise after
treatment. Salivary IgG and IgA anti-A. naeslundii levels were
barely detectable both before and after treatment. The
explanation given for the anti-A. viscosus increase was that, in
diseased tissues, antibodies would be consumed by interaction with
antigens in excess, thus lowering the local antibody
concentration. This is consistent with the findings of Doty et al
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(1982) who reported higher serum antibody titres to certain
periodontopathic bacteria in healing controls than in diseased
subjects. On the other hand, total salivary IgA has been shown to
be higher in subjects with periodontitis than those with healthy
gingivae (Brandtzaeg, 1965; Shillitoe & Lehner, 1972; Lindstrom &
Folke, 1973), while salivary IgG was found by Basu et al (1976) to
decrease following periodontal therapy. Thus, such evidence as
exists at present appears to be contradictory.
The data accumulated over the past decade, show that chronic
human periodontitis is a predominantly B-lymphocyte/plasma cell
lesion and that, except in the development of the early lesion,
cell mediated hypersensitivity is not likely to be important
(Page & Schroeder, 1982). This is not to say that T-cells are
unimportant; they may play an essential role in regulating B-cells
and plasma cells through their suppressor and helper activities.
It is generally accepted that microbial substances from the
gingival crevice and, in particular, the pocket, have access to
the gingival tissues where they interact with lymphoid cells,
causing B-lymphocyte activation and differentiation of large
numbers of antibody-producing plasma cells. Most, if not all the
microorganisms implicated as periodontal pathogens, are potent
polyclonal activators of human B-lymphocytes (Page & Schroeder,
1982) so that antibody produced locally in the diseased gingival
tissue is of mixed specificity. Consequently, immune complex
formation either does not occur, or occurs to only a minor extent.
On the other hand, as mitogens are more potent activators of
lymphocytes than antigens and, since cells activated by mitogens
produce lymphokines (as do cells activated specifically by
antigens), a high level of lymphokine production in diseased
gingival tissues can be expected (Page & Schroeder, 1982).
The significance of such a potent local antibody response to
B. gingivalis and A. actinomycetemcomitans (Tew et al, 1985b;
Tynelius-Bratthal1 & Ellen, 1985) is not clear, but may relate to
a basic pathogenic mechanism such as ability to invade the
gingival lesion. The selectivity of the local response to these
organisms is consistent with the hypothesis that these two species
are important pathogens in early onset perdiodontitis. This is
also supported by the case report of Haffajee et al (1984) which
indicated that most sites with elevated levels of anti-A.
actinomycetemcomitans antibodies suffered periodontal damage after
the detection of the local antibody response. The question of
whether these two organisms are unique in their ability to induce
such potent local antibody responses in patients with juvenile
periodontitis and severe generalised periodontitis remains open.
Further study is indicated to determine whether advanced local
production of antibody, detectable in gingival crevicular fluid,
is related to active disease progression.
8.1.4 THE PRESENT STUDY
Immunoglobulin studies were designed to examine both the
non-specific and specific anti-A. viscosus extract serum
immunoglobulin levels in classes IgG, IgA and IgM in an attempt to
determine the role of the humoral immune system in the induction
of disease in the A. viscosus mouse model.
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8.2 MATERIALS AND METHODS
All immunoglobulin studies were performed using an indirect
Enzyme-Linked Immunosorbent Assay (ELISA) technique on serum from
all genotypes except bg/bg and +/xid for the non-specific assays
and all except +/xid for the specific assays.
8.2.1 THE ELISA TECHNIQUE
This technique, as described by Voller et al (1980), involves
the placement of known antigen at known concentration on the
bottom of the wells of disposable polystyrene plates. The test
serum, whose levels of antibody to the known antigen are to be
determined, is added to the plates. Subsequently, enzyme-
conjugated antiglobulin and finally enzyme substrate are added
resulting in the development of a colour change, the depth of
which, as read by a colorimetric detector, is directly related to
the concentration of antibody present in the test serum.
All ELISA assays were performed in triplicate, with a
standard mouse serum used for all experiments coming from 20
BALB/c mice, each of which had been inoculated subcutaneously with
10^ cfu A. viscosus in 50 pi of supplemented PPY. These animals
were bled immediately postmortem three weeks later and the
resultant serum was pooled, aliquoted into 0.25 ml portions and
stored at -40°C till required. This standard serum was used at
a 1 in 1000 dilution for the non-specific ELISAs and undiluted for
the specific anti-A. viscosus assays. Each test serum was a




Rabbit anti-mouse antiserum IgG, IgA or IgM (Sigma Chemical
Company Ltd, Poole, UK) was diluted to the appropriate working
concentration in coating buffer (see Appendix) and 150 pi aliquots
plated into individual wells in polystyrene, disposable, flat-
bottomed, 96-well microtitration plates (Flow Labs, Rickmansworth,
UK). IgG was used at a 1 in 500 dilution while both IgA and IgM
were used at a 1 in 100 dilution, with separate plates for each Ig
class. The plates were then stored for 18 h at 4°C to allow them
to become sensitised by passive adsorption. All plates were then
washed three times in a phosphate buffered saline-tween 20 mixture
(PBS-tween) (see Appendix) using a mini-microwash system (Flow
Labs, Rickmansworth, UK) and then tapped dry. To each well was
then added 100 pi of a 1% mixture of newborn calf serum (NCS) in
PBS-tween. To the first well of the first row of each plate was
added 50 pi of 1 in 1000 diluted standard serum in 1% NCS-PBS-
tween. The second row had no serum added and acted as a negative
control. The first wells of all the remaining rows had 50 pi of
the undiluted test serum added, and serial dilutions of all sera,
both test and standard, were performed along the rows. All plates
were then incubated at room temperature for 1.5 h after which all
were washed three times in PBS-tween and tapped dry. To each well
was then added 100 pi of the appropriate Ig class alkaline-
phosphate-conjugated goat anti-mouse serum, diluted 1 in 1000 in
1% NCS-PBS-tween. The plates were incubated at room temperature
for 1 h and again washed three times in PBS-tween and tapped dry.
Each well then had 100 pi of phosphate substrate solution placed
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in it (see Appendix) and, once a yellow colour had developed, all
plates were read in the Multiskan Detector (Flow Labs,
Rickmansworth, UK). This machine could be programmed to regard
the second row of each plate as a zero blank, thus allowing for
any slight yellowing due to non-specific change of the substrate.
The actual concentrations of total IgG, IgA and IgM in the
standard serum were then measured by performing the same ELISA
technique on the standard serum and a mouse immunoglobulin
reference serum (Miles Scientific, Slough, UK). Thus,
immunoglobulin concentrations could be expressed in mg rnl"^"
serum.
8.2.3 SPECIFIC ANTI-A. VISCOSUS IMMUNOGLOBULIN
The procedure used for measuring the concentrations of
specific anti-A. viscosus immunoglublin was as detailed for the
non-specific assays, except that undiluted standard serum was used
and that the plates were sensitised with 100 |il of the EDTA
A. viscosus extract per well instead of the rabbit anti-mouse
antiserum. However, it was necessary to test which concentration
of the A. viscosus extract would be appropriate.
The protein content of each A. viscosus extract was estimated
by the Lowry method and concentrations of 1, 10 and 100 yg ml"^"
were prepared and a standard ELISA using these was performed as
above. The optimum concentration in terms of colour change of 50
pg ml ^ was then chosen and used for all the specific ELISAs.
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8.3 RESULTS
8.3.1 SOURCES OF VARIATION
Nested analysis of variance showed that for both non-specific
(Table 8.1) and specific (Table 8.2) immunoglobulins of all three
classes there was statistically significant variation between
genotypes and between inoculum groups. For the specific
immunoglobulins, where two pooled samples were studied, there was
a significant difference between samples for IgG but not for IgA
or IgM.
8.3.2 NON-SPECIFIC IMMUNOGLOBULIN AND INOCULUM SIZE
For the non-specific immunoglobulin assays (Table 8.3) there
was a similar pattern of results for both IgG and IgM, with
immunoglobulin concentration tending to increase with inoculum
size in all genotypes except xid/Y. The only exception was for
IgM in ob/ob mice where serum from the 10^ cfu group showed a
significantly lower immunoglobulin concentration than that from
the 107 group. One way analysis of variance for each of these
two immunoglobulin classes showed that, of the total of 27
possible comparisons between pairs of inoculum groups within
genotypes (except xid/Y), 23 comparisons for IgG and 23 for IgM
showed a statistically significant difference (P < 0.05). For
xid/Y, no two inoculum groups were significantly different for
either IgG or IgM.
By contrast, the IgA results showed a markedly positive
relationship between immunoglobulin concentration and inoculum
size for xid/Y with a similar though generally less clear-cut
trend for the other genotypes except C57, where there was a
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definite peak at 107 cfu. The only difference that failed to
reach statistical significance for xid/Y was that between the
10^ and 107 cfu groups, while 19 of the 27 possible
comparisons between pairs of inoculum groups within the other
genotypes showed a statistically significant difference
(P^- 0.05).
8.3.3 SPECIFIC IMMUNOGLOBULIN AND INOCULUM SIZE
For the specific anti-A. viscosus immunoglobulin assays
(Table 8.4) there was a general tendency for immunoglobulin
concentration to increase with inoculum size for both IgG and IgM
in all genotypes, including xid/Y. The most marked exception was
for IgM in ob/ob mice, where serum from the 10^ cfu group showed
a significantly lower specific immunoglobulin concentration, not
only compared with serum from the 107 cfu group, as found for
non-specific immunoglobulin, but also compared with that from
uninoculated animals (P-^0.05). Also for IgM, there were no
significant differences between inoculum groups for bg/bg. One
way analysis of variance for each of these two immunoglobulin
classes showed that of the 39 possible comparisons between pairs
of inoculum groups within genotypes, 26 showed a statistically
significant difference for IgG and 22 for IgM.
By contrast, the IgA concentrations showed a marked peak at
107 cfu for all genotypes except xid/Y. For each of the
genotypes BALB/c, C57, +/bg, and ob/ob, the concentration of IgA
in serum from the 107 cfu group was significantly greater than
that in serum from all other inoculum groups (P^O.05). For
bg/bg, although a similar peak at 107 cfu was observed, the
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differences between inoculum groups were not statistically
significant. For the increase in IgA concentration with inoculum
size in xid/Y mice, four of the six comparisons between inoculum
groups showed a statistically significant difference (P <10.05).
8.3.4 THE RATIO OF SPECIFIC/NON-SPECIFIC IMMUNOGLOBULIN
The ratio of specific/non-specific immunoglobulin
concentration for each genotype and inoculum group is shown in
Table 8.5. Specific immunoglobulin amounted to only 1-300 parts
per million non-specific immunoglobulin.
Table8.1
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86
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Table8.3
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n Mean s.e. n Mean s.e.
6 2.27 0.12 3 1.27 0.08
6 14.08 0.88 3 3.90 0.21
6 19.02 1.03 3 4.61 0.21
6 32.94 0.69 3 28.64 3.65

















































4 3.90 0.36 6 27.23 2.27 3 6.97 0.34
Table8.5R tioofspecific/non-specificimmunoglobulinc n entrationf achgen type andinoculumgroup(x10). IgGAM INOCULUM:010679 GENOTYPE BALB/c312.319575.48..74 132 35.256 C57103.70.39817 427 53.84642 96 +/bg19.42138 854.7.570 918 2 ob/ob92.6168.377.8 039 78.4 3 CBA54.971 486.6113.0 32 849.132 5 xid/Y13.341 59 1281.2.209.463
8.4 DISCUSSION
The relevance of the results lies in the response, in terms
of immunoglobulin production, to increasing numbers of organisms
inoculated, and in the differences of response between genotypes,
between non-specific and specific anti-A. viscosus immunoglobulin
and between immunoglobulin classes. The patterns of response
observed are summarised in Table 8.6 and are represented
diagrammatically in Figures 8.1-8.8.
Table8.6
Summaryoftherelationshipbetweenimmunoglobulin concentrationandino ulumsizefthediffer ntge o ypes. Non-specific
IgG1.BALB/c,C57+/bg,' ob/ob,BA 2. 3.xid/Y 4.bg/bg,+/xid IgA1.BALB/c,+/bg,ob/obCBAxid Y 2.C57 3. 4.bg/bg,+/xid
Specific
1.Allgenotypesexcept+/ id 2. 3. 4.+/xid 1.xid/YK 2.BALB/c,C57,+/bgob/obBA 3.bg/bg 4.+/xid
IgM1.BALB/c,C57+/bgBA 2.ob/ob 3.xid/Y 4.bg/bg,+/xid
1.BALB/c,C57,+/bgBAxid/Y 2.ob/ob 3.bg/bg 4.+/xid



























Fig 8. 1 Mean non-specific immunoglobulin concentration
by inoculum group in mg pi-! pooled serum.
















































Fig 8.2 Mean non-specific immunoglobulin concentration
by inoculum group in mg pl~l pooled serum.




























Fig 8.3 Mean non-specific immunoglobulin concentration
by inoculum group in mg pi pooled serum.


























Inoculum: o id idioq
Fig 8.4 Mean non-specific immunoglobulin concentration
by genotype and inoculum group in mg pl-^ pooled
serum.




















Inoculum: o icjr Id* ion
Fig 8.5 Mean specific anti-A. viscosus immunogloublin
concentration by inoculum group in mg ml--'- for
IgG and mg 100 ml-'- for IgA and IgM pooled serum.


























Fig 8.6 Mean specific anti-A. viscosus immunoglobulin
concentration by inoculum group in mg ml-' for
IgG and mg 100 ml--'- for IgA and IgM pooled
serum.
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IgA







Inoculum: O id*" toq
Fig 8.7 Mean specific anti-A. viscosus immunoglobylin
concentration by inoculum group in mg ml
for IgG and mg 100 ml for IgA and IgM pooled
serum.
C57 (black), ob/ob (red).
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Inoculum: O let Icfto"
IgM
Inoculum: o iofo id*
Fig 8.8 Mean specific anti-A. viscosus immunoglobulin
concentration by inoculum group in mg ml~l for
IgG and mg 100 ml~l for IgA and IgM pooled serum.
CBA (black), xid/Y (red).
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8.4.1 DIFFERENCES BETWEEN GENOTYPES
Table 8.6 shows that in classes IgG and IgM of both non¬
specific and specific anti-A. viscosus ELISAs, there was a general
tendency for Ig concentration to increase with increasing inoculum
size, indicating that the host's immune system was responding to
increasing exposure to A. viscosus. Exceptions to this pattern
were found for genotypes ob/ob in class IgM of both non-specific
and specific ELISAs, xid/Y in classes IgG and IgM in the non¬
specific ELISAs only and bg/bg in classes IgA and IgM in the
specific ELISA tests.
As far as ob/ob mice are concerned, this may have been
associated with defects of cell-mediated immunity thought to occur
in obese mice (Meade et al, 1979; Clark et al, 1981), although it
has been postulated that these defects may be the result of the
metabolically abnormal tissue environment rather than intrinsic
defects of the immune system (Meade et al, 1979; Chandra, 1980).
If cellular immune function in these animals is defective,
however, this could profoundly affect the B-cells and thus Ig
levels through alteration of T-cell help or suppressive
activities.
The xid defect is characterised by the inability of affected
mice to mount an antibody response to various helper T-cell
independent antigens (Amsbaugh et al, 1972,1974; Scher et al,
1973; Press, 1981; Scher, 1982b). It may be that A. viscosus
antigens fall into this category. Metcalf et al (1980) found xid
mice to be extremely susceptible to tolerance, which could perhaps
explain the pattern of immunoglobulin concentrations in classes
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IgG and IgM of the non-specific ELISAs. Perhaps the most likely
explanation, however, is the decreased magnitude of response of
the secretory immune system of these mutants as described by
Kiyono et al (1983).
The serum of bg/bg mice showed no significant difference
between inoculum groups in respect of the specific anti-
A. viscosus tests in classes IgA and IgM. Some other defect, such
as that of NK function, as detailed in Chapter 2, may be
responsible.
8.4.2 DIFFERENCE BETWEEN NON-SPECIFIC AND SPECIFIC
IMMUNOGLOBULINS
It is noticeable that Table 8.5 records a non-zero ratio of
specific/non-specific Ig for uninoculated animals, even though the
recovery experiments (Section 5.3) showed that these animals did
not carry A. viscosus in their mouths. It is possible that this
anomalous finding was caused by cross-reaction of certain
A. viscosus antigens with those of commensal organisms. Table 8.5
also shows that, for both IgG and IgM, there was no consistent
pattern of ratios, indicating comparable responses to inoculum
size by both specific and non-specific Igs. For IgA, however, the
ratio peaked at 10^ cfu in all genotypes except xid/Y,
reflecting the difference of response between specific and non¬
specific IgA, as summarised in Table 8.6. 0
8.4.3 DIFFERENCES BETWEEN IMMUNOGLOBULIN CLASSES
In class IgG, the variation between samples was significantly
greater than that between repeat measurements within samples
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(Table 8.2), which may imply that the assay technique was more
sensitive for IgG, perhaps through greater specificity for the
test sera of this class of antiserum compared with IgA and IgM.
The ratio of specific/nonspecific IgG was generally higher
than for either IgA or IgM. This is consistent with the
explanation that, in the course of normal eating and swallowing,
there was continued organism ingestion in sufficient numbers to
induce the equivalent of a secondary antibody response,
characterised by a predominance of IgG (Amos, 1981).
8.4.4 THE IgA PEAK AT 107 CFU
The most important point to emerge from the Ig studies was
the peak found in specific anti-A. viscosus levels associated with
the 107 cfu inoculations which were, in turn, consistently
associated with the greatest bone loss (Section 3.4).
The IgA peak at 107 cfu is consistent with high and low
zone tolerance having been induced by oral inoculations of 10^
and 10^ cfu live A. viscosus respectively, as discussed in
Section 3.4.3. The present findings are compatible with those of
Andre (1975) who showed that the serum from "intragastrically
immunised mice contained an active toleragen which seemed to
consist of immune complexes with IgA as the antibody. It had
earlier been demonstrated that intragastric administration of
antigens caused the appearance of circulating antibodies, often
predominantly of the IgA class (Heremans, 1974). It is,
therefore, logical to assume that orally inoculated antigen would
induce a similar response, since much of it must be swallowed, and
that comparable immune complexes might be formed.
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Immune complexes (ICs) form as a result of the combination of
antibodies with their evoking antigenic determinants. ICs formed
in great antigen excess are small, do not fix complement and
generally cannot initiate inflammatory processes. On the other
hand, ICs formed at great antibody excess, although capable of
activating complement, are large, insoluble, rapidly phagocytosed
and thus of limited pathogenicity. The greatest pathological
potential seems to lie between these two extremes when ICs are of
intermediate size, soluble and large enough to fix complement
(Theofilopoulos & Dixon, 1980). If the host's exposure to antigen
is of limited duration, even though some complexes form, tissue
injury and other clinical manifestations are transient, as in
classical 'one shot serum sickness' (Wilson & Dixon, 1970, 1971).
In contrast, if the antigen remains long in the circulation, or if
there is a continuous supply of antigenic material, as with
chronic infections or autoantigens, the potential exists for
continuing IC formation. The closest approximation to such
chronic IC disease in man is 'chronic' serum sickness (Wilson &
Dixon, 1976). It is possible that inoculated mice in the current
work, by virtue of their continued oral infection through oral
colonisation, fall into this latter category.
When ICs arise, their reaction with complement leads to many
complex molecular events. Among these are cleavage of C3, binding
of C3b to the IC, release of C3a, and, on cleavage of C5, release
of C5a. In acting on mast cells, C3a and C5a effect histamine
release and thus increased capillary permeability. In acting on
polymorphs, the C5a component chemotactically attracts leucocytes
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to the site of IC deposition. There, leucocytes are trapped by
IC-bound C3b, C3bi, C3d and C4b, which exhibit reactivity with the
various complement receptors on the leucocytes. Subsequently, the
accumulated leucocytes release hydrolases and cause tissue injury
(Dixon, 1971; Cochrane & Dixon, 1978).
The gingivae have a good blood supply with a relatively high
blood flow per unit mass of tissue and are thereby exposed to and
can trap large quantities of ICs in their vascular walls. The
damaging sequellae of IC presence, as detailed above, could thus
lead to the local damage found in the experimental mice of the
current work.
8.5 CONCLUSION
It appears that, in the mouse model studied, the most
important correlation between Ig concentration and induced disease
occurred for the specific anti-A. viscosus IgA level. It is
possible that IgA reacted with A. viscosus antigen to produce ICs
which resulted in local damage. It is also possible that there
£
may have been some form of tolerance associated with 10 cfu and
Q .
107 cfu inoculations. Although no supporting evidence of such
tolerance was apparent from the serum studies, it could be that
saliva studies would be more informative in relation to local Ig
production. Fitzgerald et al (1981) found that serum antibody
levels "did not increase significantly above baseline levels in
any colonised animals". Thus, no comparison of the present results






In view of the consistency with which maximum bone loss was
induced by oral inoculations of 10^ cfu A. viscosus over all
genotypes, it seemed appropriate to attempt immunisation of lO''
cfu inoculated mice. Immunisation experiments were carried out
only on BALB/c mice fed the special diet.
9.2 MATERIALS AND METHODS
All mice involved in immunisation procedures received oral
inoculations of 10^ cfu A. viscosus as described in Section 2.4.
Measurement of bone loss, lymphocyte transformation and ELISA
tests were carried out 12 weeks after oral inoculation as
described in previous chapters.
Three immunisation procedures were attempted. For each, a
group of ten BALB/c mice was used:
Q
Group '9-7': 50 ul subcutaneous inoculation containing 10
cfu heat-killed A. viscosus on each of three successive days two
weeks before oral inoculation.
9
Group '7-9': 50 ^1 subcutaneous inoculation containing 10
cfu heat-killed A. viscosus on each of three successive days two
weeks after oral inoculation.
Group 'IV': 50 |il intravenous inoculation of 10^ cfu live
A. viscosus into the lateral tail vein on each of three successive
days two weeks before oral inoculation.
For bone loss measurements two further groups were studied, a
group of uninoculated and unimmunised mice, and a group of mice
given oral inoculations of 10^ cfu only. These groups were
investigated to provide confirmation of bone loss observed in the
main experiment and baseline levels for the immunisation studies.
Heat killing was achieved by placing glass vials of
viscosus culture in an 80°C water bath for 10 mins. The efficacy
of this treatment was determined by plating samples of treated
culture on SA plates in triplicate.
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9.3 RESULTS
No heat-treated cultures of A. viscosus yielded growth
indicating efficacy of the killing procedure.
Bone loss findings are summarised in Table 9.1. The three
immunised groups, their uninoculated and lO'7 cfu controls, with
corresponding uninoculated and 10^ cfu groups from the main
experiment, are included. The 7-9 and 9-7 groups were not
significantly different from each other or the 10'' cfu groups,
showing that these immunisation procedures were ineffective. The
IV group was not significantly different from either of the
uninoculated groups and these three groups all showed
significantly less bone loss than the other four. Thus, IV
immunisation conferred complete protection against A. viscosus
induced bone loss.
Tables 9.2 and 9.3 give the mean blastogenic response of MLN
and spleen cells respectively, with and without I/E combined. One
way analysis of variance showed that only with zero stimulation of
both spleen and MLN cells, and PHA stimulation of MLN cells, was
the variation between groups significantly greater than that
within them. (P-^0.05).
The non-specific and specific anti-A. viscosus serum
immunoglobulin concentrations are presented in Tables 9.4 and 9.5
respectively. One-way analysis of variance showed the variation
between groups to be significantly greater than that within them
for classes IgG and IgM in the non-specific investigations and
classes IgG and IgA in the specific anti-A. viscosus assays.
(P 0.05) .
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Table 9.6 shows the ratio of specific/non-specific
immunoglobulin concentration for each immunisation group in each
of the three Ig classes. In class IgA the ratios associated with
uninoculated controls and the IV group were lower than any of the
others, but this pattern was not apparent in classes IgG and IgM.
Table9.1
2
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Table 9.2 Mean blastogenic response in cpm for MLN cells with
and without I/E combined. Single cultures and
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Table 9.3 Mean blastogenic response in cpm for spleen cells
with and without I/E combined. Single cultures and
co-cultures, n = number of repeat measurements.
Stimulation
Group 0 PHA A. viscosus
Uninoculated (U) n 36 20 18
Mean 2001.6 9298.4 10157.3
s. e. 312.3 2159.1 1876.8
107 n 36 21 20
Mean 2063.2 12262.6 7825.6
s. e. 355.6 2851.7 1255.9
9-7 n 3 3 3
Mean 3571.3 6261.7 6771.3
s. e. 254.1 93.4 771.0
7-9 n 3 2 3
Mean 4278.0 7888.5 14177.7
s. e. 293.6 204.5 251.6
IV n 11 6 6
Mean 1122.4 18512.5 13056.3
s. e. 246.7 1005.3 645.2
U/107 n 2 3 3
Mean 5222.5 1676.7 3863.3
s. e. 86.5 241.2 496.0
U/9-7 n 3 3 3
Mean 4780.3 6357.3 7698.7
s. e. 377 .5 198.3 200.5
U/ 7-9 n 2 3 3
Mean 6772.5 4752.3 7173.3
s. e. 387.5 505.7 441.7
10 7/9-7 n 3 3 2
Mean 6966.3 2452.0 3858.0
s. e. 1780.7 91.8 695.0
10 7 / 7 - 9 n 3 3 3
Mean 7220.0 1783.3 5750.7
s. e. 751.4 291.6 299.7
Table9.4Non-specificimmunoglobulin^concentrationbyi m nisat n/ inoculationgr upnmg^il~ pooledserum, n=umberofrepeatmeasurementsadenpool ds mpl . IgGI AIgM
GroupnMean+s.e.. .Means.e. Uninoculated213.13+.9476.670.009.38 1072113.38+5.97212.008 830 64.76 7-92328.21+5.97207.592.0814 50 9-72328.21+9.841 .764.424 630 19 IV2202.89+11.94225 264.4.781.1
























































Table 9.6 Ratio of specific/non-specific immunoglobulin
concentration for each immunisation/inoculation
group (xlO ).
Group IgG IgA IgM
Uninoculated 312.3 1.7 21.5
107 75.4 13.4 5.2
7-9 300.6 2.1 5.8
9-7 591.5 2.4 8.4
IV 368.6 1.44 8.3
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9.4 DISCUSSION
The first two immunisation procedures, involving subcutaneous
inoculation of 10 cfu heat-killed A. viscosus were used to
introduce A. viscosus antigens to the animals without the danger
of inducing disease or provoking a brisk acute inflammatory
reaction. In group 9-7, it was thought that exposure to the
antigens might reduce bone loss either by priming the immune
system for an effective response to live organisms or, perhaps
less likely, by inducing tolerance to the organism and so
preventing a potentially damaging host response. The 7-9 group
was included to see whether the proven destructive effect of the
10^ cfu oral inoculations could be overcome by either an
enhanced host immune response or tolerance subsequently induced by
the subcutaneous injection. However, there were two potential
difficulties in using subcutaneous inoculations of heat-killed
organisms. First, it was not certain that heat-killed A. viscosus
would retain all the antigenic specificities of their live
counterparts, although this could not be confirmed without further
investigation. Second, it could be argued that tolerance would
more readily occur after oral rather than subcutaneous
immunisation, although Andre et al (1975) showed that tolerance
could be induced by intraperitoneal immunisation.
Intravenous immunisation was used to provide maximal exposure
of the immune system to A. viscosus antigens. A possible
difficulty here was the induction of generalised disease, but 9 of
the original 10 mice in this group survived these inoculations
without apparent distress. IV immunisation was the only procedure
that was effective in protecting mice against periodontal damage
from oral inoculations of live organisms (Table 9.1).
282.
In terms of lymphocyte transformation, for both MLN and
spleen cells, co-cultures tended to have higher values than their
individual component cultures with zero stimulation but often
lower values with PHA and A_^_ viscosus. This implies mutual help
and suppression in unstimulated and stimulated co-cultures
respectively. Within stimulation groups, there was no obvious
relationship of the findings with bone loss. All cultures reacted
to stimulation, thus tolerance was apparently not induced.
In terms of immunoglobulin concentration, groups 7-9 and 9-7
tended to have relatively high values in classes IgG and IgM for
both non-specific and specific anti-A. viscosus tests. This
finding may have been caused by the fact that these immunisation
procedures involved introduction of greater numbers of organisms,
allbeit including some that had been heat-killed, than in any of
the other groups. Also for classes IgG and IgM, IV inoculation
of 10-' cfu resulted in greater serum response, both non-
specifically and specifically to A. viscosus, than did oral
inoculations of 10^ cfu. It must be assumed that the
intravenous route resulted in greater antigen exposure to the
immune system than the oral route, but the higher immunoglobulin
level was not matched by higher bone loss.
The non-specific IgA data show no correlation with bone loss
in that the uninoculated and IV groups, for which bone loss did
not differ significantly, showed the lowest and highest serum
concentrations respectively. For specific anti-A. viscosus IgA,
however, the highest concentration was found in the 10^ group
and the lowest in the IV group and in uninoculated controls. Thus
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it is only for specific anti-A. viscosus IgA that there was
correlation with bone loss. This is consistent with the
hypothesis that high levels of specific anti-A. viscosus IgA are
associated with disease in the mouse model.
Again there was no indication of tolerance as all groups
responded to stimulation with A. viscosus.
The authors of the original mouse model paper (Fitzgerald et
al, 1981) have reported no immunisation experiments so no
comparison of results is possible.
The conclusion from this brief study is that only IV
immunisation was effective and that this induced the lowest serum
specific anti-A. viscosus IgA response of the three immunisation
attempts. The work could be continued by examining histological
sections of the gingiva of immunised mice for the presence of IgA
immune complexes in all the groups. It might be anticipated that
only groups with high levels of bone loss would show these in any
pro-fusion. Further studies could also include salivary Ig




10.1 THE PRESENT STUDY
Two problems are encountered in the study of periodontal
disease. First, the weight of evidence suggests that the natural
history and progression of the disease is essentially cyclic in
nature (Hirschfeld & Wasserman, 1978; Becker et al, 1979;
Socransky, 1984). Examples exist which show that active
periodontitis may undergo spontaneous arrest and that, in any
given periodontitis patient at any one time, only some sites have
active disease (Moskow, 1978; Vandesteen et al, 1981). This means
that clinical and laboratory findings may not correlate with
disease activity. Second, many body systems are involved in the
pathogenesis of periodontal disease and it is not easy to assess
the contribution of each of these, alone or through interaction
with others. The A. viscosus mouse model, however, appears to be
a way of circumventing these problems, in that it provides a means
of inducing periodontal disease in a reproducible but adaptable
manner.
Periodontal research has provided three principles relevant
to the present study:-
(a) All mammals from mice to men have only a limited number of
defence responses to microbial challenge or tissue injury. These
self-protection mechanisms, when examined in isolation, react in a
consistent and predictable manner and vary little between
species.
(b) The host defence system also participates in host tissue
damage, thus activation of any one of its constituent parts, be it
the immune response, acute inflammation, complement cascade,
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phagocytic leucocytes or various combinations of these, brings to
bear the apparently opposing forces of protection and destruction.
In most cases, the price of damage paid is very small relative to
the protection gained.
(c) The factors involved in determining whether and to what
extent host damage occurs and how long the destructive process
continues are only poorly understood.
In no known case is periodontitis in animals identical to
that seen in humans, so no true analogue of the human disease has
been found. At first sight this appears to be a tremendous
handicap to periodontal disease research. However, the different
animals available, each with their own special features, provide
many investigative opportunities. Nevertheless, the questions
asked of each animal model must be precisely defined and the
animal chosen with great care. For investigations of microbially
induced alveolar bone destruction, rodents are particularly
useful.
Mice are very small relative to humans and their periodontal
structures are minute. On the other hand, the infecting bacteria
and both resident cells and infiltrating leucocytes are of roughly
the same dimensions in mice and men. Mice live for only 1-2
years, thus the rates of growth and development are relatively
high causing rapid shifts in the relationships between teeth and
jaws. In man, tissue turnover is much slower. The opportunities
for microbial interference are therefore very different in these
two species. Of relevance to this difference is the work of
Garant & Cho (1979) in rats, which demonstrated that bone
resorption occurs up to a finite distance away from the plaque
causing the loss. Waerhaug (1979a & b) applied this principle to
human periodontitis, and this helps explain why mice, with their
thin bone, suffer much greater bone loss relative to their size
than do human periodontitis patients.
The current work was an attempt to shed light on the
functions and actions of three different major components of the
host defence system, phagocytic cells (Chapter 6), the cellular
immune response (Chapter 7) and the humoral immune response
(Chapter 8). The most important finding was the peak of specific
anti-A. viscosus IgA found in the serum of animals orally
inoculated with 10^ cfu live A. viscosus, consistently in all
genotypes examined and associated with maximum bone loss. The
hypothesis that low and high dose tolerance operated in the 10^
Q ,
cfu and 10 cfu inoculated animals is attractive and, while
confirmation of this is not possible with the present results,
there is certainly no indication to the contrary.
In theory, any disease of microbial origin could be
prevented by immunising the susceptible host at the appropriate
time with a vaccine containing the necessary protective antigen or
antigens. Many diseases previously responsible for much mortality
and morbidity have now been greatly reduced in incidence or
eliminated by vaccination. The presence of antibody per se is
merely an indication of antigenic exposure and whether or not an
antibody is protective or not has to be established. If the
antibody is found to be protective, then immunisation would be
protective. If the antibody is found to be damaging, then
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enhancement would accelerate the disease. In the latter case,
which appears to apply to specific anti-A. viscosus serum IgA,
immunisation, if it were to be protective, would have to be
directed towards desensitisation or the induction of specific
£
immune tolerance. Is it possible that this occurred in the 10
9 •
cfu and 10 inoculated mice?
Perhaps the next effective approach to immunisation in the
A. viscosus model would be the induction of antibodies to inhibit
colonisation of the organisms, which would presumably render
arguments about protective or damaging immune responses irrelevant.
It is in this respect that the recent work of Donkersloot et al
(1985), Clark et al (1984) and Clark (1985), which investigated
the role of fimbriae on the colonisation of tooth surfaces by
A. viscosus, may prove to be important.
The present work has demonstrated a tantalising association
between bone loss and specific IgA concentration, but has also
posed many additional questions to those it set out to answer.
Various possibilities for further studies are outlined below and
it is hoped that these, if implemented, might help to shed light
on some of these questions.
289.
10.2 POSSIBILITIES FOR FUTURE WORK
There are attractions in extending the work to see whether
similar results to those presented here could be obtained using
oral inoculations of other periodontopathic bacteria such as
Actinobacillus actinomycetemcomitans, Capnocytophaga species or
Bacteroides gingivalis in place of A. viscosus. Other
possibilities include increasing the number of mouse genotypes
subjected to the A. viscosus inoculation schedule, or adding to
the existing information by examining the effects of 10 cfu
A. viscosus inoculations in the genotypes already studied.
Perhaps the most interesting avenue to explore, however, would be
attempting to increase our understanding of what is happening in
the existing A. viscosus inoculation model in BALB/c mice.
Various possibilities come to mind:-
1. Try to correlate the histological picture with bone loss.
It would be valuable to perform weekly sacrifices and subsequent
serial sectioning of both uninoculated and 10^ cfu inoculated
BALB/c mice. This is currently in progress.
2. Attempt separation, isolation and purification of the A.
viscosus EDTA extract into its constituent fragments with the
intention of identifying the antigenic/mitogenic constituents.
This would be a cornerstone of all further immunological work.
Such specific agent(s) could then be added to lymphocyte cultures,
chemiluminescence assays and ELISA plates, thus increasing the
accuracy of such experimentation. Obtaining these fragment(s)
would be the result of a protracted period of specialised work,
which would require a great deal of detailed bacteriological
knowledge. It would therefore be logical to embark on a joint
venture in collaboration with a microbiologist.
3. Separate lymphocytes for the cell-mediated immunity studies
into the constituent B and T cell subsets. If they were
available, the antigenic/mitogenic A. viscosus standard
fragment(s) could be used in addition to the standard mitogens to
stimulate cultures of separated B and T cells.
4. Continue humoral immunity studies. The major area of
extension here would be to measure the salivary levels of anti-
A. viscosus antibody found in the different inoculation groups.
It is anticipated that this would be possible employing the ELISA
technique and the isolated standard A. viscosus antigenic/
mitogenic fragment(s). Should greater accuracy be required,
however, gel electrophoresis could be used.
5. Continue the PMN work using both MPO and chemiluminescence
assays for both uninoculated and 10^ cfu inoculated BALB/c
mice. In addition, the chemiluminescence assays could have either
whole A. viscosus organisms or the standard antigenic/mitogenic
fragment(s) thereof as stimulants.
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APPENDIX
All chemicals in this section were obtained from B.D.H. (Poole,
UK) unless stated otherwise.
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Acetate Buffer
5.75 ml glacial acetic acid
94.25 ml distilled water
Take 20 ml of this and add to 6 ml of 1 M NaOH.
Make this up to 100 ml with distilled water. pH = 4.2
Coating Buffer
1-59 g sodium carbonate
2.93 g sodium hydrogen carbonate
0.2 g sodium azide
Make up to 1 litre.
Cooked Meat Broth (CMB)
25 g basic nutrient broth (Oxoid Ltd, Basingstoke, UK)
1 litre distilled water
Add 10 ml to a 1 inch vial with j inch cooked meat.
Diet
(i) Normal diet
Oxoid mouse diet (Oxoid Ltd, Basingstoke, UK)
(ii) Special diet
40 g sucrose
15 g wheat flour
32 g skimmed milk
5 g brewers' yeast
2 g vitamin-mineral protein supplement
Formic Citrate
35 ml formic acid
65 ml 20% sodium citrate
Nitrate Test: Solution 1
0.5 g sulphanilic acid
30 ml glacial acetic acid
120 ml distilled water
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Nitrate Test: Solution 2
0.2 g 1,6 cleves acid
30 ml glacial acetic acid
120 ml distilled water
PBS Tween
8 g sodium chloride
0.2 g potassium dihydrogen orthophosphate
2.9 g disodium hydrogen orthophosphate dodecahydrate
0.2 g potassium chloride
0.5 ml Tween 20
Make up to 1 litre.
Phosphate Substrate Solution
1 phosphatase substrate tablet in 5 ml of diethanolamine.
(Sigma Chemical Co Ltd, Poole, UK)
Diethanolamine
97 ml diethanolamine
800 ml distilled water
0.2 g NaCo^
100 mg MgC^ 6H2O
1 M HCR - pH 9.8
Make up to 1 litre with distilled water.
Proteose Peptone Yeast Medium (PPY)
2 g proteose peptone (Oxoid Ltd, Basingstoke, UK)
1 g yeast extract (Difco Laboratories, East Molesey, UK)
0.5 g NaCl
100 ml distilled water
2 ml 3.75% cysteine hydrochloride
2 ml 2% Na2C03
2 ml haemin (250 ug/ml)




1. Sections to water.
2. Azure stain - 10 mins.
3. Directly into absolute alcohol to dehydrate.
4. Clear and mount.
1. Sections to water.
2. Mayer's haematoxylin - 3 mins.
3. Wash in water.
4. Saturated lithium carbonate - 1 min (to blue haematoxylin).
5. Wash in water.
6. 1% eosin in 1% calcium chloride - 3 mins.
7. Wash in water.
8. Dehydrate, clear and mount.
Van Gieson
1. Sections to water.
2. Celestin blue/haemalum - 5 mins each.
3. Wash well in water.
4. Van Gieson stain - 5 mins.
5. Rinse in distilled water.
6. Dehydrate, clear and mount.
Azure stain
0.1% in AzurA in 30% alchohol
H + E
Van Gieson stain
100 ml saturated.aqueous picric acid
5-10 ml 1% aqueous acid fuchsin
Standard solutions for gas liquid chromatography
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